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Voorwoord

Tijdens mijn promotietraject ben ik voortdurend in goed gezelschap 
geweest. Met goed gezelschap bedoel ik mensen met tegenwoordigheid 
van geest, uitstekend methodologisch inzicht en prettig in de omgang. 
De volgende mensen hebben in belangrijke mate bijgedragen aan de 
totstandkoming van dit proefschrift: Daniëlle van der Windt, Geert van 
der Heijden, Lex Bouter, Joan Boeke, Maurits van Tulder, Jos Twisk, 
Yvonne Vergouwe, Gert Bergman, Jacques Geraets, Camiel de Bruijn, en 
Marjan Uittenbosch. 
Met stip op één staat Daniëlle, mijn co-promotor en dagelijkse begeleider, 
door wie mijn promotie een prettige, kalme en ontspannen tijd is 
geworden. Daan, je begon vriendelijk door me 3 maanden later te laten 
beginnen dan gepland en me de kans te geven door een deel van Azië te 
trekken. Dat was pas het begin. Je groeide door naar aardig toen ik ook 
nog eens een ﬂinke reis naar Nieuw-Zeeland kon maken. Je piekte toen 
ik eind 2003 zonder problemen 2 maanden naar Midden-Amerika kon. 
Hier ben ik je erg dankbaar voor. Je gebrek aan methodologisch inzicht, 
(Engelse) schrijfvaardigheid, organisatorisch talent en toegankelijkheid 
zou hier ruimschoots mee gecompenseerd kunnen worden. Van een 
gebrek is echter geen sprake. In tegendeel zelfs! De combinatie van deze 
eigenschappen maakt je een begeleider die iedereen zich wenst en waar 
menigeen jaloers op is. Voor alles wat ik van je geleerd heb, dat je me mijn 
gang hebt laten gaan en me niet te veel achter mijn broek hebt aangezeten: 
Bedankt!
Geert, co-promotor op afstand. Eerst in Maastricht later in Utrecht. In 
het bezit van een uitmuntend methodologisch inzicht en het vermogen 
methodologische valkuilen te signaleren waarvan anderen nog geen ﬂauw 
idee hebben. Altijd bereid mee te denken, bijvoorbeeld over nieuwe banen! 
Bedankt voor de vruchtbare samenwerking. 
Lex, promotor. In het bezit van bovenmenselijke methodologische en 
didactische kwaliteiten. Ik heb genoten van jouw ‘Lexiaans’: heldere, klare, 
sturende taal met een vleugje ironie. 
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Joan, je beloofde 25 patiënten en het werden er 47, briljant! Jos, garantie 
voor een solide statistische basis van dit proefschrift! Helderheid boven 
alles. Maurits, met jou samenwerken is erg relaxed en de kostenstudie was 
inderdaad een appeltje-eitje. Yvonne, dank voor het wijzen van de weg 
in de wereld van predictieregels. Ik heb enorm veel van je geleerd! Gert, 
Jacques en Camiel, dank voor het plezier, de erg prettige samenwerking en 
het verzamelen van de data in de Groningse en Maastrichtse takken van 
het onderzoek. Marjan, door jouw kordate en doelgerichte optreden werd 
de Amsterdamse dataverzameling een ongekend succes!
Het was een eer met jullie te mogen samenwerken en dankzij jullie ligt er 
een helder en samenhangend proefschrift.
Ton Kuijpers
Amsterdam, 27 juni 2005
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Introduction

Definition
In this thesis shoulder pain is deﬁned according to the 1999 version of the 
Dutch guidelines for shoulder complaints, issued by the Dutch College 
of General Practitioners.1;2 Shoulder pain is characterised as pain in the 
deltoid and upper arm region, as illustrated in Figure 1. Pain and stiﬀness 
are the prominent complaints. Pain and stiﬀness restrict the use of the arm 
and therefore limit daily activities, especially when using the hands above 
shoulder level. Lying on the aﬀected shoulder is painful, which means that 
severe shoulder pain can cause problems with sleeping. Shoulder pain is 
associated with increased sick leave and incapability of performing daily 
activities.3
Prevalence / incidence
Shoulder pain is common with a one year prevalence ranging between 5% 
and 47%.3-7 The prevalence in the general population in The Netherlands 
has recently been estimated at 17%.8 The annual incidence of consultation 
for a new episode of shoulder pain in Dutch general practice ranges 
between 12 and 25/1000/year.5;8-10 
Course and prognosis 
Shoulder pain has an unfavourable outcome in many patients. Only 
about 50% of all new episodes of shoulder pain presented in primary care 
show complete recovery within 6 months11-13, after 1 year this proportion 
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Figure 1  Location of shoulder pain
increases to only 60%.12 In a narrative review Van der Heijden (1999) 
concluded that evidence for all reported prognostic factors was weak, and 
that most studies appeared to be of relatively poor methodological quality. 
Little was known about the prognostic value of psychosocial factors.3 
The Dutch Shoulder Study
The 2nd edition of the Dutch guidelines for shoulder pain, issued by 
the Dutch College of General Practitioners1;2, was published in 1999. 
Regarding several topics there was lack of evidence to provide clinicians 
with evidence based recommendations. Information about the predictive 
value of potential prognostic factors, above all occupational and 
psychosocial factors, was lacking. There was insuﬃcient evidence for 
several interventions such as manual therapy, (graded) exercise therapy, and 
cognitive behavioural interventions. Besides, there was hardly any evidence 
on the costs associated with shoulder pain. This lack of information 
resulted in the development of a large research program seeking valid and 
applicable evidence on shoulder pain in primary care: The Dutch Shoulder 
Study (DSS).14
The DSS is a comprehensive cohort study, carried out between January 
2000 and May 2005. The DSS consists of a prognostic cohort study 
(presented in this thesis) and three randomised controlled trials, which 
were carried out alongside each other. Between January 2001 and June 
2003, 103 general practitioners (GP) recruited patients at ﬁrst consultation 
for a new episode of shoulder complaints in three geographic areas in the 
Netherlands (Amsterdam, Groningen and Maastricht). All patients in the 
DSS had to meet the same general inclusion criteria, and speciﬁc additional 
inclusion criteria if eligible for a trial. Patients not eligible for a trial were 
invited for participation in the prognostic cohort study. The Groningen 
Manipulation Study (GMO)15;16 studies the eﬀectiveness of manipulative 
therapy for the shoulder girdle in addition to usual GP care. In two other 
trials a Graded Exercise Therapy (GET)17 and an Education and Activation 
Program (EAP)18 were studied. Baseline and follow-up assessments for all 
patients in the core dataset of the DSS were identical. 
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Clinical prediction rules
Knowing more about the prognostic value of clinical, psychosocial, and 
occupational factors in patients with shoulder pain will help to provide 
patients with adequate information regarding their risk of persistent 
symptoms on the short term (6 weeks) and long term (6 months). Such 
information may also support decisions regarding treatment and referral 
of patients. In our cohort study we developed clinical prediction rules to 
provide physicians with easy-to-use tools for calculating an individual’s 
risk of persistent shoulder symptoms or shoulder pain related sick leave on 
the short term and long term.
Objectives
The objectives of this thesis originate from discussions in the editorial 
committee of the 2nd edition of the Dutch guidelines for shoulder pain of 
the Dutch College of General Practitioners.1;2 The overall aim of this thesis 
was to provide the GP and patients with better information on the course 
and prognosis of shoulder pain. The objectives were:
1. To systematically review the available literature regarding prognostic 
factors in patients with shoulder pain. 
2. To determine the costs of shoulder pain during 6 months following 
ﬁrst consultation in general practice. 
3. To develop clinical prediction rules for calculating the risk of persistent 
shoulder symptoms for individual patients, at 6 weeks and 6 months 
after ﬁrst consultation in general practice.
4. To develop a clinical prediction rule for calculating the risk of shoulder 
pain related sick leave for individual workers, during 6 months 
following ﬁrst consultation in general practice. 
5. To evaluate the generalisability of the prediction rules to other 
populations of patients with a new episode of shoulder pain consulting 
their general practitioner. 
6. To study the eﬀect of psychological factors on the risk of a poor 
outcome in patients consulting a general practitioner for a new 
episode of shoulder pain.
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Outline of this thesis
Chapter 2 describes the results of a systematic review in which the available 
evidence from 16 studies regarding predictors of outcome of shoulder 
disorders is summarized.19 In chapter 3 we summarize the costs associated 
with shoulder pain in the 6 months following ﬁrst consultation in primary 
care. We present direct health care costs as well as indirect costs related 
to loss of productivity. In chapter 4 we present the design and results of 
our prognostic cohort study among patients with shoulder pain in general 
practice. We describe the development of  prediction rules for calculating 
the risk of persistent shoulder symptoms for individual patients, at 6 weeks 
and 6 months after ﬁrst consultation in general practice. In chapter 5 the 
generalisability of these prediction rules is tested within the framework of 
the DSS. The prediction rules derived from the prognostic cohort study, 
are tested on the merged control groups of the three trials embedded 
in the DSS. In chapter 6 we describe the development of a prediction 
rule for shoulder pain related sick leave in the 6 months following ﬁrst 
consultation in general practice. For this study we selected those patients 
from the cohort who reported paid work at enrolment. Chapter 7 describes 
the generalisability of the prediction rule for shoulder pain related sick 
leave. Again, the merged control groups of the embedded trials within the 
frame work of the DSS were used as a validation cohort. Furthermore, the 
generalisability of the prediction rule for sick leave was tested in another 
cohort of patients with shoulder pain, in which largely similar data were 
collected.20 Chapter 8 compares the eﬀects of psychological factors on the 
risk of a poor outcome in patients consulting a general practitioner for a 
new episode of shoulder pain or low back pain. This study was carried out 
to investigate whether similar mechanisms play a role in the transition 
from acute to chronic pain in patients with diﬀerent types of pain. 
Finally, in chapter 9 the results of this thesis are critically reviewed, and 
recommendations for future research are given. 
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Systematic review of prognostic cohort 
studies on shoulder disorders
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Background  Shoulder complaints are common and have an unfavourable 
outcome in many patients. Only 50% of all new episodes of shoulder 
disorders end in complete recovery within 6 months. There is no consensus 
about prognostic indicators that can identify patients at high and low risk 
of chronicity. 
Methods  By a systematic search of the literature we identiﬁed 16 studies 
focusing on the prognosis of shoulder disorders. 
Results  The methodological quality of these 16 studies was assessed. Six 
of these were considered to be of relatively ‘high quality’. There was a 
wide variety among the studies in length of follow-up, study population, 
evaluated prognostic factors, type of outcome measure and method of 
analysis. Due to this large heterogeneity, we refrained from statistical 
pooling. Instead, we used a best-evidence synthesis. There is strong 
evidence that high pain intensity predicts a poorer outcome in primary 
care populations and that middle age (45-54) is associated with poor 
outcome in occupational populations. There is moderate evidence that a 
long duration of complaints, and high disability score at baseline predict a 
poorer outcome in primary care. 
These results need to be interpreted with caution because of the small 
number of studies on which these conclusions are based, and the large 
heterogeneity among studies regarding follow-up, outcome measures, and 
analysis. 
ABSTRACT
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Introduction
Shoulder disorders are common. The one year prevalence in various 
studies ranges between 5% and 47%.1;2 The point prevalence in the general 
population in The Netherlands has recently been estimated at 21%.3 In a 
British study a lower point prevalence of 14% has been found.4 The annual 
incidence of shoulder disorders in Dutch general practice ranges between 
12 and 25/1000/year.5;6 
Shoulder complaints have an unfavourable outcome in many patients. 
Only about 50% of all new episodes of shoulder complaints presented in 
primary care show complete recovery within 6 months7-9, after 1 year this 
proportion increases to only 60%.9
Van der Heijden reviewed the literature on prognostic indicators of a 
favourable outcome within 3 months, in a narrative way. Evidence for all 
reported factors was weak, and most studies appeared to be of relatively 
poor methodological quality. Little is known about the prognostic value 
of psychosocial factors. It is suggested that psychosocial factors such as 
inadequate pain cognitions and pain behaviour, are likely to predict a poor 
outcome of painful musculoskeletal conditions.2 
It is of importance for clinical practice to know more about the prognostic 
value of clinical, psychosocial, and occupational factors in patients 
with shoulder disorders. It may help to provide patients with adequate 
information regarding the most likely course of their symptoms. Health 
care providers need prognostic information to distinguish between patients 
with a favourable outcome and those with a high risk of chronic shoulder 
pain and disability. This may facilitate decisions regarding treatment and 
referral of patients. However, no attempts have been made to conduct a 
systematic search of the literature and to summarise the available evidence 
regarding prognostic factors of shoulder disorders.
Methods
Identiﬁcation and selection of the literature
We conducted a systematic, computerised search of the literature based on 
recommendations by Haynes et al.10 in Medline (1966 through February 
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2003), Embase (1991 through February 2003), Cinahl (1982 through 
February 2003), Psychinfo (1967 through February 2003), Sportdiscus 
(1949 through February 2003). The following key words and medical 
subject headings were used: shoulder, shoulder pain, shoulder joint, 
shoulder injuries, shoulder impingement syndrome, prognos*(truncated), 
predict*(truncated), course, clinical study, longitudinal study, prospective 
study and retrospective study. The citations we found were screened by two 
reviewers independently (TK and DW). The reference lists of all selected 
publications were checked to retrieve relevant publications which had not 
been found with the computerised search. The publications had to meet 
the following selection criteria:
· the study focussed on patients suﬀering from shoulder complaints
· the association (ORs or RRs, with corresponding p-value or 95% CI) 
of at least one prognostic factor with the outcome of shoulder pain 
had to be presented
· the design had to be a cohort study 
· the article was published in English
· results were published as a full report before February 2003
· studies that focussed on shoulder pain due to luxation, cancer or 
systemic diseases such as rheumatoid arthritis or osteoporosis were 
excluded. Also studies that focussed on the results of surgery were 
excluded.
Quality assessment
The methodological quality of each of the studies was assessed 
independently by three reviewers (TK, DW, and GH). A standardised 
checklist of predeﬁned criteria was used, which is a modiﬁed version of the 
checklists by Scholten et al.11, Borghouts et al.12, and Hudak et al.13, and is 
based on theoretical considerations and methodological aspects described 
by Altman14 and Hudak et al.13 (Table 1). Disagreements among the 
reviewers were discussed during a consensus meeting. In case of persisting 
disagreement between 2 reviewers it was the third that made the ﬁnal 
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decision. The checklist covers aspects of internal validity (criteria A, D, E, 
F, G, H, I, J, K, L, M, P, Q), generalisability (criteria B, C, N, O)  and 
precision (criterion R), which are all of great importance in descriptive 
epidemiological studies14. The list contains 7 categories: study population, 
response rate, follow-up, treatment, outcome, prognostic factors and data 
presentation. The list contains 18 criteria which can be scored positive 
(‘+’), negative (‘-‘) or ‘unclear (‘?’). If an item is scored as ‘unclear’ it means 
that the paper provides insuﬃcient information about this criterion. A 
positive score indicates suﬃcient information and a positive assessment. 
A negative score indicates suﬃcient information, but potential bias due 
to inadequate design or conduct. A negative score can only be assigned 
to criteria of internal validity. Exceptions are criteria N, O and R, because 
an ‘unclear’ did not make sense here. A more detailed explanation of each 
criterion is given in the Appendix.
The maximum attainable score on the criteria list is 18 points. The total 
score is the sum of all  the criteria which are scored positive, negative scores 
are not subtracted. A priori, we chose to  consider a study of ‘high quality’ 
when it scores more than 10 points (>60% of the maximum attainable 
score) and of ‘low quality’ when it scores ≤10 points. Sensitivity analyses 
were conducted to assess the robustness of this cut-oﬀ point, that is, 
whether this change will lead to diﬀerent conclusions.
Data extraction
Data were extracted of the selected studies regarding study population, 
design, setting, outcome measures, prognostic factors and strength of 
association. To facilitate interpretation and comparison of the results 
the studies are categorised per setting (primary care, secondary care and 
occupational setting). When not given, and suﬃcient data were available, 
for each study the univariate association was calculated between prognostic 
factors and outcome in terms of Risks Ratios (RR) or Odds Ratios (OR) 
with 95% conﬁdence intervals (CI). Univariate, or if available multivariate 
associations were presented in tables.
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 Table 1  Criteria list for assessing the methodological quality of prognostic cohort studies on shoulder pain
Criteria Score
Study population
A. Inception cohort (deﬁned in relationship to onset of symptoms) + /  -  /  ?
B. Description of inclusion and exclusion criteria + /  ?
C. Description of studypopulation + /  ?  
Response
D. Response ≥ 75% + /  -  /  ?
E. Information about non-responders versus responders + /  -  /  ?
Follow-up (extent and length)
F. Prospective data collection + /  -  /  ?
G. Follow-up of at least 6 months + /  -  /  ?
H. Drop-outs/loss to follow-up < 20% + /  -  /  ?
I. Information completers versus loss to follow-up/drop-outs + /  -  /  ?
Treatment
J. Treatment in cohort is fully described/standardised + /  -  /  ?
Outcome
K. Standardised assessment of relevant outcome criteria + /  ? 
Prognostic factors
L. Standardised assessment of patient characteristics and potential 
clinical prognostic factor(s)  
+ /  ? 
M. Standardised assessment of potential psychosocial prognostic factor(s) + /  ?
Data presentation
N. Frequencies of most important outcome measures + /  - 
O. Frequencies of most important prognostic factors + /  -  
P. Appropriate analysis techniques + /  -  /  ?
Q. Prognostic model is presented + /  -  /  ?
R. Suﬃcient numbers + /  -  
+, positive (suﬃcient information and a positive assessment); - (suﬃcient information, but potential bias due to inadequate design 
or conduct); ?, unclear (insuﬃcient information)
Analysis
Depending on homogeneity in study population, type of prognostic 
factors, outcome measures, and study quality, statistical pooling was 
considered. When a pooled estimate could not be computed, a qualitative 
analysis (best evidence synthesis) was performed to summarize the value 
of the prognostic indicators. In this analysis the available evidence for a 
prognostic factor was summarised by taking into account the number of 
studies evaluating this factor, the methodological quality of these studies, 
and the consistency of the available evidence. We present prognostic factors 
which showed in at least one study a RR or OR above 2.0 or below 0.5, or 
a statistically signiﬁcant (p<0.05) association. We did not want to depend 
solely on statistical signiﬁcance, as many cohorts included in the review 
were rather small, and relevant associations between prognostic factors 
and outcomes may have remained undetected. Findings were considered 
consistent if  ≥75% of the studies which reported a factor showed the same 
direction of the association. In Table 2 we deﬁned four levels of evidence 
which are based on Sackett et al.15 and Ariëns et al.16 (Table 2). 
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Table 2  Levels of evidence for prognostic factors on shoulder disorders
Level of evidence
Strong Consistent ﬁndings (≥75%) in at least 2 high quality cohorts
Moderate Consistent ﬁndings (≥75%) in one high quality cohort and at least one low 
quality cohort
Weak Findings of one high quality cohort or consistent ﬁndings (≥75%) 
in at least 3 or more low quality cohorts
Inconclusive Inconsistent ﬁndings irrespective of study quality, 
or less than 3 low quality cohorts available
No evidence No data presented
Results
Selection of studies
We found 1273 citations (468 Pubmed, 507 Embase, 211 Cinahl, 54 
Psychinfo, 33 Sportdiscus). Out of this number 48 abstracts seemed to 
fulﬁl the selection criteria and the full publications of these were retrieved. 
When assessing the full publications some turned out to focus on rotator 
cuﬀ tears (n=2), some papers aimed at aetiology instead of prognosis 
(n=4), some dealt with treatment (n=7), and some with diagnoses (n=1). 
Not presenting a separate analysis for shoulder disorders (n=18) was a 
major reason for excluding papers. Finally, 16 papers were included and 
the methodological score was assessed.
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Methodological quality
The results of the quality assessment are presented in Table 3. The overall 
quality score ranged from 4 to 15 points, with a median score of 10 points. 
Using our cut-oﬀ point of >10 points, six studies were classiﬁed as high 
quality studies. The items of the criteria list which most often (>8 of the 
16 publications) obtained a negative score were ‘Inception cohort’ (item 
A),  ‘Adequate response rate’ (item D), ‘Information about responder/
non-responders’ (item E), ‘Follow-up >6 months’ (item H), ‘Adequate 
information about loss to follow-up’ (item I), ‘Treatment described/
standardised’ (item J), ‘Assessment of psychosocial factors’ (item M) and 
‘Prognostic model presented’ (item Q). Only 2 studies17;18 presented 
information about response-rate and information about characteristics 
of responders versus non-responders in order to evaluate whether the 
response was selective or not. Only 5 studies19-23 presented information 
regarding treatment and whether it was standardized. Seven studies9;17-19;24-
26 used adequate methods to compose a multivariable prognostic model. 
The studies23;27-29 with a method score in the lowest tertile of the scale 
(≤33%) all suﬀered from inadequate data presentation (item N, O, P, Q, 
R).
Study characteristics
Table 4 (see end of chapter) summarises the study characteristics of the 
publications including study population, outcome measures, follow-up, 
prognostic factors and the strength of the association with their 95% 
conﬁdence interval. Four studies were conducted in a primary care setting, 
another 4 in an occupational setting and 8 in a hospital setting. Most 
frequently reported prognostic factors were pain, duration of complaints, 
age and gender. A few studies17;19;24 assessed the value of psychosocial 
predictors. There was considerable variation among the studies with respect 
to the length of follow-up  (range 2 months to 7 years), type of outcome 
measure (pain, disability, recovery, sick leave, ROM, diﬀerent shoulder 
questionnaires) and method of analysis (univariable vs. multivariable). 
Hence, we considered statistical pooling to be not sensible, and therefore 
used a best-evidence synthesis to summarize the importance of prognostic 
factors (Table 2). 
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Table 5  Overall level of evidence for prognostic factors and their association with (long term) poorer outcome
Prognostic factor Outcome QS>60% QS≤60%
Level of  
evidence
Primary care
Sick leave at baseline
Regular medication
Concomitant neck pain
High pain intensity
No precipitating trauma
No acute bursitis
Long duration of complaints
High disability score
Previous episodes of pain
Severe restricted passive elevation 
(<101°)
Neer-score
Neer-score
Symptoms
Symptoms
Symptoms
Symptoms
Disability, pain 
Pain
Pain
Disability
1/1 (100%) 
1/1 (100%) 
1/1 (100%) 
2/2 (100%) 
1/1 (100%) 
1/1 (100%) 
1/1 (100%) 
1/1 (100%) 
-
-
-
-
-
-
-
-
1/1 (100%) 
1/1 (100%) 
1/1 (100%) 
1/1 (100%) 
Weak
Weak
Weak
Strong
Weak
Weak
Moderate
Moderate
Inconclusive
Inconclusive
Occupational setting
Middle aged 
Previous musculoskeletal disorders
High job demand
Overload at work
No sporting activities
Worker group
 (blue vs. white color)
Sick leave 
(preceding examination)
Duration of symptoms 
(0-2 vs. >7 days)
Continuous high intensity pain 
Rotation of head (pain)
Abduction of arm (pain)
Symptoms
Symptoms
Symptoms
Symptoms
Symptoms
Sick leave
Sick leave
Sick leave
Sick leave
Sick leave
Sick leave
2/2 (100%)*
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/2 (50%)
-
-
-
-
-
-
-
-
-
-
0/1 (0%) 
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
Strong 
Weak
Weak
Weak
Inconclusive
Inconclusive 
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
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Levels of evidence
In Table 5 we only present those prognostic factors which in at least 1 
study showed RR or OR above 2.0 or below 0.5 or a statistically signiﬁcant 
(p<0.05) association. Most factors were only measured in one study, and 
consequently their prognostic value remains uncertain. There is, however, 
strong evidence that high pain intensity predicts a poorer outcome9;25 in 
primary care populations and that middle age (45-54)17;24 is associated 
with poor outcome in occupational populations (Table 5). In addition, 
there is moderate evidence that a long duration of complaints, and high 
disability score at baseline predict a poorer outcome in primary care (Table 
5). Factors with RR or OR between 0.5 and 2.0 or a not statistically 
signiﬁcant association were, for example, years of education, repetitive 
work, precipitating trauma and instability of the glenohumeral joint 
(Table 4).
Psychosocial factors
There are a few studies17;19;24;28;31 which considered psychosocial factors 
(locus of  control, emotional distress, job demand, job control, mental 
stress). None of these studies showed RR or OR above 2.0 or below 0.5 or 
a statistically signiﬁcant (p<0.05) association. 
Discussion
The present paper is the ﬁrst systematic review of the current literature on 
potential prognostic indicators of shoulder disorders. Van der Heijden2 
conducted a narrative review of the literature, and found the following 
prognostic indicators of a favourable outcome within 3 months: mild 
trauma preceding symptoms, early presentation, preceding overuse and 
heavy and unusual activities of the upper extremity, an acute onset, a 
high erythrocyte sedimentation rate, and restricted prescription and use 
of medication. Factors that were reported to predict a poor outcome at 
3 months were severe pain at ﬁrst presentation, a prior episode, a severe 
Table 5 Continued
Prognostic factor Outcome QS>60% QS≤60%
Level of  
evidence
Secondary care
Gradual onset
Long duration of complaints
Dominant side involved
Type acromion (type II or III)
Tenderness acromion
Severe functional impairment 
Weakness
Moderate or large tear
Manual work
Referral to specialist
Worse baseline pain
Worse baseline function
More education (per year)
More education (per year)
Osteoarthritis
Continuing overhead sports
Age
UCLA-score
UCLA-score
ROM
UCLA-score
UCLA-score
UCLA-score
UCLA-score
UCLA-score 
ROM
Pain
Pain
Function
Pain
Function
Pain
Symptoms
Symptoms#
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1/3 (33%)$ 
1/4 (25%)$
1/4 (25%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/3 (0%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/1/ 
(100%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/1 (100%)
1/6 (100%)
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Inconclusive
Only factors are presented which scored clinically relevant associations  (RRs, ORs >2.0 or <0.5 or signiﬁcant associations, p<0.05) 
in at least one study. QS, quality score; UCLA, Shoulder-Rating scale of the University of California at Los Angeles; ROM, range of 
motion; RR, relative risk; OR, odds ratio; * in 1 study24 only signiﬁcant for women; #2 studies reported age on ROM, n.s; $outcome 
is ROM
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restriction of the passive abduction range, diabetes mellitus, concomitant 
neck pain, cervical spondylosis and radicular symptoms, higher age, 
involvement of the dominant side and sick-leave from work. Evidence 
for each of these factors was weak, and most studies appeared to be of 
relatively poor methodological quality.
In our systematic review we found disappointingly little evidence for 
most factors which in current literature are suggested to be of prognostic 
importance. Caution is needed with the interpretation of the results 
of our analysis, because the majority of studies suﬀer from many ﬂaws 
in the design and conduct. Yet, there is consistent evidence that high 
pain intensity in primary care populations and middle age (45-54) in 
occupational populations are strong predictors for a poor prognosis, 
while there is some evidence that long duration of complaints and high 
disability score at baseline are predictors for a poor prognosis in primary 
care populations. There were no studies of suﬃcient quality of methods in 
secondary care. To date, there is no evidence for the prognostic importance 
of psychosocial factors. 
Only 16 studies met our inclusion criteria, of which 6 were of high quality 
of methods. Besides the overall lack of quality of methods there was 
considerable heterogeneity regarding design, study populations, prognostic 
factors and outcome measures. This heterogeneity impedes meta-analysis. 
Therefore we decided to perform a best evidence synthesis of the available 
evidence. 
Limitations
We restricted our search to full papers published in English. However, the 
inﬂuence of language bias is disputed, and its eﬀect has not been ﬁrmly 
established.32-34 We searched in electronic databases that are considered to 
be important and relevant for the topic of our review. Yet, we may have 
missed studies which are not included in these databases and which were 
not identiﬁed during our additional reference checking, for instance non-
journal publications or unpublished cohort studies. The addition of non-
journal publications has been shown to move the eﬀect estimates towards 
a null result.35;36 Given the fact that our review could not demonstrate 
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strong evidence for many relevant prognostic factors, we do not believe 
that inclusion of unpublished material or non-journal publications would 
strongly inﬂuence our conclusions regarding prognostic factors in shoulder 
pain.
Levels of evidence
Any system for deﬁning levels of evidence is arbitrary. We chose a system 
that has been used in a systematic review on prognostic factors for 
whiplash related disorders.11 We believe to have used a robust cut-oﬀ point 
to identify studies of high quality of methods, although any cut-oﬀ point 
is arbitrary. With a cut-oﬀ point of 50% (instead of 60%) there is also 
weak evidence for the prognostic importance of sick leave, duration of 
symptoms, continuous high pain intensity, rotation of head and abduction 
of arm in the  occupational setting, and for acromion type III, tenderness 
acromion, severe functional impairment, weakness, moderate or large tear 
change in the hospital setting. In contrast, with a cut oﬀ  point of 70% 
there is less strong evidence for the prognostic importance of middle age 
(45-54) in occupational setting, while there is no evidence left for overload 
at work.
Outcome assessment
As can be seen in Table 4 there is wide variation in the use of outcome 
measures between studies. Although most studies used a standardised 
assessment for at least one outcome measure, outcome measures used 
diﬀered from a validated questionnaire to percentages patients reporting 
recovery or persistent pain. Only few studies9;18 reported results for both 
within and after 6 months follow-up. This variation between studies makes 
it very diﬃcult to pool results or to draw consistent and ﬁrm conclusions 
regarding the predictive value of any prognostic factor.
Psychosocial factors
It is suggested that there is a relationship between psychosocial factors 
such as depression, catastrophizing and kinesiophobia, and the persistence 
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or recurrence of chronic musculoskeletal pain.2;37;38 For shoulder pain the 
importance of these factors, and their putative mechanism are not clear. 
Perhaps partly the same mechanism plays a role. There is a need for sound 
research regarding the prognostic importance of these psychosocial factors 
in patients with shoulder disorders.
Recommendations
Systematically reviewing prognostic studies is still in development and 
no validated or widely used criteria list is available. But this review 
unmistakably shows the need for well-conducted prospective cohort studies 
on putative prognostic factors of shoulder disorders. Moreover, because of 
the few small studies on which our conclusions are based, and the high 
heterogeneity among studies regarding follow-up, outcome measures, and 
analysis, we feel that the results of this review need to be interpreted with 
considerable caution. 
In our opinion an appropriate prospective cohort study should fulﬁl all 
the criteria of our  checklist (Table 1). Such future studies should focus 
on the predictive value of socio-demographic and clinical factors, but in 
particular on psychosocial factors, notably distress, fear and avoidance, 
kinesiophobia, coping-styles and job demand and control for shoulder 
disorders. New evidence on these putative prognostic predictors will 
enable better decisions on the choice of interventions. Outcomes estimates 
preferably are to be expressed as absolute risks, instead of RRs or ORs. A 
multivariable prognostic analysis may help to generate a prognostic index 
for diﬀerentiation between patients at high and low risk of persistent 
shoulder complaints. Such index needs to be validated both internally, i.e. 
with a split sample technique in the same population and externally, i.e. 
tested on another population.39 Such an index should allow care providers 
easily to predict the likelihood of recovery in, for example, 6 months for 
any patient. 
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Appendix  Explanation of the criteria from Table 1
A. Positive if patients were identiﬁed at an early uniform point (inception cohort) in the course of their 
disease (ﬁrst episode -with restriction to duration of symptoms- of shoulder pain in lifetime or ﬁrst 
treated episode of shoulder pain).
B. Positive if criteria were formulated for at least: age, duration of symptoms, relevant co-morbity (i.e 
cervical radiculopathy, luxation)/systemic diseases.
C. Positive if was described in what setting the patients were recruited (i.e. general practice, hospital, 
occupational setting).
D. Positive if the response rate was ≥75%.
E. Positive if information was presented about patient/disease characteristics of responders and non-
responders or if there was no selective response.
F. Positive if a prospective design was used, also positive in case of an historical cohort in which the 
determinants had been measured before outcome was determined. 
G. Positive if the follow-up period was at least 6 months.
H. Positive if the total number of participants was ≥75% on the last moment of follow-up compared to 
the number of participants at baseline.
I. Positive if demographic/clinical information (patient/disease characteristics such as age, sex and other 
potential prognostic predictors) was presented for completers and those lost to follow-up/drop-outs 
at the main moment of outcome measurement, or no selective drop-outs/lost to follow up, or no 
drop-outs/lost to follow-up. 
J. Positive if treatment subsequent to inclusion in cohort is fully described or standardised. Also positive 
in case of no treatment given. 
K. Positive if standardised questionnaires or objective outcome measurements of at least 1 of the 
following 5 outcome measures were used for each follow-up measurement: pain, general improvement, 
functional status, general health status or lost days of work. 
L. Positive if standardised questionnaires or objective measurements were used at baseline for at least 4 of 
the following 8 potential prognostic factors: age, sex, pain, functional status, duration of complaints, 
neck complaints, physical workload, or dominant shoulder aﬀected.
M. Positive if standardised questionnaires or objective measurements were used at baseline of at least 1 
of the following 6 potential prognostic factors: depression, somatisation, distress, fear & avoidance, 
coping strategies, or psychosocial work-related factors (social support, psychological demands, and 
job decision latitude).
N. Positive if frequency, percentage or mean, median (Inter Quartile Range) and standard deviation/CI 
(conﬁdence interval) were reported for the most important outcome measures.
O. Positive if frequency, percentage or mean, median (Inter Quartile Range) and standard deviation/CI 
were reported for the most important prognostic factors. 
P. Positive if univariate crude estimates were provided for the association of a prognostic factor with 
outcome.
Q. Attempt is made to determine a set of prognostic factors with the highest prognostic value. 
R. Positive if the number of cases in the multivariate analysis was at least ten times the number of 
independent variables in the analysis40
42
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Costs of shoulder pain in primary care

Background  Shoulder pain is common in primary care, and has an 
unfavourable outcome in many patients. Information on the costs 
associated with health care use and loss of productivity in patients with 
shoulder pain is very scarce.
Objective  To determine shoulder pain related costs during the 6 months 
after ﬁrst consultation in general practice. 
Methods  A prospective cohort study with 6 months of follow-up was 
conducted among 587 patients with a new episode of shoulder pain. Data 
on costs were collected by means of a cost diary during 6 months. 
Results  84% of the patients completed all cost diaries. The mean 
consumption of direct health and non-health related care was low. During 
6 months after ﬁrst consultation for shoulder pain, the mean total costs 
a patient generated were € 689. Almost 50% of this concerned indirect 
costs, caused by sick leave from paid work. A small proportion (12%) of 
the population generated 74% of the total costs. 
Conclusions  The total costs in the 6 months after ﬁrst consultation in 
primary care, mostly generated by a small part of the population, are not 
alarming. However, after 6 months 46% of the patients still reported 
persistent symptoms. More extensive research with a longer follow-up is 
needed. It is important to include patients with fractures, dislocation, or 
previous surgery to accurately estimate the total costs of illness for patients 
consulting with shoulder pain in primary care. These patients were not 
included in our inception cohort, but possibly generate substantial costs.
 
ABSTRACT
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Introduction
Shoulder pain is common with a one-year prevalence ranging between 
5% and 47%.1-5 The point prevalence in the general population in The 
Netherlands has recently been estimated at 21%6, while a British study 
reported 14%.7 The annual incidence of shoulder pain in Dutch general 
practice ranges between 12 and 25/1000/year.8;9  Shoulder pain has an 
unfavourable outcome in many patients. About 40 to 50% of all patients 
who present with a new episode of shoulder pain in primary care report 
persistent symptoms after 6 to 12 months.10-12 
Musculoskeletal disorders are the second most expensive disease group 
for health care costs in the Netherlands, and represent 6% of the total 
healthcare costs.13 Information on the costs associated with health care 
use and loss of productivity in patients with shoulder pain is very scarce, 
especially for the large majority of patients who are treated in primary 
health care.
We performed a cohort study among patients who presented shoulder 
pain to their general practitioner, and followed them for 6 months. 
Our objective was to determine the shoulder pain related costs during 
the 6 months following ﬁrst consultation for their complaints in general 
practice. 
Methods
Recruitment
Between January 2001 and June 2003, 103 general practitioners (GPs) 
recruited patients at ﬁrst consultation for a new episode of shoulder 
complaints in three geographic areas in the Netherlands (Amsterdam, 
Groningen and Maastricht). Patients were selected if they were older 
than 18 years of age, and had not consulted their GP or received any 
form of treatment for the aﬄicted shoulder in the preceding three 
months. Suﬃcient knowledge of the Dutch language was required to 
complete written questionnaires. Exclusion criteria were severe physical 
or psychological conditions (i.e. fractures or dislocation in the shoulder 
region; rheumatic disease; neoplasm; neurological or vascular disorders; 
dementia).
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Management of shoulder pain
The participating GPs were educated and trained to apply treatment 
according to the 1999 version of the Dutch guidelines for shoulder 
disorders issued by the Dutch College of General Practitioners.14;15 The 
guidelines recommend giving information on the prognosis of shoulder 
pain, advice regarding provoking activities, and stepwise treatment 
consisting of paracetamol, Non-Steroidal Anti-Inﬂammatory Drugs 
(NSAIDs), corticosteroid injection or referral to physiotherapy. The 
participating GPs made the decision regarding the content of treatment 
based on duration and severity of pain and disability. 
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Table 1  Cost used in the economic evaluation
Costs €
Direct health care costs
General practitioner (max 10 min)
Manual therapist (max 20 min)
Other therapists (max 30 min)
(physiotherapist, ‘Mensendieck’, ‘Cesar’ and occupational therapist)
Specialists
(orthopaedist, neurologist, rheumatologist, and physician for rehabilitation medicine)
Hospitalisation (per day)
18.97
19.65
19.65
44.21
337.00
Direct non-health care costs
Alternative therapists  
(acupuncturist, homeopath, chiropractor, and others)
Home care
Paid help at home
Help from partner/relatives/friends
Extra activities (i.e. swimming, ﬁtness, gymnastics)
As indicated 
by patient
8.60
8.60
8.60
8.60
Indirect costs
Sick leave from paid work
Sick leave from unpaid work
Unable to perform usual activities
Unable to perform hobbies
FCM
8.60
8.60
8.60
€: Euro’s (€1= 1.30 US Dollars, 02/02/2005); FCM: friction cost method
Costs
Cost data were collected from a societal perspective, using a cost diary 
that has been shown to be valid and feasible for patient completion.16 
The diary was presented in a booklet form, containing instructions, an 
example of how to complete the diary, and a telephone number in case 
of questions. Patients were asked to complete ﬁve cost diaries during 
the entire follow-up period of 26 weeks, which was divided in ﬁve time 
periods: weeks 1-6, weeks 7-12, weeks 13-18, weeks 19-22, and weeks 
23-26. Patients received a new diary by post at the beginning of a period 
and a return envelop for the previous diary. Patients were reminded by 
post after two weeks or telephoned after three weeks if they had not 
returned the previous diary. The cost diary included direct health care costs 
relevant to treatment of shoulder complaints, such as visits to a general 
practitioner, physiotherapist, manual therapist, occupational therapist, 
‘Mensendieck’ or ‘Cesar’ exercise therapist or complementary health 
therapists (e.g. acupuncturist), visits to a consultant in orthopedic surgery, 
neurology, rheumatology, or rehabilitation medicine, and hospitalization. 
Direct non-health care costs included out of pocket expenses, costs of 
performing extra activities (i.e. swimming, ﬁtness, gymnastics), homecare 
and costs for paid and unpaid help. Indirect costs included costs of loss of 
production due to shoulder complaints, which was measured by sick leave 
from paid and unpaid work, and inability to perform usual activities and 
hobbies. Indirect costs for paid work were calculated using the friction 
cost method17;18, with a friction period of 123 days. Friction costs were 
based on the mean income and sex of the Dutch population.17;18 We used a 
shadow price for unpaid work of € 8.60 per hour.18;19 A complete overview 
of the unit costs we used is given in Table 1. Medication costs were based 
on the prices provided by the Royal Dutch Society for Pharmacy.20
 
Data analysis
We compared the baseline characteristics of patients who completed all 
cost diaries with those who did not and analysed possible diﬀerences in a 
multiple logistic regression analysis. Health care consumption for shoulder 
pain and associated costs are presented in tables, for three time periods 
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separately: short-term (1-6 weeks), intermediate term (7-12 weeks), 
and long-term follow-up (13-26 weeks). The arithmetic mean, standard 
deviations, maximum value (only for consumption) were computed for 
direct (health and non-health related), and indirect costs. Despite the 
skewness in the distribution of costs, it is the arithmetic mean that is the 
most informative measure for health care policy makers.21;22 Measures 
other than the arithmetic mean provide no information about the total 
cost of treating all patients. We also described the costs separately for 
patients with persistent symptoms after 6 months and for those reporting 
recovery.
 
Results
Patients
A total of 587 patients were included in the cohort study. A total of 95 
patients did not return one or more of their cost diaries. A multiple logistic 
regression analysis showed that patients with incomplete cost data were 
signiﬁcantly (p<0.10) younger (46 years versus 52 years) and had more 
concomitant neck pain (38% versus 35%). The results of this study were 
based on the 492 patients (84%) who completed all ﬁve cost diaries. Table 
2 presents their baseline characteristics.
Health care consumption and sick leave
Health care consumption and sick leave are presented in Table 3. The 
mean number of visits to GPs, specialists, allied health professionals, 
and complementary health therapists were low, as well as the mean 
consumption of non-health related care (home care, paid and unpaid help, 
extra activities). Productivity losses were not considered high as well, with 
a mean number of days sick leave from paid work of 2.8 (sd ± 13) over 
a period of 6 months. Table 3 shows that most estimations have large 
standard deviations. 
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Table 2  Baseline characteristics of patients with shoulder pain 
Variable n =492 n=61*
Demographic
Age (years); mean (SD)
Gender: male; n (%)
Paid work; n (%)
52 (14)
245 (50)
350 (60) 
50 (14)
25 (41)
38 (62) 
Disease characteristics
Duration of current shoulder complaints; n (%)
0-6 weeks
7-12 weeks
>12 weeks
Sick leave at baseline in preceding 2 months; n (%)
0 weeks
≥1 weeks
>1 weeks
Gradual onset; n (%)
Precipitating cause; n (%)
Strain/overuse: usual activities; n (%)
Shoulder complaints in the past; n (%)
Neck complaints in the past; n (%)
Dominant side involved; n (%)
Comorbid psychological complaints; n (%)
Concomitant musculoskeletal complaints; n (%)
Neck/high back
Low back pain
Upper extremity
Shoulder pain (0-10); mean (SD)
Shoulder disability (0-100); mean (SD)
179 (37)
117 (24)
195 (40)
254 (74)
44 (13)
46 (13)
310 (63)
115 (23)
291 (59)
251 (51)
302 (61)
42 (9)
173 (35)
117 (24)
152 (31)
4.7 (2.3)
60.0 (23.8)
18 (30)
15 (25)
28 (46)
21 (57)
5 (13)
11 (30)
36 (59)
22 (36)
42 (69)
41 (68)
42 (69)
9 (15)
35 (57)
24 (39)
21 (34)
6.2 (1.9)
72.0 (20.2)
Physical examination
Pain shoulder with movement (0-18); median (IQR)
Pain neck with movement (0-18); median (IQR)
6 (4-6)
0 (0-0) 
8 (6-8)
3 (0-2) 
Physical factors
Dynamic physical workload (0-5); median (IQR)
Repetitive movements; n (%) 
1 (0-1)
316 (64)
1 (1-1)
43 (71)
*Subgroup of patients generating costs of >€10.000 in 6 months.  SD=standard deviation; IQR=Inter quartile range
Costs
The mean costs and standard deviations are presented in Table 4. During 
the 6 months after ﬁrst consultation for shoulder pain, the mean total costs 
a patient generated were € 689 (sd ± 1965). A large proportion (47%) of 
the total costs was due to indirect costs of productivity losses. Mean total 
costs due to sick leave from paid work in patients with a paid job were € 523 
(sd ± 2054). Treatment by a therapist (mostly physiotherapists, Table 3) 
accounted for 37% of the total direct costs. One patient underwent surgery 
for his shoulder complaints, and generated € 2715, which reﬂects 1 day of 
hospitalization and the costs of a neck operation. The costs generated in the 
ﬁrst six weeks (€ 276 ± 758) were almost equal to the costs generated in the 
ﬁnal three months of the follow-up period (€ 257 ± 962).  So, the highest 
costs per week were generated in the ﬁrst 6 weeks after consultation. Table 
5 shows that patients reporting persistent symptoms generated more than 
twice as much costs compared with patients reporting recovery after 6 
months.
Figure 1 describes the distribution of the total costs in the population. 
A small proportion of the population (n=61; 12 %) generated more than 
€ 1000 per patient during 6 months after ﬁrst consultation. This skewness 
was illustrated with a median total direct costs of € 105 (Inter Quartile 
Range 19-317) and median total indirect costs of € 0 (IQR 0-75). These 
61 patients (12%) were responsible for 74% of the total costs, which 
consisted for 78% of indirect costs. These small subset of the population 
diﬀered considerably (>10%) at baseline from the total study population, 
regarding sick leave at baseline in the preceding 2 months, strain due 
to usual activities as precipitating cause, shoulder or neck complaints 
in the past, concomitant neck, high back, or back pain, intensity of 
shoulder pain, shoulder disability, and shoulder and neck pain at physical 
examination (Table 2). The prevalence of persistent symptoms after 6 
months in this subgroup was 70%. Sick leave from paid work in 6 months 
after consultation accounted for 61% of the total costs in this subgroup.
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Table 4  Mean costs (€) made in 26 weeks after ﬁrst consultation for shoulder complaints (n=492)
week 1-6 week 7-12 week 13-26
     Total
week 1-26
Direct health care costs 69 ± 66 32 ± 57 52 ± 179 152 ± 232 
General Practitioner 
Allied health professionals 
Specialists 
Prescribed medication
Hospitalisation 
31 ± 17
34 ± 62
2 ± 12
2 ± 6 
-
4 ± 54 
25 ± 53
1 ± 9
1 ± 3 
-
5 ± 14 
34 ± 87
5 ± 26
1 ± 4 
6 ± 138 
40 ± 29 
93 ± 158 
8 ± 36
4 ± 10 
6 ± 138
Direct non-health care costs 30 ± 102 26 ± 108 41 ± 146 98 ± 293
Alternative therapists 
Over-the-counter medication
Out-of-pocket expenses
Home care 
Paid help 
Help from partner/relatives/friends 
Extra activities 
5 ± 33 
2 ± 9 
2 ± 16
1 ± 10
4 ± 31 
10 ± 75 
7 ± 34 
3 ± 28 
1 ± 9 
1 ± 8 
0.4 ± 7 
5 ± 37 
7 ± 76 
8 ± 45 
8 ± 55 
4 ± 51 
1 ± 6 
2 ± 17 
6 ± 49 
8 ± 54 
12 ± 59 
16 ± 94 
7 ± 58 
4 ± 21 
3 ± 27 
15 ± 107 
25 ± 168 
28 ± 100 
Total direct costs 99 ± 130 58 ± 134 93 ± 244 250 ± 408
Sick leave from paid work 
Sick leave from unpaid work 
Unable to perform usual activities 
Unable to perform hobbies 
125 ± 654
16 ± 83 
12 ± 66 
24 ± 85 
69 ± 461 
12 ± 85 
7 ± 57 
10 ± 49 
130 ± 790 
13 ± 82 
9 ± 63 
12 ± 59 
324 ± 1635 
42 ± 208 
28 ± 139 
46 ± 140 
Total indirect costs 177 ± 711 99 ± 505 164 ± 829 439 ± 1751
Total costs 276 ± 758 156 ± 564 257 ± 962 689 ± 1965
Presented are group means, standard deviations
Table 5  Mean costs (€) and standard deviations in patients with persistent symptoms versus those in 
recovered patients after 6 and 26 weeks (n=492) 
week 1-6 week 1-26
Persistent symptoms Recovered Persistent symptoms Recovered
Direct health care costs
Direct non-health care costs
Total direct costs
Indirect costs
82 ± 71
37 ± 115
120 ± 144
208 ± 727
48 ± 49
20 ± 82
68 ± 98
127 ± 679
206 ± 301
133 ± 316
339 ± 477
628 ± 2049
107 ± 133
70 ± 274
177 ± 325
279 ± 1458
Total costs 328 ± 780 195 ± 696 966 ± 2334 457 ± 1573
Presented are group means, and standard deviations.
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Figure 1  Distribution of the total costs (€) in the population (n=492) 
> 10,000
(1%)1000-10,000
(11%)
0-20
(27%)
20-100
(16%)
100-1000
(45%)
Discussion
The present study is the ﬁrst to evaluate the overall costs generated by 
patients presenting with shoulder pain in primary care. Healthcare 
consumption and sick leave did not seem to be alarmingly high in this 
primary care population with mean total costs of  € 689 per patient during 
the 6 months after ﬁrst consultation. A small part (12%) of the population 
accounted for 74% of the total costs.
The response rate was high (84%) and diﬀerences at baseline between 
completers (all 5 ﬁve cost diaries) and non-completers (<5 cost diaries) 
were small. We expect that the diﬀerences in age and concomitant neck 
pain between completers and non-completers will not have substantially 
inﬂuenced our cost estimates. 
Although there was a high percentage of patients who reported  persistent 
symptoms after 6 weeks (70%) and 6 months (46%) in this population23, 
there was little health care consumption and shoulder pain related sick 
leave in this study. As a consequence shoulder pain related costs per patient 
were low. Only one patient reported 130 days of sick leave in the 6 months 
after consultation, which was more than the friction period of 123 days. 
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An explanation for the modest health care costs could be that general 
practitioners stick to the interventions recommended in the Dutch 
guidelines for shoulder disorders14;15 (wait-and-see policy with pain 
medication, followed by injections), which are relatively inexpensive. The 
costs of physiotherapy represented a relatively large proportion of the 
direct health care costs, but accounted for only 14% of the total costs, as 
few patients were referred for therapy (Table 4). Indirect costs accounted 
for a large proportion (47%) of the total costs. Nevertheless, the total 
number of days sick leave per patients was small (2.8 days) over a period 
of 6 months. Possibly, factors such as shoulder pain, sleeping problems, or 
loss of function have caused loss of productivity in patients without sick 
leave from  paid work. Our study does not provide information on the 
actual loss of productivity among those who kept on working regardless 
of the shoulder pain. 
Similar to studies on low back pain24, in this study a small proportion of 
the population (n=61; 12%) caused a substantial part (74%) of the total 
costs. In this subgroup sick leave from paid work accounted for 61% of the 
total costs. In a prognostic study we found the following factors predicting 
sick leave from paid work in 6 months after consultation: sick leave in the 
preceding 2 months, shoulder pain, precipitating cause: usual activities and 
concomitant psychological complaints.25 Table 2 shows that the subgroup 
who generated most costs, not surprisingly, also showed higher scores on 
these variables compared to the total population (Table 2). Table 2 also 
shows substantial diﬀerences between the groups regarding shoulder or 
neck pain at physical examination, and concomitant back pain at baseline. 
This seems plausible as these factors were shown to be of predictive value 
for persistent shoulder pain after 6 weeks and 6 months in our cohort.23
In this study we were able to include a follow-up of 26 weeks. It is possible 
that prolonged and recurrent pain episodes generate additional costs 
for more expensive care, e.g. diagnostic imaging and surgical treatment, 
including hospitalization. Given the poor prognosis of shoulder pain 
(approximately 40% of patients report persistent symptoms after 12 to 
18 months10-12) higher health care costs and productivity losses may be 
expected when follow-up times are longer. In the 6 months following ﬁrst 
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consultation, few costs were made due to referrals to other health care 
providers, additional diagnostic procedures, or surgery. We expect these 
kind of health care expenses to occur in the long-term in a small subset of 
the population. In our inception cohort patients with fractures, dislocation, 
or previous surgery were not included. These patients are not included in 
this study, but may generate substantial costs in current practice.
Information on the costs associated with health care use and loss of 
productivity in patients with shoulder pain is very scarce, and therefore a 
comparison with other studies is diﬃcult. In the framework of this cohort 
study a randomised controlled trial on the eﬀectiveness of manipulative 
therapy has been  carried out.26 This trial was similar regarding outcome 
assessments  and length of follow-up. The control group of this trial 
(n=71), who also received usual care according to the Dutch general 
practice guidelines, generated slightly lower costs (mean total costs € 555) 
compared to our cohort.  
In conclusion, the total costs in the 26 weeks after ﬁrst consultation for 
shoulder pain, mostly generated by a small part of the population, are 
not alarming. However, after 26 weeks 46% of the patients still reported 
persistent symptoms. More extensive research with a longer follow-up 
to monitor these patients, is needed. These patients possibly generate 
substantial costs. Given the high incidence of shoulder pain (12/1000/year )8;9 
in general practice the total costs to society could be substantial. It may 
be important to include patients with fractures, dislocation, or previous 
surgery to estimate the total costs of illness for patients consulting with 
shoulder pain in primary care.
61
Reference List
1. Luime JJ, Koes BW, Hendriksen IJ, et al. Prevalence and incidence of shoulder pain in the 
general population; a systematic review. Scand J Rheumatol 2004;33:73-81.
2. Van der Heijden GJMG. Shoulder disorders: a state-of-the-art review. Baillieres Best Pract 
Res Clin Rheumatol 1999;13:287-309.
3. Bernard B, Sauter S, Fine L, Petersen M, and Hales T. Job Task and Psychosocial Risk 
Factors for Work-Related Musculoskeletal Disorders Among Newspaper Employees. 
Scand J Work Environ Health 1994;20:417-26.
4. Skov T, Borg V, and Orhede, E. Psychosocial and Physical Risk Factors for Musculoskeletal 
Disorders of the Neck, Shoulders, and Lower Back in Salespeople. Occup Environ Med 
1996;53:351-6.
5. Trinkoﬀ AM, Lipscomb JA, Geiger-Brown J, and Brady B. Musculoskeletal Problems of 
the Neck, Shoulder, and Back and Functional Consequences in Nurses. Am J Ind Med 
2002;41:170-8.
6. Picavet HS, Schouten JS. Musculoskeletal pain in the Netherlands: prevalences, 
consequences and risk groups, the DMC(3)-study. Pain 2003;102:167-78.
7. Bongers PM. The cost of shoulder pain at work. BMJ 2001;322:64-65.
8. Okkes IM, Oskam SK, Lamberts H. Van klacht naar diagnose: Episodegegevens uit de 
huisartspraktijk. Bussum. Coutinho, 1998.
9. Van der Windt DAWM,  Koes BWK,  Jong BAD, et al. Shoulder disorders in General 
Practice: incidence, patients characteristics, and management. Annals of Rheumatic 
Diseases 1995;54:959-64.
10. Croft P, Pope D, Silman A. The clinical course of shoulder pain: prospective cohort study 
in primary care. BMJ 1996;313:601-2.
11. Van der Windt DAWM, Koes BWK, Boeke AJP, et al. Shoulder disorders in general 
practice: prognostic indicators of outcome. Br J Gen Pract 1996;46:519-23.
12. Winters JC, Sobel JS, Groenier KH, et al. The long-term course of shoulder complaints: a 
prospective study in general practice. Rheumatology 1999;38:160-3.
13. Meerding WJ, Bonneux L, Polder JJ, Koopmanschap MA, van der Maas PJ. Demographic 
and epidemiological determinants of healthcare costs in Netherlands: cost of illness study. 
BMJ 1998;317:111-15.
14. The Dutch College of General Practitioners (NHG) Practice Guideline. Accessed at 
http://nhg.artsennet.nl/upload/104/guidelines2/E08.htm on 1 september 2003.
15. Winters JC, Jongh AC, van der Windt DAWM, et al. Practice Guideline “Shoulder 
complaints’ [In Dutch: NHG-Standaard Schouderklachten]. Huisarts en Wetenschap. 
1999;42:222-31.
16. Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM. The cost 
diary: a method to measure direct and indirect costs in cost-eﬀectiveness research. J Clin 
Epidemiol 2000;53:688-95.
17. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Manual costs research [In Dutch: 
Handleiding voor kostenonderzoek, methoden en richtlijnprijzen voor economische 
evaluaties in de gezondheidszorg]. Amstelveen: College voor zorgverzekeringen, 2000.
62
18. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch 
Manual for Costing in economic evaluations. Pharmacoeconomics 2002;20:443-54.
19. Taxe report: Z-Index [In Dutch].  2000. The Hague. 
20. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations 
for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig 
2003;7:2-7.
21. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised 
controlled trials: review of published studies. BMJ 1998;317:1195-00.
22. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be 
analysed? BMJ 2000;320:1197-00.
23. Kuijpers T, Van der Windt DAWM, Boeke AJ, Twisk J, Vergouwe Y, LM Bouter, Van der 
Heijden GJMG. Clinical prediction rules for the prognosis of shoulder pain in general 
practice. Pain, in press.
24. Cats-Baril WL, Frymeyer JW. The economics of spinal disorders. In: Frymeyer JW, editor. 
The adult spine: principles and practice. New York: Raven Press, 1991.
25. Kuijpers T, Van der Windt DAWM, Van der Heijden GJMG, Twisk J, Vergouwe Y, Bouter 
LM. A prediction rule for shoulder pain related sick leave. Submitted.
26. Bergman GJD, Winters JC, Groenier KH, Pool JJ, Meyboom-de Jong B, Postema K 
et al. Manipulative therapy in addition to usual medical care for patients with shoulder 
dysfunction and pain: a randomized, controlled trial. Ann Intern Med 2004;141:432-
39.
4Ton Kuijpers
Daniëlle AWM van der Windt
A Joan P Boeke
Jos WR Twisk
Yvonne Vergouwe
Lex M Bouter
Geert JMG van der Heijden
Cl inical  prediction rules for the prognosis 
of shoulder pain in general  practice
Pain, in press

Background  Shoulder pain is common in primary care, and has an 
unfavourable outcome in many patients. Information about predictors 
of outcome is scarce and inconsistent. The objective of this study was 
to develop clinical prediction rules for calculating the absolute risk of 
persistent shoulder symptoms for individual patients, 6 weeks and 6 
months after the ﬁrst consultation in general practice. 
Methods  A prospective cohort study with 6 months follow-up was 
carried out in three geographic areas in The Netherlands. In this study 
587 patients with a new episode of shoulder pain were included. The main 
outcome measure was persistent symptoms at 6 weeks and 6 months, 
perceived by the patient. Potential predictors included the results of a 
physical examination, sociodemographic variables, disease characteristics 
(duration of symptoms, pain intensity, disability, comorbidity), physical 
activity, physical workload, and psychosocial factors. 
Results  Response rates to the follow-up questionnaires were 83% at 6 
weeks and 92% at 6 months. A longer duration of symptoms, gradual onset 
of pain, and high pain severity at presentation were consistently associated 
with persistent symptoms at 6 weeks and 6 months. The discriminative 
validity of our prediction rules was satisfactory with area under the curves 
of 0.74 (95% CI 0.70; 0.79) at 6 weeks and 0.67 (95% CI 0.63; 0.71) 
at 6 months. The performance of our rules needs to be tested in other 
populations of patients with shoulder pain to enable valid and reliable use 
of the rules in everyday clinical practice.
ABSTRACT
65
Introduction
Shoulder pain is common with a one year prevalence ranging between 
5% and 47%.1-5 The point prevalence in the general population in The 
Netherlands has recently been estimated at 17%.6 The annual incidence of 
consultation for a new episode of shoulder pain in Dutch general practice 
ranges between 12 and 25/1000/year.1;6-8 
Shoulder pain has an unfavourable outcome in many patients. Only 
about 50% of all new episodes of shoulder pain presented in primary 
care show complete recovery within six months9-11, after one year this 
proportion increases to only 60%.10 Knowing more about the prognostic 
value of clinical, psychosocial, and occupational factors in patients with 
shoulder disorders will help to provide patients with adequate information 
regarding the most likely course of their symptoms. Such information may 
also support decisions regarding treatment and referral of patients. 
In a systematic review of the literature we summarized the available 
evidence from 16 studies regarding predictors of outcome of shoulder 
pain.12 Only six studies were of relatively high quality. In a primary care 
population strong evidence for predicting poor outcome was only found 
for ‘high pain intensity’. For any other variable, including psychosocial 
variables, convincing evidence for their predictive value is lacking. We 
performed a cohort study among patients with shoulder pain consulting 
their general practitioners, and followed them for 6 months. The objective 
of this study was to determine which combination of factors predicts the 
outcome of an episode of shoulder pain 6 weeks and 6 months after the 
ﬁrst consultation in a general practice population. Our aim was to develop 
a clinical prediction rule for calculating the absolute risk of persistent 
symptoms for individual patients in general practice.
Methods
Recruitment
Between January 2001 and June 2003, 103 general practitioners (GP) 
recruited patients at ﬁrst consultation for a new episode of shoulder pain 
in three geographic areas in the Netherlands (Amsterdam, Groningen and 
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Maastricht). The primary reason for consultation had to be shoulder pain. 
In this study shoulder pain was deﬁned according to the 1999 version of 
the Dutch guidelines for shoulder complaints, issued by the Dutch College 
of General Practitioners.13;14 In the guideline shoulder pain is characterised 
as pain in the deltoid and upper arm region. GPs used this deﬁnition to 
select patients with shoulder pain for our study. 
Patients were selected by their GP if they were 18 years or older of age, 
and had not consulted their GP or received any form of treatment for 
the aﬄicted shoulder in the preceding 3 months. GPs were instructed to 
select consecutive patients. Suﬃcient knowledge of the Dutch language 
was required to complete written questionnaires. Exclusion criteria were 
severe physical or psychological conditions (i.e. fractures or luxation in 
the shoulder region; rheumatic disease; neoplasm; neurological or vascular 
disorders; dementia). Data collection was approved by the Medical Ethics 
Committee of the VU University Medical Center, Amsterdam, The 
Netherlands.  
Management of shoulder pain
All patients received standardised treatment according to the 1999 version 
of the Dutch guidelines for shoulder complaints issued by the Dutch 
College of General Practitioners.13;14 The guidelines recommend giving 
information on the prognosis of shoulder pain, advice regarding provoking 
activities, and stepwise treatment consisting of paracetamol, Non-Steroidal 
Anti-Inﬂammatory Drugs (NSAIDs), corticosteroid injection or referral 
for physiotherapy. The GP made the decision regarding the content of 
treatment based on duration and severity of pain and disability. The 
participating general practitioners were educated and trained to apply 
treatment according to this guideline. 
Prognostic factors
Within 10 days after they had consulted the GP participants gave written 
informed consent and completed an extensive baseline questionnaire. The 
questionnaire contained questions on socio-demographic variables, disease 
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characteristics (i.e. pain intensity, disability, duration of complaints, onset, 
and comorbidity), physical activity, physical workload and psychosocial 
factors, and had a physical examination by a trained assistant at baseline. 
The sociodemographic variables and disease characteristics were measured 
using checklist which mainly consisted of yes or no questions. Physical 
activity was measured with a single question (less/equally/more active 
than others). We measured physical workload with a self-constructed scale 
of  5 questions (yes/no) concerning pushing and pulling, lifting weights, 
working with hands above shoulder level, and the use of vibrating tools on 
at least two days a week (total score 0-5, Crohnbach’s α= 0.74). Repetitive 
movements, on at least two days a week, was also measured with a single 
question answered with yes or no. 
The psychosocial factors coping, anxiety, depression, somatization, distress, 
fear-avoidance beliefs, and kinesiophobia were measured with widely used 
standardized questionnaires. Coping was assessed with the 43-item Pain 
Coping and Cognition List (PCCL)15, consisting of the subdomains 
catastrophizing (1-6 points, Crohnbach’s α= 0.63), coping with pain (1-6 
points, Crohnbach’s α= 0.83), internal (1-6 points, Crohnbach’s α= 0.76) 
and external locus of control (1-6 points, Crohnbach’s α= 0.65). Anxiety 
(0-24 points, Crohnbach’s α= 0.77), depression (0-12 points, Crohnbach’s 
α= 0.90), somatization (0-32 points, Crohnbach’s α= 0.82), and distress 
(0-32 points, Crohnbach’s α= 0.92), were measured with the 50-item 
Four-Dimensional Symptom Questionnaire (4DSQ).16;17 Fear-avoidance 
beliefs were assessed using the 4-item physical activity subscale of  the Fear 
Avoidance Beliefs Questionnaire (FABQ; 0-24, Crohnbach’s α= 0.73).17;18 
Kinesiophobia, ﬁnally, was measured using two items (no. 1 and no 9.) 
of the Tampa Scale for Kinesiophobia (TSK; 0-12 points, Crohnbach’s 
α= 0.82).20;21 The questionnaire also included a general one-item question 
regarding the presence (yes/no) of any psychological problems (e.g. distress, 
depression, anxiety).
Function of the shoulder joint and cervicothoracic spine were tested 
during a physical examination. For the glenohumeral joint active and 
passive abduction, passive exorotation22, and shoulder impingement23 were 
tested. Two alternative functional tests, HIB (Hand-in-back) and HIN 
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(Hand-in-neck)24;25 measured on a 7-point scale (score 0 = very poor range 
of motion, score 7 = full range of motion) were performed as well. The 
assistant made an estimation of the range of motion in degrees (°). 
During all mobility tests self-reported pain was assessed on a 4-point scale 
(0 = no pain; 3 = severe pain). A factor analysis on the results of a physical 
examination in a similar population of patients with shoulder pain resulted 
in four factors: shoulder mobility, shoulder pain, neck mobility, and neck 
pain.22
The factor ‘shoulder mobility’ consisted of 6 mobility tests: HIB, HIN, 
active abduction, passive abduction, exorotation, and impingement. For 
calculation of the sum score (0-18 points) variables were recoded into a 4-
point scale,  with 0 reﬂecting full range of motion and 3 points reﬂecting 
very poor range of motion. HIB/HIN scores were recoded as: score 7 = 0; 
score 5 and 6 = 1; score 3 and 4 = 2; score 1 and 2 = 3. Abduction (active 
and passive) was recoded as 170-180° = 0; 140-170° = 1; 90-140° = 2; 0-
90° =3. Exorotation was recoded as >80° = 0; 70-80° = 1; 50-70° = 2; <50° 
=3. During the impingement test pain was measured (0 = no pain; 3 = 
severe pain). The factor ‘shoulder pain’ (0-18 points) consisted of the sum 
of the pain scores during the mobility tests. 
The factor ‘neck mobility’ (0-4 points) consisted of rotation of the 
cervicothoracic spine in neutral, ﬂexed, and extended position and lateral 
bending. These range of motion tests were scored as (1= decreased range 
of motion, and 0 = no decreased range of motion). The factor ‘neck pain’ 
(0-18 points) consisted of the sum of the pain scores during ﬂexion and 
extension of the neck, rotation in a neutral, ﬂexed and extended position, 
and lateral bending. 
Outcome measurements
The outcome was measured by postal questionnaires at 6 weeks, 3 and 
6 months. We restricted the length of the follow up period to 6 months 
because the recovery rate, which is about 50% after 6 months9-11, only 
slightly increases thereafter. This means that little information can be 
gained after 6 months follow-up. Our primary outcome measure ‘Patient 
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perceived recovery’ was measured on an 8-point scale. Patients who did 
not report full recovery or very much improvement were denoted as having 
“persistent symptoms”.26;27 Patients who did not reply at 6 weeks were re-
contacted at 3 and 6 months. Secondary outcome measures were shoulder 
disability, measured with the 16-item shoulder disability questionnaire 
(SDQ; 0-100)28, pain (0-10 numeric rating scale)26, and severity of the 
main complaint (0-10 numeric rating scale).29 We studied the relationship 
between our primary and secondary outcome measures to determine if 
patients with persistent symptoms after 6 weeks and 6 months showed 
higher levels of pain and disability.
Analysis
Missing values of patient characteristics were imputed (approx. 1% of all 
required values at both 6 weeks and 6 months). Imputation was based 
on the correlation between each variable with missing values with the 
other patient characteristics. Univariable logistic regression analyses were 
performed for all potential prognostic factors with our primary outcome 
measure, i.e. persistent symptoms, at either short term (6 weeks) or long 
term (6 months). The linearity of the associations of continuous variables 
with outcome was studied. Factors were categorized if they did not show 
a linear association with the outcome. Variables that had a statistically 
signiﬁcant association with the outcome (p-value ≤0.20) were selected as 
candidate predictors for the multivariable analysis. Nor more than one 
independent variable per ten events was included in the multivariable 
analysis.30;31 We presented the univariable ORs along with the 95% 
conﬁdence intervals, as well as with p-values to enable the reader to choose 
alternative statistical signiﬁcance levels for the selection of variables for the 
multivariable analysis. 
Separate prediction models were developed for persistent symptoms at 
short term and long term. A second selection step was performed in the 
multivariable model, that contained all candidate predictors with stepwise 
backward selection. Variables with the lowest predictive value were deleted 
from the model until further elimination of a variable resulted in a 
statistically signiﬁcant lower model ﬁt estimated with the log likelihood 
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ratio test (p<0.20).  
Bootstrapping techniques were used to study the internal validity of the 
ﬁnal prediction model, i.e. to adjust the estimated regression coeﬃcients 
for overﬁtting and the model performance for overoptimism.32;30 The 
model’s performance obtained after bootstrapping can be considered as 
the performance that can be expected in similar future patients. Random 
bootstrap samples were drawn with replacement (100 replications) from 
the full data set. The multivariable selection of variables was repeated 
within each bootstrap sample. All analyses were performed using S-plus 
6.1 (Insightful Corp., Seattle, WA, USA).
Evaluation of the model
The reliability of the multivariable model was determined by use of the 
Hosmer-Lemeshow goodness-of-ﬁt statistic.33 Calibration of the model 
predictions was assessed by plotting the predicted individual probabilities 
against the observed individual probabilities for persistent symptoms. 
For this, patients were grouped into deciles according to their predicted 
probability for persistent symptoms according to the model. The 
prevalence of the endpoint within each decile represents the observed 
individual probability. The area under the receiver-operating characteristic 
curve (ROC) was used to assess the discriminative ability of the model. 
The ROC-curve plots the true positive rate (sensitivity) against the false-
positive rate (1-speciﬁcity) at any given cut-oﬀ value. The curve illustrates 
the ability of the model to discriminate between patients with and without 
persistent symptoms at subsequent cut-oﬀ points along the range of the 
predicted probabilities. An area under the curve (AUC) of 0.5 indicates 
no discrimination above chance, whereas an AUC of 1.0 indicates perfect 
discrimination. 
From a prediction model to an individual patient risk
We developed a clinical prediction rule34-36 for outcome at 6 weeks and 6 
months, to provide an estimate for individual patients of their absolute 
risk of persistent symptoms. The probability (P) of persistent symptoms 
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was predicted by P=1/[1+ exp – (a
0
 + b
1
x
1
 + …… + b
j
x
j
)]. The status of a 
patient for any dummy or binary variable included in the prediction rule 
can be either 0 or 1, while for a (semi) continuous variable it takes the 
actual observed value. 
Score charts
To facilitate the calculation of an individual patient’s risk, we developed 
score charts. We divided the regression coeﬃcients by the lowest coeﬃcient 
and rounded them to the nearest integer to form the scores for the 
predictors. The sum of the scores correspond to a risk of poor outcome.
Results
Study population and follow-up
At baseline 587 patients were questioned and physically examined. Table 1 
lists the baseline characteristics of the participants. At 6 weeks 487 (83%) 
and at 6 months 538 (92%) patients returned the postal questionnaire. 
The drop-outs at 6 weeks and 6 months were younger than the responders 
(mean diﬀerence 4 years and 6 years, respectively). The drop-outs at 6 
months showed more often an acute onset (49% versus 36%), and less 
repetitive movements in their work (26% versus 36%) at baseline in 
comparison with the responders. 
At 6 weeks 70% (n=340) and at 6 months 46% (n=249) patients reported 
persistent symptoms. Of these 249 patients, only 22 reported that 
symptoms had recurred after initial recovery at 6 weeks. Table 2 shows that 
patients with persistent symptoms reported also more pain, more shoulder 
disability and higher severity of the main complaint. 
Management of shoulder pain
At baseline most patients (n=423, 72%) received a wait and see policy, 
paracetamol, or NSAIDs. Furthermore, 68 patients (12%) received 
an injection with corticosteroid, 58 patients (10%) were referred for 
physiotherapy and 28 patients (6%) received other therapies. 
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Prognostic factors
Table 1 also presents the univariable association of potential predictors 
with outcome at 6-weeks and 6-months follow-up. Given the fact that 
median baseline scores on distress, anxiety and somatization were very 
low, scores on these psychological factors were dichotomized. Variables 
which showed an univariable association (p≤0.20) were selected for 
the backward stepwise selection analysis. Table 3 presents the variables 
included in the prediction models for persistent symptoms at 6 weeks and 
6 months after backward stepwise selection (p≤0.20). A longer duration 
of symptoms at baseline, gradual onset of shoulder complaints, and higher 
pain intensity were associated with a poorer prognosis at both 6 weeks and 
6 months. Furthermore, concomitant psychological complaints, repetitive 
movements, and increasing neck pain scores at physical examination 
were associated with persistent symptoms at 6 weeks. A poor prognosis 
at 6 months was additionally predicted by concomitant back pain and 
increasing shoulder pain scores at physical examination. 
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Table 2  Secondary outcome measures (mean; SD) for patients with and without persistent symptoms at 6 
weeks and 6 months
6 weeks 6 months
Persistent symptoms Yes No Yes No
Pain (0-10)
Shoulder disability (SDQ) (0-100)
Severity of main complaint (0-10)
4.3 (2.1)
53.0 (25.5)
4.8 (2.6)
0.5 (0.9)
10.4 (16.6)
0.8 (1.5)
4.1(2.3)
52.2 (26.7)
5.0 (2.8)
0.4 (1.1)
5.9 (14.5)
0.6 (1.3)
Evaluation of the models
The reliability of the models was adequate, according to the Hosmer-
Lemeshow statistic, with a p-value of 0.51 for the model at 6 weeks and 
0.16 at 6 months. Figure 1 shows the calibration of the predictions. The 
predicted and observed probabilities are rather close to the 45° line, 
demonstrating good calibration of the predictions by the two models. The 
AUCs for the models at 6 weeks and 6 months were 0.74 (95% CI 0.70; 
0.79) and 0.67 (95% CI 0.63; 0.71). The predicted risks of persistent 
symptoms are widely distributed (Figure 2). 
Score charts
Figure 3 shows the score charts for calculating the risk of persistent 
symptoms at the short and long term. For instance, a patient with shoulder 
complaints for 3 weeks at baseline with a gradual onset of symptoms, and 
a shoulder pain score of 1 point, has a prognostic score of  8 points for the 
short term and 12 points in the long term, which implies 40 to 50% risk 
of persistent symptoms at 6 weeks and 20 to 30% at 6 months.
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Table 3  Multivariable model with predictors of persistent shoulder symptoms (yes/no) at 6 weeks and 6 
months after stepwise backward selection
Predictor Scale OR 95% CI
6 weeks (n=486)
Duration of complaints 
0-6 weeks*
7-12 weeks
>3 months
Gradual onset 
Concomitant psychological complaints
Repetitive movements
Shoulder pain
Neck pain score at physical examination
(yes/no)
(yes/no)
(yes/no)
(yes/no)
(yes/no)
(0-10) 
(0-18)
1.9
2.6
1.8
2.3
2.0
1.1
1.1
1.1-3.3
1.5-4.4
1.1-2.9
0.9-6.4
1.2-3.1
1.0-1.2
1.0-2.7
6 months (n=538)
Duration of complaints 
0-6 weeks* 
7-12 weeks
>3 months
Gradual onset 
Concomitant low back pain
Shoulder pain 
Shoulder pain score at physical examination
(yes/no)
(yes/no)
(yes/no)
(yes/no)
(0-10)
(0-18)
1.4
1.9
1.4
1.6
1.1
1.0
0.9-2.3
1.2-3.0
1.0-1.8
1.1-2.5
1.0-1.2
1.0-1.1
*Reference category
Figure 1  Calibration plots showing the observed frequencies versus the predicted probabilities for persistent 
symptoms at 6 weeks and 6 months
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Figure 2  Number of patients in risk categories for persistent symptoms of the score charts for 6 weeks (n=486) 
and 6 months (n=538)
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Instruction
If a predictor is scored positively, the given weight needs to be ﬁlled in. Subsequently the scores are added to calculate the ‘Total score’. 
From the table next to the score chart the risk (%) of persistent symptoms for an individual patient can be determined.
Score chart for prediction of persistent shoulder symptoms at 6 weeks
Duration of complaints 
<6 weeks
6-12 weeks
>3 months
Gradual onset
Concomitant psychological complaints
Repetitive movements
Shoulder pain (0-10)
Neck pain score at PE (0-18)
0
7
11
7
10
8
score
score
…
…
…
…
…
…
…
…
+
 Total score
≤2
3 – 7
8 – 11
12 – 16
17– 21
22 – 27
28 – 36
≥37
Risk
20% - 30%
30% - 40%
40% - 50%
50% - 60%
60% - 70%
70% - 80%
80% - 90%
  90% - 100%
Total score …
Score chart for prediction of persistent shoulder symptoms at 6 months
Duration of complaints 
<6 weeks
6-12 weeks
>3 months
Gradual onset
Concomitant low back pain
Shoulder pain (0-10)
Shoulder pain score at PE (0-18)
0
9
17
10
13
score x 2
score
…
…
…
…
…
…
…
+
 Total score
≤1
2 – 16
17 – 28
29 – 39
40– 49
50 – 61
≥62
Risk
10% - 20%
20% - 30%
30% - 40%
40% - 50%
50% - 60%
60% - 70%
  70% - 100%
Total score …
Figure 3  Prognostic score charts for prediction of persistent symptoms at 6 weeks and 6 months
PE = Physical Examination
The predicted probability of persistent symptoms at 6 weeks was determined by P=1/[1+ exp – (–1.19 + 0.64 × duration of complaints 
6-12 weeks + 0.95 × duration of complaints >3 months + 0.59 × gradual onset  + 0.85 × concomitant psychological complaints  + 0.68 
× repetitive movements  + 0.13 × shoulder pain + 0.09 × neck pain score at physical examination)]. 
PE = Physical Examination
The predicted probability of persistent symptoms at 6 months was determined by P=1/[1+ exp – (–1.48 + 0.34 × duration of 
complaints 6-12 weeks + 0.64 × duration of complaints >3 months + 0.37 × gradual onset  + 0.50 × concomitant low back pain + 
0.08 × shoulder pain + 0.04 × shoulder pain score at physical examination)].
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Discussion
This is the ﬁrst prospective cohort study on shoulder pain, in which a 
score chart is developed that may be used by general practitioners to 
calculate the risk of persistent symptoms for individual patients. Duration 
of complaints, gradual onset and pain intensity were strong predictors for 
both short and long term prognosis. 
Prognostic factors
In a systematic review12 of the literature we found only strong evidence for 
‘high pain intensity’ as a predictor of poor outcome. In our study high pain 
intensity was also found to be a strong predictor of  persistent symptoms 
at short term (6 weeks) and long term (6 months) follow-up. The results 
of our analyses showed somewhat diﬀerent sets of  predictors for short 
and long term results, but both analyses demonstrated that duration and 
severity of symptoms (disease characteristics) were more important in 
predicting outcome than physical or psychosocial factors. It has previously 
been suggested that psychosocial factors such as dysfunctional pain 
cognition or mistaken beliefs about pain and inappropriate pain behaviour 
are likely to predict a poor outcome of painful musculoskeletal conditions.5 
The association between psychosocial factors and musculoskeletal pain 
has been established in patients with chronic pain syndromes. The scores 
on all psychosocial variables measured in our population were low. 
Although signiﬁcant univariable associations with persistent symptoms at 
6 weeks were found in this study for several psychosocial factors (distress, 
somatisation, catastrophising), in a multivariable model these factors 
had little to add to a simple yes or no questions about the presence of 
psychological complaints. For the applicability of the prediction rules in 
primary care this is an advantage, as easy to measure predictors are preferred 
above predictors which are measured with time tasking questionnaires.
Management of shoulder pain
We did not include treatment in the model, as we assumed that confounding 
by indication could inﬂuence our ﬁndings. Patients with more severe 
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symptoms and thus, probably a poorer outcome are more likely to receive 
more extensive treatment.37 Only 68 patients (12%) received an injection 
and 58 (10%) were referred to a physiotherapist, which is a low proportion 
compared to an earlier study in The Netherlands.10 The Dutch practice 
guidelines on shoulder complaints, which recommend a wait-and-see 
policy during the ﬁrst 2 to 4 weeks may have lead to a change in practice 
over the past 5 years. As most patients received wait and see policy or 
medication, we had a relatively homogeneous group regarding treatment 
at baseline. Adding treatment variables to our models, indeed, did not 
improve their predictive value, nor strongly inﬂuenced the association of 
other predictors with outcome (data not shown).
Model ﬁt and discrimination
The calibration plots (Figure 1) show that some predicted probability 
deciles were slightly too high and some slightly too low. But in general 
both models are rather well calibrated. The AUCs of the models (0.74 
for 6 weeks and 0.67 for 6 months) implied satisfactory discrimination 
between patients with persistent shoulder symptoms and patients without 
persistent symptoms. 
Analysis
To facilitate comparison between the univariable and multivariable 
regression analysis we presented uni- and multivariable ORs in Table 1 and 
3. In case of high event rates (30-50% risk of persistent symptoms) ORs 
are an overestimation in comparison to the underlying relative risks (RR), 
and should not be interpreted as such. In our study we provide, using 
the prediction rule, the patient and the general practitioner with absolute 
risks instead of relative risks or odds ratios, because these are easier to 
understand. 
Internal and external validity of collected data 
The response to the questionnaires was high (between 83% and 92%) 
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in this large cohort study. Given the low drop-out rate and only slight 
diﬀerences at baseline between drop-outs and responders we assume that 
the results can be generalised to all shoulder patients in our study. The GPs 
were instructed to recruit consecutive patients. We do not have reliable 
information to gain insight in the percentage of patients who were eligible 
at ﬁrst consultation of their GP, and actually participated in the study. 
In the 10 day period between ﬁrst consultation and baseline assessment 
most patients only received advice or medication. Nevertheless, symptoms 
might have changed in some patients, which may have resulted in a 
diﬀerent population at baseline assessment compared to the moment of 
GP consultation. This could have had an inﬂuence on the discriminative 
ability of our prediction rules. It  is diﬃcult to estimate this potential 
inﬂuence as we have no data about changes in symptoms between selection 
and baseline assessment. This is one of the reasons why we want to stress the 
importance of validating the prediction rules in a daily practice situation, 
for which they have been developed.
The recovery rates of 30% after 6 weeks and 54% after 6 months are similar 
to those found in other studies carried out in primary care populations9-11, 
which may strengthen generalisability of our ﬁndings to other primary care 
patients with shoulder pain. However, before considering implementation 
of our score charts in clinical practice, the generalisability (‘external 
validity’) of the models needs to be tested in other populations of patients 
with shoulder pain.38 First, the generalisability to another primary care 
population can be tested. If satisfactory, the generalisability to a community 
sample, occupational setting, or secondary care population may be tested. 
Clinical usefulness
Perhaps most importantly, the clinical usefulness of the developed 
prediction rules should be established: can the prediction rules be helpful 
to the clinician when making decisions in the management of patients 
with shoulder pain, for example, whether or not to consider additional 
diagnostic testing, start a certain treatment or refer the patient to secondary 
care.39 Figure 2 shows that a relatively small proportion of patients is 
shifted into the lower risk categories at 6 weeks, and a somewhat higher 
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proportion at 6 months. So, a small number of patients can be reassured 
by their GP. Patients in the high risk categories possibly beneﬁt from earlier 
and more extensive treatments. An important objective for future research 
is to study from which interventions patients in the high risk categories 
beneﬁt most. 
Conclusion
In conclusion, longer duration of symptoms, a gradual onset of symptoms, 
and high pain intensity at baseline were consistently associated with a 
poor outcome. The prediction rule and score chart may be used by general 
practitioners to calculate the absolute risk of persistent symptoms in 
individual patients with shoulder pain. The performance of our models 
still needs to be tested in other populations of patients with shoulder pain 
to enable valid and reliable use of the score charts in clinical practice. 
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General isabi l ity of cl inical  prediction 
rules for the prognosis of shoulder 
pain in general  practice

Background  Shoulder pain is common in primary care, and has an 
unfavorable outcome in many patients. Recently we developed clinical 
prediction rules for the short and long term prognosis of shoulder pain in 
general practice.
Objective  The objective was to evaluate the generalisability of these 
prediction rules by applying them to a diﬀerent but comparable population 
of patients with a new episode of shoulder pain consulting their general 
practitioner. 
Methods  A large research program, consisting of a prognostic cohort 
study and three randomized controlled trials with 6 months follow-up, was 
carried out in diﬀerent geographic area’s in The Netherlands. The clinical 
prediction rules were derived from the results of the prognostic cohort 
study (n=587). The main outcome measure was persistent symptoms at 
6 weeks (short term) or 6 months (long term). The control groups of the 
trials who received usual care were merged (n=212), and used to validate 
the prediction rules. Generalisability of the prediction rules was tested by 
studying calibration and discrimination in the validation cohort.
Results  The prediction rule for short term outcome showed reasonable 
calibration and discriminative ability in the validation cohort. The area 
under the ROC curve (AUC) was 0.72 compared to 0.74 in the derivation 
cohort. The prediction rule for long term outcome performed less well. 
Discriminative ability (AUC) decreased to 0.56 in the validation cohort 
compared to 0.67 in the derivation cohort.
Conclusions  The prediction rule for the short term prognosis of shoulder 
pain in general practice showed good generalisability. The prediction 
rule for the long term prognosis showed poor generalisability. Hence, it 
seems diﬃcult to make accurate predictions of the long term outcome of 
shoulder pain in general practice.
ABSTRACT
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Introduction
Shoulder pain is common with a one year prevalence ranging between 5% 
and 47%.1-5 The prevalence in the general population in The Netherlands 
has recently been estimated at 17%.6 The annual incidence of consultation 
for a new episode of shoulder pain in Dutch general practice ranges between 
12 and 25/1000/year.3;6-8 Shoulder pain has an unfavorable outcome in 
many patients. About 40 to 50% of all patients who present with a new 
episode of shoulder pain in primary care report persistent symptoms after 
6 to 12 months.9-11 
We developed clinical prediction rules consisting of a limited number 
of (easily measurable) prognostic factors to predict the risk of persistent 
shoulder symptoms at the short (6 weeks) and long term (6 months). Such 
information may also support decisions regarding treatment and referral 
of patients. The performance (that is, calibration and discrimination) of 
the prediction rules was evaluated in the development study12. Calibration 
refers to what extent the observed frequencies agree with the predicted 
probabilities. Discrimination refers to the ability to distinguish between 
a patient with persistent symptoms and a patient without persistent 
symptoms. 
Before considering implementation of the prediction rules in clinical 
practice their generalisability needs to be tested.13-15 Generalisability refers 
to the performance in patients drawn from a diﬀerent but comparable 
population.13 Our objective was therefore to evaluate the performance 
of our clinical prediction rules for the prognosis of shoulder pain in a 
diﬀerent population of patients with shoulder pain in primary care. 
Methods
Dutch Shoulder Study
The Dutch Shoulder Study (DSS) is a comprehensive cohort study, 
carried out between January 2000 and May 2005. The DSS consists 
of one prognostic cohort study and three randomised controlled trials, 
which were carried out alongside each other. Between January 2001 
and June 2003, 103 general practitioners (GP) recruited patients at ﬁrst 
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consultation for a new episode of shoulder complaints in three geographic 
areas in the Netherlands (Amsterdam, Groningen and Maastricht). All 
patients in the DSS had to meet the same general inclusion criteria, and 
speciﬁc additional inclusion criteria if eligible for a trial (Table 1). For the 
prognostic cohort study no additional inclusion criteria were speciﬁed. 
Data of the prognostic cohort study were used to derive the prediction 
rules. Data of the control groups of the three trials were used to study the 
generalisability of the rules.
The Groningen Manipulation Study (GMO)16;17 studies the eﬀectiveness 
of manipulative therapy for the shoulder girdle in addition to usual care. 
In two other trials a Graded Exercise Therapy (GET)18 and an Education 
and Activation Program (EAP)19, respectively, were studied. Patients in the 
control groups of the trials received usual care, similar to the patients in 
the cohort study. 
Baseline and follow-up assessments for all patients in the DSS were 
identical. The outcome was measured by postal questionnaires at 6 
weeks, 3 and 6 months. The primary outcome measure ‘Patient perceived 
recovery’ was measured on an 8-point scale. Patients who did not 
report full recovery or very much improvement were denoted as having 
“persistent symptoms”.17;20 Secondary outcome measures were shoulder 
disability, measured with the 16-item shoulder disability questionnaire 
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Table 1  Selection criteria of the Dutch Shoulder Study 
General inclusion criteria
Patients older than 18 years of age
Not consulted GP or received any form of treatment for the aﬄicted shoulder in the preceding 3 months
Suﬃcient knowledge of the Dutch language 
Speciﬁc inclusion criteria trials
Groningen Manipulation Study (GMO)
Dysfunction of the cervicothoracic spine and adjacent ribs with accompanying pain or restricted movement
Graded Exercise Therapy Study (GET)
Duration of complaints >3 months
Education and Activation Program (EAP) 
Duration of complaints <3 months
Exclusion criteria
Severe physical or psychological conditions (i.e. fractures or luxation in the shoulder region; rheumatic 
disease; neoplasm; neurological or vascular disorders; dementia)
(SDQ; 0-100)21, pain (0-10 numeric rating scale)20, and severity of the 
main complaint (0-10 numeric rating scale)22. 
Management of shoulder pain
All participants in the cohort study and the trial participants randomised 
to the control groups, received standardised treatment according to the 
1999 version of the Dutch guidelines for shoulder disorders issued by the 
Dutch College of General Practitioners.23;24 The guidelines recommend 
giving information on the prognosis of shoulder pain, advice regarding 
provoking activities, and stepwise treatment consisting of paracetamol, 
Non-Steroidal Anti-Inﬂammatory Drugs (NSAIDs), corticosteroid 
injection or referral for physiotherapy. The GP made the decision 
regarding the content of treatment based on duration and severity of pain 
and disability. The participating general practitioners were educated and 
trained to apply treatment according to this guideline. 
Prediction rules
The prediction rules for persistent symptoms (yes/no) after 6 weeks and 
6 months were developed using information from the 587 patients of the 
derivation cohort. Sociodemographic variables, disease characteristics (i.e. 
pain intensity, disability, duration of complaints, onset, comorbidity), 
physical workload, psychosocial factors and results of a physical examination 
were used  to derive the prediction rules. We tested the internal validity 
with bootstrapping techniques.13 The calibration of the prediction rules 
was adequate. The discriminative ability was satisfactory with area under 
the receiver operating characteristic (ROC) curve of 0.74 (95% CI 0.70; 
0.79) at 6 weeks and 0.67 (95% CI 0.63; 0.71) at 6 months. Figure 1 
presents the prediction rules as score charts, which development has been 
described in detail elsewhere.12 
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Instruction
If a predictor is scored positively, the given weight needs to be ﬁlled in. Subsequently the scores are added to calculate the ‘Total score’. 
From the table next to the score chart the risk (%) of persistent symptoms for an individual patient can be determined.
Score chart for prediction of persistent shoulder symptoms at 6 weeks
Duration of complaints 
<6 weeks
6-12 weeks
>3 months
Gradual onset
Concomitant psychological complaints
Repetitive movements
Shoulder pain (0-10)
Neck pain score at PE (0-18)
0
7
11
7
10
8
score
score
…
…
…
…
…
…
…
…
+
 Total score
≤2
3 – 7
8 – 11
12 – 16
17– 21
22 – 27
28 – 36
≥37
Risk
20% - 30%
30% - 40%
40% - 50%
50% - 60%
60% - 70%
70% - 80%
80% - 90%
  90% - 100%
Total score …
Score chart for prediction of persistent shoulder symptoms at 6 months
Duration of complaints 
<6 weeks
6-12 weeks
>3 months
Gradual onset
Concomitant low back pain
Shoulder pain (0-10)
Shoulder pain score at PE (0-18)
0
9
17
10
13
score x 2
score
…
…
…
…
…
…
…
+
 Total score
≤1
2 – 16
17 – 28
29 – 39
40– 49
50 – 61
≥62
Risk
10% - 20%
20% - 30%
30% - 40%
40% - 50%
50% - 60%
60% - 70%
  70% - 100%
Total score …
Figure 1  Prognostic score charts for prediction of persistent symptoms at 6 weeks and 6 months
PE = Physical Examination
The predicted probability of persistent symptoms at 6 weeks was determined by P=1/[1+ exp – (–1.19 + 0.64 × duration of complaints 
6-12 weeks + 0.95 × duration of complaints >3 months + 0.59 × gradual onset  + 0.85 × concomitant psychological complaints  + 0.68 
× repetitive movements  + 0.13 × shoulder pain + 0.09 × neck pain score at physical examination)]. 
PE = Physical Examination
The predicted probability of persistent symptoms at 6 months was determined by P=1/[1+ exp – (–1.48 + 0.34 × duration of 
complaints 6-12 weeks + 0.64 × duration of complaints >3 months + 0.37 × gradual onset  + 0.50 × concomitant low back pain + 
0.08 × shoulder pain + 0.04 × shoulder pain score at physical examination)].
Analysis
The performance of the prediction rules was tested in the validation cohort 
by evaluating their calibration and discrimination. Calibration was assessed 
by plotting the predicted probabilities of persistent symptoms according 
to the prediction rule, against the observed frequencies. For this, patients 
were grouped into quintiles according to their predicted probability of 
persistent symptoms. The prevalence of the endpoint within each quintile 
equals the observed frequency. A more formal indication of calibration can 
be obtained by ﬁtting a logistic regression model with the logodds of the 
predicted risks as only covariate. This model has an intercept and a slope. 
If predicted risks and observed frequencies are in agreement, the intercept 
is equal to 0 and the slope equal to 1.
The area under the ROC curve was used to assess the discriminative 
ability of the model. An area under the curve (AUC) of 0.5 indicates no 
discrimination above chance, whereas an AUC of 1.0 indicates perfect 
discrimination. Since the discriminative ability of a rule is related to the 
homogeneity of the sample in which the rule is applied, we estimated 
the maximum attainable AUC. Using the predicted risks of the patients 
in the validation cohort, outcomes were generated with Monte Carlo 
Simulation.25;26 This mimics the situation that the model is perfectly 
calibrated. The AUC that was estimated for the predicted risks and 
generated outcomes was considered the maximum attainable AUC for the 
validation sample.
Furthermore, to gain insight in the performance of our prediction rules, 
we estimated the multivariable logistic regression coeﬃcients for each 
of the predictors of our prediction rule in the validation cohort. This 
analysis shows which of the diﬀerent elements of the rule are the strongest 
predictors of persistent shoulder pain in the validation cohort.
Results
Study population
Table 2 presents the baseline characteristics of the derivation cohort and 
validation cohort. Patients in the validation cohort clearly showed a longer 
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duration of complaints at baseline (13% less often complaints between 
0-6 weeks, and 14% more often complaints >3 months), and reported 
10% more neck complaints in the past in comparison with the derivation 
cohort. 
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Table 2 Description of baseline characteristics and outcome measures at 6 weeks and 6 months of patients 
with shoulder pain in the derivation (n=587) and validation cohort (n=212)
Baseline characteristics Derivation Validation
Demographic
Age (years); mean (SD)
Gender: male; n (%)
51 (14)
292 (50)
51 (12)
92 (44)
Disease characteristics
Duration of complaints; n (%)
 0-6 weeks* 
 7-12 weeks
 >3 months
Gradual onset (vs. acute); n (%)
Precipitating cause; n ( %)
 Strain/overuse: usual activities
Shoulder complaints in the past; n (%)
Neck complaints in the past; n ( %)
Comorbid psychological complaints; n (%)
Concomitant musculoskeletal complaints; n (%)
 Neck/high back
 Low back pain
 Upper extremity
Shoulder pain (0-10); mean (SD)
Shoulder disability (0-100); mean (SD)
205 (35)
139 (24)
242 (41)
363 (62)
138 (24)
348 (62)
296 (51)
55 (9)
209 (36)
139 (24)
174 (30)
4.8 (2.3)
60 (24)
46 (22)
49 (23)
115 (55)
144 (69)
58 (28)
136 (65)
128 (61)
20 (10)
85 (41)
59 (28)
76 (36)
5.3 (2.2)
62 (24)
Physical examination
Shoulder pain score (0-18); median (IQR)
Neck pain score (0-18); median (IQR)
4 (2-4)
0 (0-0)
7 (4-7)
2 (0-2)
Physical factors
Dynamic physical workload (0-5); median (IQR)
Repetitive movements; n ( %)
1 (1-2)
384 (65)
1 (0-1)
151 (73)
Outcome measures 6 weeks 6 months 6 weeks 6 months
Persistent symptoms; n (%)
Pain* (0-10); mean (SD)
Shoulder disability* (0-100); mean (SD)
Severity of main complaint* (0-10); mean (SD)
340 (70)
4.3 (2.1)
53.0 (25.5)
4.8 (2.6)
249 (46)
4.1(2.3)
52.2 (26.7)
5.0 (2.8)
161 (89)
4.3 (2.1)
56.0 (25.6)
4.9 (2.5)
125 (69)
4.0 (2.0)
54.4 (27.2)
5.6 (2.6)
SD= standard deviation; IQR = Inter quartile range; *Mean and SD presented for group reporting persistent symptoms.
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Course of symptoms
Table 2 shows that more patients in the validation cohort reported 
persistent symptoms after 6 weeks (89% versus 70%) and 6 months (69% 
versus 46%), compared to the derivation cohort. Nevertheless, patients 
in the derivation and validation cohort reported similar levels of pain and 
disability at the diﬀerent time points. Likewise, patients reporting recovery 
in the validation cohort and in the derivation cohort showed similar low 
levels of pain (<1 point), disability (<13 points), and severity of the main 
complaint (<1 point). 
Management of shoulder pain
At baseline most patients in the derivation cohort (n=423, 72%) received 
a wait and see policy, paracetamol, or NSAIDs. Furthermore, 68 patients 
(12%) received an injection with corticosteroid, 58 patients (10%) were 
referred for physiotherapy and 28 patients (6%) received other therapies. 
In the validation cohort 141 patients (83%) received a wait and see policy, 
paracetamol, or NSAIDS; 9 patients (5%) received an injection; 11 
patients (7%) were referred for physiotherapy and 8 patients (5%) received 
other therapies.
Performance 
Figure 2 shows the calibration of the predictions. For 6 weeks the plotted 
points were rather close to the 45° line, although most predictions 
slightly underestimated the observed probabilities. This is in agreement 
with an intercept of 0.44 in a model, using the logodds of the predicted 
probabilities as only covariate. The intercept above 0 confrims that the 
predicted probabilities were generally too low. The slope of the model was 
1.1, which is close to 1. 
For 6 months the plotted points were further away of the 45° line, 
demonstrating a rather poor calibration of the model. This is conﬁrmed by 
an intercept of 0.39 (not close to 0) and a slope of 0.43 (not close to 1).
The discriminative ability (AUCs) of the prediction rules was 0.72 (95% 
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Figure 2 Calibration plots showing the observed frequencies versus the predicted probabilities for persistent 
symptoms at 6 weeks (n=175) and 6 months (n=180) in the validation cohort. 
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CI 0.63; 0.82) at 6 weeks, and 0.57 (95% CI 0.48; 0.66) at 6 months. The 
Monte Carlo Simulation showed a maximum attainable AUC of 0.70 at 6 
weeks, and 0.64 at 6 months.
Table 3 shows the estimates of the regression coeﬃcients for each predictor 
when the rule is applied to the validation cohort. A duration of  complaints 
>3 months and repetitive movements were strong predictors of persistent 
symptoms at 6 weeks. For long term outcomes a duration >3 months and 
a gradual onset seemed strongly related with persistent symptoms at 6 
months. 
Discussion
The performance of the prediction rule for the short term (6 weeks) 
prognosis of shoulder pain in the validation cohort was satisfactory. 
Calibration and discriminative ability were reasonable, and similar to 
Table 3  Prediction rules for persistent shoulder symptoms at 6 weeks and 6 months after ﬁrst consultation. 
Derivation Validation
Predictor Scale β 95% CI β 95% CI
6 weeks 
Duration of complaints 
0-6 weeks*
7-12 weeks
>3 months
Gradual onset 
Concomitant psychological complaints
Repetitive movements
Shoulder pain
Neck pain score at physical examination
(yes/no)
(yes/no)
(yes/no)
(yes/no)
(yes/no)
(0-10) 
(0-18)
-
0.64
0.95
0.59
0.85
0.68
0.13
0.09
  0.1, 1.2
  0.4, 1.5
  0.1, 1.1
 -0.1, 1.9
  0.2, 1.1
  0.0, 0.2
  0.0, 1.0
 -
 0.42
 1.67
 0.36
 0.74
 1.05
 0.06
 0.03
-0.9, 1.7
 0.2, 3.1
-0.7, 1.4
-1.5, 3.0
-0.1, 2.2
-0.2, 0.3
-0.1, 0.2
6 months 
Duration of complaints 
0-6 weeks* 
7-12 weeks
>3 months
Gradual onset 
Concomitant low back pain
Shoulder pain 
Shoulder pain score at physical examination
(yes/no)
(yes/no)
(yes/no)
(yes/no)
(0-10)
(0-18)
-
0.34
0.64
0.37
0.50
0.08
0.04
 -0.1, 0.8
  0.2, 0.1
  0.0, 0.6
  0.1, 0.9
  0.0, 0.2
  0.0, 0.1
-
-0.10
 1.24
 0.70
 0.01
 0.04
 0.09
-1.3, 1.1
-0.1, 2.6
-0.3, 1.7
-1.1, 1.2
-0.2, 0.3
-0.0, 0.2
The β’s are derived from a multiple logistic regression analysis. The β’s for the validation cohort are derived from the results of a 
multiple logistic regression analysis conducted with the predictors from the derivation cohort. *Reference category  CI=Conﬁdence 
Interval  
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that found in the derivation cohort (AUC=0.74 in derivation cohort, and 
AUC=0.72 in validation cohort). The prediction rule for long term (6 
months) outcome showed poor calibration and discrimination. The AUC 
decreased from 0.67 in the derivation cohort to 0.57 in the validation 
cohort, not much more than a ﬂip of a coin (AUC=0.50), which means 
that the performance of the long term prediction rule was disappointing.
The patients in the validation cohort diﬀered from the derivation cohort 
regarding several aspects. In general, the shoulder complaints from the 
patients in the validation cohort were more severe (Table 2). They showed a 
longer duration of symptoms, which is an important predictor of outcome12, 
and reported more neck complaints in the past. This may indicate that we 
have tested the performance of the prediction rule in patients who, on 
average, were more advanced in their disease process or who may have had 
a somewhat diﬀerent type of shoulder problem (which has been described 
as spectrum transportability13). More severe complaints at baseline may 
have resulted in more frequent reports of persistent symptoms (Table 
2). Another possible explanation for the higher occurrence of persistent 
symptoms could be that the validation cohort more often received a wait 
and see policy (83% versus 72%) and were less frequently treated with 
local inﬁltration of a corticosteroid (5% versus 12%). 
Diﬀerences in prognosis between the derivation and validation cohort 
may have substantially altered the calibration of our prediction rules in 
the validation cohort, especially for the long term. The reason for this is 
that statistical models are calibrated to the overall outcome prevalence. 
For a substantial part, this prevalence is determined by the characteristics 
of the patient population. As long as the overall prevalence is explained 
by predictors which are included in the prediction rule, the model will 
still be well calibrated. This may have resulted in a reasonable calibration 
of our short term prediction rule, despite diﬀerences at baseline between 
the derivation and validation cohort regarding important predictors, i.e. 
duration of complaints and repetitive movement. The poor performance 
of the prediction rule for long term outcomes may be explained by patient 
characteristics which are not documented in this study, but yet strongly 
inﬂuenced outcome in the validation cohort. 
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The maximum attainable AUC for the short term of 0.70 strengthens our 
ﬁndings of adequate discriminative ability of this rule. Calibration was 
reasonable, although an intercept of 0.44 showed that the risk of persistent 
shoulder pain was generally underestimated (see also Figure 2). For the 
long term, a substantially lower maximum attainable AUC of 0.64 diﬀered 
considerably from the achieved AUC of 0.57. This indicated a model 
with poor discriminative ability. Regression coeﬃcients were generally 
to high, and insuﬃcient shrinking of the regression coeﬃcients had been 
achieved in the development stage of the prediction rule. Justice13 stated 
that perhaps the most diﬃcult test of discrimination occurs when the 
spectrum of a disease narrows from both sides; that is, the test sample 
includes many patients who have an illness of intermediate severity and 
very few who are either severely ill or not very ill at all. This could partly 
explain the poor performance of our long term prediction rule as most 
observed probabilities of persistent symptoms were distributed between 
0.5 and 0.7 (Figure 2). This reﬂects a homogeneous  population resulting 
in a low maximum attainable AUC of 0.64.
We developed prediction rules to predict the prognosis of shoulder pain in 
general practice. Most elements of the prediction rules were derived from 
a questionnaire, ﬁlled out by the patient. If these prediction rules would 
be implemented in daily practice it is the general practitioner who asks 
the questions and calculates the risk by using a score chart. Or in a more 
sophisticated way, enters the responses into a personal computer (PC) or 
personal digital assistant (PDA), which calculates the risk of persistent 
symptoms. So, future research should also evaluate the methodologic 
transportability of the prediction rules (i.e. performance when data are 
collected by using alternative methods13) in a new sample of patients. And 
perhaps most importantly, the clinical usefulness of these instruments 
should be established: can the prediction rules be helpful to the clinician 
when making decisions in the management of patients with shoulder pain, 
for example, whether or not to consider additional diagnostic testing, start 
a certain treatment or refer the patient to secondary care.15
In conclusion, the prediction rule for the short term (6 weeks) prognosis 
of shoulder pain in general practice showed adequate generalisability in 
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the validation cohort. For the long term outcome (6 months) it seems 
diﬃcult to make accurate predictions of persistent shoulder pain in this 
population.
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A prediction rule for shoulder pain 
related sick leave

Background  Shoulder pain is common in primary care, and has an 
unfavourable outcome in many patients. Information about predictors of 
shoulder pain related sick leave in workers is scarce and inconsistent.
Objective  To develop a clinical prediction rule for calculating the risk 
of shoulder pain related sick leave for individual workers, during the 6 
months following ﬁrst consultation in general practice. 
Methods  A prospective cohort study with 6 months follow-up was 
conducted among 350 workers with a new episode of shoulder pain. 
Potential predictors included the results of a physical examination, 
sociodemographic variables, disease characteristics (duration of symptoms, 
sick leave in the 2 months prior to consultation, pain intensity, disability, 
comorbidity), physical activity, physical workload, and (work related) 
psychosocial factors. The main outcome measure was sick leave during 6 
months following ﬁrst consultation in general practice. 
Results  Response rate to the follow-up questionnaire at 6 months was 
85%. During the 6 months after ﬁrst consultation 30% (89/298) of 
the workers reported sick leave. 16% (47) reported 10 days sick leave or 
more. Sick leave during this period was predicted in a multivariable model 
by a longer duration of sick leave prior to consultation, more shoulder 
pain, strain (overuse) as a result of usual activities, and concomitant 
psychological complaints. The discriminative ability of the prediction 
model was satisfactory with an area under the curve of 0.70 (95% CI 
0.64; 0.76).
Conclusions  Although 30% of all workers with shoulder pain reported 
sick leave during follow-up, the duration of sick leave was limited to a 
few days in most workers. We developed a prediction rule and a score 
chart that can be used by general practitioners and occupational health 
care providers to calculate the absolute risk of sick leave in individual 
workers with shoulder pain, which may help to identify workers who need 
additional attention. The performance of our models needs to be tested in 
other working populations with shoulder pain to enable valid and reliable 
use of the score charts in everyday practice. 
ABSTRACT
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Introduction
Shoulder pain is common with a one-year prevalence ranging between 
5% and 47%.1-7  In occupational settings, the one year prevalence ranges 
between 16% and 47%.3-5 A Finnish study8 reported a one-year incidence 
of shoulder pain of 14% among forestry workers. Shoulder pain has an 
unfavourable outcome in many patients. About 50% of all new episodes 
of shoulder disorders presented in primary care show complete recovery 
within 6 months9-11, while after one year this proportion increases to only 
60%.10 In an occupational study a one year persistence of shoulder pain of 
55% was reported.8
In a systematic review of the literature we summarized the available evidence 
from 16 studies regarding prognostic factors of shoulder disorders.12 Only 
six studies were of relatively high quality. In an occupational setting strong 
evidence for predicting poorer outcome was only found for age (45-54 
years). Evidence for (work related) psychosocial variables was lacking.2 In 
a systematic review of occupational risk factors it has been  suggested that 
many factors play a role in the occurrence of new episodes of shoulder 
pain, including physical load and the psychosocial work environment.13 
Also in studies on other musculoskeletal disorders, such as low back pain 
or neck pain, a relationship between work-related psychosocial factors and 
the occurrence of pain or sickness absence has been reported.14;15 Possibly 
these factors are also of importance in the persistence of shoulder pain 
related sick leave, and may help to identify workers who need additional 
attention.
We performed a cohort study among workers who had presented shoulder 
complaints to their general practitioner, and followed them for 6 months. 
Our objective was to develop a score chart to identify workers who will 
report at least 1 day of shoulder pain related sick leave during 6 months 
following ﬁrst consultation for their complaints. 
Methods
Study population
Between January 2001 and June 2003, 103 general practitioners recruited 
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workers with a new episode of shoulder disorders in three geographic area’s 
in the Netherlands (Amsterdam, Groningen and Maastricht). Workers 
were selected if they were older than 18 years of age, had a paid job, and 
did not consult their GP or receive any form of treatment in the preceding 
3 months for the aﬄicted shoulder. Suﬃcient knowledge of the Dutch 
language was required to complete written questionnaires. Exclusion 
criteria were severe physical or psychological conditions (i.e. fractures 
or dislocation in the shoulder region; rheumatic disease; neoplasm; 
neurological or vascular disorders; dementia). There was no restriction 
with respect to type of work or occupation.
Management of shoulder disorders
All workers received standardised treatment according to the 1999 version 
of the Dutch guidelines for shoulder disorders issued by the Dutch College 
of General Practitioners16;17 which consists of information on the prognosis 
of shoulder pain, advice regarding provoking activities, and stepwise 
treatment consisting of paracetamol, NSAIDs, corticosteroid injection 
or referral for physiotherapy. The GP made the decision regarding the 
content of treatment based on duration and severity of pain and disability. 
The participating general practitioners were educated and trained to apply 
treatment according to this guideline. 
Prognostic factors
Within a few days after consultation all workers completed a questionnaire, 
which contained questions on sociodemographic variables, disease 
characteristics (i.e. pain intensity, disability, duration of complaints, sick 
leave in the 2 months prior to consultation, pain onset, comorbidity), 
physical activity, physical workload, work-related psychosocial factors, and 
individual psychological factors. A physical examination was carried out 
by a trained assistant. 
Physical activity was measured with a single question (less/equally/more 
active than others). We measured physical workload with a self-constructed 
scale of  5 questions concerning pushing and pulling, lifting weights, and 
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working with hands above shoulder level, on at least two days a week (total 
score 0-5, Crohnbach’s α= 0.74). Repetitive movements and sitting in the 
same position for extended time periods, on at least two days a week, were 
measured with single questions answered by yes or no. 
Work-related psychosocial factors, were assessed with the 27-item Job 
Content Questionnaire (JCQ)18, which measures all dimensions of the 
widely used Demand-Control-Support model. On a four point scale 
(totally disagree, disagree, agree, totally agree) workers rated certain 
aspects of their work. The JCQ consists of the dimensions quantitative 
job demands (4-20); skill discretion (4-20); decision authority (4-12); 
co-worker support (4-16) and supervisor support (4-16), as proposed by 
Karasek et al.18 and clinimetrically evaluated by De Jonge et al.19
The following individual psychosocial variables were measured: coping, 
anxiety, depression, somatization, distress, fear-avoidance beliefs, and 
kinesiophobia. Coping was assessed with the 43-item Pain Coping and 
Cognition List (PCCL)20, consisting of the subdomains catastrophizing 
(1-6 points), coping with pain (1-6 points), internal (1-6 points) and 
external locus of control (1-6 points). Anxiety (0-24 points), depression 
(0-12 points), somatization (0-32 points), and distress (0-32 points), were 
measured with the 50-item Four-Dimensional Symptom Questionnaire 
(4DSQ).21 Fear-avoidance beliefs were assessed using the 4-item physical 
activity subscale of the Fear Avoidance Beliefs Questionnaire (FABQ; 0-
24).22 Kinesiophobia was measured using two items of the Tampa Scale for 
Kinesiophobia (TSK; 0-12).23 Our baseline questionnaire also included 
a general one-item question regarding the presence (yes/no) of any 
psychological problems (e.g. distress, depression, anxiety).
The physical examination by a research assistant contained testing of the 
shoulder joint and cervicothoracic spine. For the glenohumeral joint active 
and passive abduction, passive exorotation, and shoulder impingement24 
were tested. Two alternative functional tests, HIB (Hand-in-back) and 
HIN (Hand-in-neck)25;26 measured on a 7-point scale were performed as 
well. The mobility of the cervicothoracic spine was tested with ﬂexion, 
with extension, with rotation in ﬂexed, extended and neutral position and 
with lateral bending. During all mobility tests pain was assessed on a 4-
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point scale (0 = no pain; 3 = severe pain). A factor analysis on the results 
of a physical examination in a similar population of patients with shoulder 
disorders resulted in four factors: shoulder mobility (0-18), shoulder pain 
(0-18), neck mobility (0-4) and neck pain (0-18).27
Outcome measurements
The outcome was measured by postal questionnaires at 6 weeks, 3 and 6 
months. Our primary outcome measure was sick leave due to shoulder 
pain (yes =≥1 day, no = 0 days). Secondary outcome measures were patient 
perceived recovery, shoulder disability, measured with the 16-item shoulder 
disability questionnaire (SDQ; 0-100)28, shoulder pain (0-10 numeric 
rating scale)29, and severity of the main complaint (0-10 numeric rating 
scale)30. We studied the relationship between our primary and secondary 
outcome measures to determine if workers reporting sick leave during 
follow-up showed higher levels of pain and disability.
Analysis
Missing values of patient characteristics were imputed (approx. 2% of 
all required values). Imputation was based on the correlation between 
the variable with missing values with the other patient characteristics. 
Univariable logistic regression analyses were performed for all potential 
prognostic indicators with our primary outcome measure, i.e. sick 
leave during 6 months following ﬁrst consultation. Variables that had 
a statistically signiﬁcant association with the outcome (p-value ≤0.20) 
were selected for the backward selection in the multivariable analysis, 
and checked for co-linearity. If the correlation between the determinance 
was higher than 0.5, the most feasible was included in our analysis. We 
adopted a hierarchically approach in the variable selection in which 
easily obtainable predictors were included ﬁrst. Therefore, variables were 
selected in blocks of increasing eﬀort to obtain during consultation: 1) 
socio-demographic factors and disease characteristics; 2) physical factors; 
3) work-related psychosocial factors; 4) individual psychological factors; 
5) physical examination. Variables with the lowest predictive value were 
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deleted from the model until further elimination of a variable resulted in a 
statistically signiﬁcant lower model ﬁt estimated with the likelihood ratio 
test (p≤0.20).  
Prediction models, usually provide too extreme estimates, when in the 
development phase no correction is applied. Therefore, we used bootstrap 
samples to estimate a shrinkage factor.31 Bootstrap samples were drawn 
with replacement (100 replications) from the full data set. The backward 
selection of variables and model ﬁtting was repeated within each bootstrap 
sample.
Bootstrapping techniques were also used to study the internal validity of 
the ﬁnal prediction model.31;32 The model’s performance obtained after 
bootstrapping can be considered as the performance that can be expected 
in similar future patients. All analyses were performed using S-plus 6.1 
(Insightful Corp., Seattle, WA, USA).
Evaluation of the model
The reliability of the multivariable model was determined with the Hosmer-
Lemeshow goodness-of-ﬁt statistic.33 Calibration of the model predictions, 
which is related to reliability, was assessed by plotting the predicted 
individual probability against the observed sick leave. For this, workers 
were grouped into quintiles according to their predicted probability for sick 
leave according to the model. The prevalence of the endpoint within each 
quintile represents the observed frequency. The area under the receiver-
operating characteristic curve (ROC) was used to assess the performance 
of the model in terms of accuracy of correct prediction. The ROC-curve 
is a plot of the true positive rate (sensitivity) against the false-positive rate 
(1-speciﬁcity) of the model. The curve illustrates the ability of the model 
to discriminate between workers with and without sick leave at subsequent 
cut-oﬀ points along the range of the predicted probabilities. An area under 
the curve (AUC) of 0.5 indicates no discrimination above chance, whereas 
an AUC of 1.0 indicates perfect discrimination. 
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Prediction of an individual patient’s risk
We developed a clinical prediction rule34-36 for sick leave during 6 
months following ﬁrst consultation, to provide general practitioners and 
occupational health care providers with an estimate of the absolute risk 
of sick leave for individual workers. Since we used logistic regression, the 
probability (P) of sick leave was predicted with P=1/[1+ exp– (a
0
 + b
1
x
1 
+ …… + b
j
x
j
)]. The status of a patient for any dummy or binary variable 
included in the prediction rule can be either 0 or 1, while for a (semi) 
continuous variable it takes the actual observed value.  
Score chart
To facilitate the calculation of an individual worker’s risk, we developed 
a score chart. We multiplied the regression coeﬃcients by 4 and rounded 
them to the nearest integer to form the scores for each of the predictors. 
The sum of these scores correspond to a range of risks of sick leave during 
follow-up.
Results
Study population and follow-up
A total of  350 workers with shoulder pain in primary care completed the 
baseline assessment. Table 1 lists the baseline characteristics. At 6 months 
298 (85%) workers returned the postal questionnaire. 
The drop-outs at 6 months (n=52) showed signiﬁcantly (p<0.10) more 
pain of the shoulder (2.4 vs. 2.3 points) and the neck (2.8 vs. 2.6 points) 
at physical examination and less decision authority (4.4 vs. 5.5 points) at 
baseline.
During the 6 months following ﬁrst consultation 30% (89/298) of the 
workers reported at least one day of sick leave (primary outcome measure) 
because of their shoulder pain, and 16% (47/298) of the workers reported 
more than 10 days of shoulder pain related sick leave in 6 months. For 25 
of the 89 workers with sick leave, this was limited to the ﬁrst 6 weeks of 
follow-up. Table 2 shows that workers with sick leave reported also more 
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Table 1  Baseline characteristics of a working population with shoulder disorders (n=350), and univariable 
associations with sick leave (yes/no) during 6 months following ﬁrst consultation in general practice
Variable n (%) OR 95% CI pa
Demographic
Age (years); mean (SD)
Gender: male 
Education
      Low*
      Middle
      High
45 (11)
193 (55)
98 (28)
148 (43)
99 (29)
1.0
0.9
-
0.5
0.4
1.0, 1.0
0.5, 1.4
0.3, 0.9
0.2, 0.9
0.26
0.56
0.02
Disease characteristics
Duration of complaints 
0-6 weeks* 
7-12 weeks
>3 months
Sick leave at baseline in preceding 2 months
0 weeks* 
≤1 weeks
>1 weeks
Gradual onset (vs. acute)
Precipitating cause
Unexpected movement
Strain/overuse: unusual activities
Strain/overuse: usual activities
Injury
Sport injury
Unknown
Shoulder complaints in the past 
Neck complaints in the past
Dominant side involved
Comorbid psychological complaints
Concomitant musculoskeletal complaints
Neck/high back
Low back pain
Upper extremity
Lower extremity
Shoulder pain (0-10); mean (SD)
0-3 points* 
4-6 points
7-10 points
Shoulder disability (SDQ) (0-100); mean (SD)
139 (40)
77 (22)
134 (38)
254 (74)
44 (13)
46 (13)
212 (61)
16 (5)
56 (16)
99 (28)
15 (4)
22 (6)
133 (38)
199 (57)
165 (48)
210 (60)
27 (8)
119 (34)
61 (17)
96 (27)
77 (22)
4.5 (2.3)
58.4 (24.0)
-
1.1
0.9
-
1.8
3.3
1.0
1.7
0.5
2.4
4..4
0.5
1.4
1.4
1.5
1.5
5.4
1.6
1.3
1.4
0.7
-
2.4
2.3
1.9
0.6, 2.1
0.5, 1.5
0.9, 3.9
1.6, 6.9
0.6, 1.6
0.5, 5.6
0.2, 1.1
1.4, 4.1
1.4, 15.3
0.1, 1.7
0.9, 2.4
0.8, 2.3
0.9, 2.4
0.9, 2.4
2.0, 13.9
1.0, 2.7
0.6, 2.4
0.8, 2.5
0.4, 1.3
1.3, 4.5
1.2, 4.5
0.8, 4.8
0.77
<0.001
0.89
0.36
0.08
<0.001
0.01
0.26
0.17
0.19
0.11
0.15
<0.001
0.07
0.50
0.21
0.30
0.01
0.24
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  Table 1 continued
Variable n (%) OR 95% CI pa
Physical examination
ROM shoulder (0-18) (median, IQR)
Pain shoulder with movement (<12, ≥ 12 points )  
ROM neck (0-4) (median, IQR)
Pain neck with movement (0-18) (median, IQR)
3 (2-5)
6.3 (4.0)
0 (0-1.5)
0 (0-3)
0.7#
2.9#
1.2#
1.1
0.3, 1.6
1.3, 6.7
0.7, 2.2
1.0, 1.3
0.74
0.03
0.41
0.01
Physical factors
Physical workload (0-5) (median, IQR)
Repetitive movements (yes/no)
Sitting in static position for long duration (yes/no)
Physical activity in comparison to others
more active*
equally active 
less active
1.6 (1.6)
279 (80)
138 (40)
130 (37)
158 (45)
60 (17)
1.3
1.0
1.2
-
1.5
2.2
1.1, 1.5
0.6, 1.9
0.7, 1.9
0.9, 2.7
1.1, 4.5
0.01
0.97
0.54
0.09
Psychosocial factors
Coping; mean (SD)
Catastrophizing (1-6) 
Coping with pain (1-6) 
Internal locus of control (1-6) 
External locus of control (1-6) 
4DSQ (median, IQR)
Distress (0-32) 
Depression (0-12)b
Anxiety (0-24)b
Somatization (0-32) 
Fear-avoidance (0-24); mean (SD)
Kinesiophobia (0-12); mean (SD)
2.2 (0.8)
2.9 (1.0)
3.4 (0.9)
3.1 (0.9)
0 (0-2)
0 (0-0)
0 (0-0)
2 (0-4)
14.4 (5.0)
3.3 (3.4)
1.6
2.6#
1.5#
1.9#
4.4$
-
-
3.0$
1.1
1.7#
1.1, 2.2
0.4, 17.9
0.4, 5.5
0.3, 14.2
1.3, 15.5
1.0, 9.1
1.0, 1.1
0.5, 5.3
0.01
0.44
0.76
0.76
0.01
0.05
0.04
0.07
Work-related psychosocial factors 
Quantitative job demands (4-20); mean (SD)
Skill discretion (4-20); mean (SD)
Decision authority (4-12); mean (SD)
Co-worker support (4-16); mean (SD)
Supervisor support (4-16); mean (SD)
12.8 (2.7)
15.3 (2.8)
9.4 (1.8)
12.3 (2.0)
11.2 (2.5)
1.4#
1.8&
0.8
10.1&
2.0&
0.6, 3.0
0.6, 5.3
0.7, 0.9
1.1, 92.4
0.9, 4.2
0.68
0.57
<0.001
0.07
0.20
SD= standard deviation; IQR = Inter quartile range;  ROM = Range of Motion; 4DSQ = Four-dimensional symptom questionnaire. 
aVariables with a univariable p-value ≤0.20 were selected for the multivariable analysis. bORs haven’t been computed due to empty 
cells in the cross-tables. *Reference category. #In case of non-linear associations continuous variables were divided into categories. The 
table presents the Odds Ratio (OR) for the highest versus lowest category. &ORs were computed for lowest versus highest categories. 
$Variable was dichotomised. 
persistent symptoms, more pain (p<0.05), more shoulder disability, and 
higher severity of the main complaint at baseline (p<0.05).
Management of shoulder disorders
At ﬁrst consultation most workers (n=253, 73%) received a wait and 
see policy, paracetamol, or NSAIDs. Furthermore at ﬁrst consultation, 
35 workers (10%) received an injection with corticosteroid, 41 workers 
(12%) were referred for physiotherapy and 17 workers (5%) received other 
therapies. 
Prognostic model
The univariable associations with shoulder pain related sick leave during 
the 6 months following ﬁrst consultation are presented in Table 1. Only 
variables which showed an univariable association (p≤0.20) were selected 
for the backward stepwise selection. Table 3 presents the variables for the 
prediction model after backward stepwise analysis. In the backward analysis 
the blocks physical factors, work-related psychosocial factors, individual 
psychological factors, and physical examination did not result in a better 
model ﬁt. A longer duration of sick leave prior to consultation, higher 
shoulder pain intensity, strain (overuse) as a result of usual activities and 
concomitant psychological complaints were associated with a higher risk 
of sick leave during 6 months. The multivariable regression coeﬃcients 
were additionally shrunk (shrinkage factor=0.72) to obtain optimism 
corrected predictions for new workers.
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Table 2  Secondary outcome measures at 6 months for patients with (n = 89) and without (n = 209) shoulder 
pain related sick leave during 6 months following ﬁrst consultation
Sick leave Yes No p
Persistent symptoms (%)
Pain (0-10)
Shoulder disability (SDQ) (0-100)
Severity of main complaint (0-10)
53
2.5 (2.7)
29.4 (30.4)
3.0 (3.3)
43
1.8 (2.4)
22.1 (28.8)
2.1 (2.8)
0.12
0.02
0.06
0.02
Evaluation of the model
The reliability of the model was adequate, according to the Hosmer-
Lemeshow statistic, with a non-statistically signiﬁcant p-value of 0.13. 
Figure 1 shows the calibration of the prediction model. The plotted points 
are rather close to the 45° line, demonstrating good calibration over the 
whole range of the predictions. The distribution of the predicted risk 
ranges between 15 and 75% (Figure 2). The AUC of 0.70 (95% CI 0.64; 
0.76) represents satisfactory discrimination.
Score charts
Figure 3 shows the score chart for predicting sick leave during 6 months 
after ﬁrst consultation. As an example, a worker with sick leave at baseline 
of 2 weeks (3 points), a score of 5 points on the shoulder pain scale (2 
points), and shoulder complaints caused by usual activities (3 points), has 
a total score of 8 points corresponding to a risk of 50-60% for sick leave 
during 6 months after consultation.
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Table 3  Multivariable model with predictors of shoulder pain related sick leave during 6 months following 
ﬁrst consultation (n=298)
Variable OR 95% CI
 Sick leave at baseline (in preceding 2 months)
0-weeks*
≤1 week
>1 months
Shoulder pain (0-10)
0-3 points*
4-6 points
7-10 points 
Strain, overuse: usual activities (yes/no)
Concomitant psychological complaints (yes/no)
1.7
2.2
1.7
1.9
1.9
4.0
0.8; 3.6
1.0; 4.7
0.9; 3.2
0.9; 3.9
1.1; 3.5
1.5; 10.8
*Reference category
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Figure 2  Distribution of predicted risk for sick leave during 6 months after ﬁrst consultation (n=298)
Figure 1  Calibration plot showing the observed frequencies versus the predicted probability for sick leave in 
workers with shoulder pain during 6 months following ﬁrst consultation. 
Patients were grouped into quintiles according to their predicted probability of persistent symptoms according to the prediction rules. 
The prevalence of the endpoint within each quintiles represents the observed individual frequency.
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Discussion
In this study we developed a score chart to predict shoulder pain related 
sick leave during 6 months following ﬁrst consultation. A longer duration 
of sick leave prior to consultation, shoulder pain, strain (overuse) as a 
result of usual activities and concomitant psychological complaints were 
associated with a higher risk of sick leave during 6 months following 
consultation.
Outcome
Even though 30% of all participants reported sick leave due to shoulder 
pain in the 6 months following consultation, only 16% reported sick leave 
during at least 10 days.  This seems to indicate that in our population, 
despite persisting pain and disability in many workers, sick leave was 
neither a very frequent nor long-lasting problem. An explanation could 
be that we did not select a high risk occupational group. Our population 
contained all kind of workers, irrespective of physical and psychosocial 
+
Sick leave in preceding 2 months 
0-weeks
0-1 week
>1 week
Shoulder pain
0-3 points
4-6 points
7-10 points
Strain, overuse: usual activities
Concomitant psychological complaints
0
2
3
0
2
3
3
6
…
…
…
…
…
…
…
…
 Total score
≤1
2 – 3
4 – 5
6 – 7
8
9 – 10
11 – 12
13 – 15
Risk
10% - 20%
20% - 30%
30% - 40%
40% - 50%
50% - 60%
60% - 70%
 70% - 80%
80% - 90%
Total score …
Instruction
If a predictor is scored positively, the given weight needs to be ﬁlled in. Subsequently the scores are added to calculate the ‘Total score’. 
From the table next to the score chart the risk (%) of sick leave for an individual patient can be determined.
The predicted probability of sick leave during 6 months was determined by P=1/[1+ exp – (–1.72 + 0.53 × sick leave 0-1 week + 0.77 
× sick leave >1 week + 0.50 × shoulder pain (4-6 points) + 0.65 × shoulder pain (7-10 points) + 0.68 × overuse due to usual activities 
+ 1.38 × concomitant psychological disorders)].
Figure 3  Prognostic score chart for prediction of sick leave during 6 months following ﬁrst consultation
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workload. Persistent symptoms, pain, and disability were also found among 
those who remained at work. The diﬀerences were not very large and only 
signiﬁcant for pain and the severity of the main complaint (Table 2). 
Prognostic factors
In a systematic review12 of the literature we found only strong evidence 
for age (45-54 years) as a predictor for poorer outcome. In our study 
no association was found for age with sick leave. It has previously been 
suggested that psychosocial factors such as inadequate pain cognitions 
and pain behaviour are likely to predict a poor outcome of painful 
musculoskeletal conditions.2 Furthermore, there is evidence that 
the psychosocial work environment (e.g. decision authority and job 
satisfaction)13 and heavy physical load (e.g. pushing and pulling, repetitive 
work)13;37 may be associated with an increased risk of new episodes of 
shoulder pain. Our study, however, shows that these risk factors do not 
predict prognosis among workers who have consulted a GP for their 
shoulder pain. The baseline scores on psychological and psychosocial 
variables were generally low in our population. Signiﬁcant univariable 
associations with sick leave during follow-up were found for several factors 
(distress, somatisation, catastrophising, fear avoidance, decision authority, 
and co-worker support), but in a multivariable model these factors had 
little to add to a few general and simple questions regarding the presence 
of psychological complaints, strain or overuse, pain intensity and sick 
leave at baseline. The prediction rule, consequently, contains easy to derive 
predictors. The prediction rule rather accurately estimates the risk of sick 
leave in individual workers with shoulder pain, and may help to identify 
workers who need additional attention. 
Model ﬁt and discrimination
The calibration plot (Figure 1) showed that the predicted probability 
categories were close to the ideal line. This indicates that in general the 
model was rather well calibrated over the complete range of predicted 
probabilities. The optimism corrected AUC of  0.70 implied satisfactory 
discrimination between shoulder patients with and without sick leave.
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Generalisability 
The response to the questionnaires was satisfactory in this study. Given 
the small diﬀerences at baseline of factors signiﬁcantly associated with 
drop-out, we assume that the results hold for our study population. Before 
considering implementation of our prognostic model (i.e. score chart) in 
general or occupational practice the generalisability (‘external validity’) of 
the model needs to be tested in other populations of workers with shoulder 
pain.38 First, the generalisability to another working population can be 
tested. If satisfactory, the generalisability to a community sample, or 
secondary care populations may be tested.
Score charts
The score charts in our study were developed to provide primary or 
occupational care physicians with an easy tool to predict the risk of 
shoulder pain related sick leave. The score charts consist of easy ‘yes or 
no’ questions, and a simple question for shoulder pain (0-10). Preferably, 
a physicians should use the prediction rule, programmed in a PC or PDA 
to calculate a risk of sick leave by answering the questions. Because we feel 
that not every physician has access to these equipment, we developed the 
score chart to enable easy implementation in everyday practice.
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General isabi l ity of a prediction rule for 
shoulder pain related sick leave

Background  Recently we developed a clinical prediction rule to predict 
shoulder pain related sick leave during a period of 6 months after patients 
have consulted the GP for a new episode of shoulder pain.
Objective The objective was to evaluate the generalisability of this 
prediction rule by testing it in two other populations of workers consulting 
for a new episode of shoulder pain in primary care. 
Methods A large research program, the Dutch Shoulder Study (DSS), 
consisting of a prognostic cohort study and three randomized trials (RCTs) 
with 6 months follow-up, was carried out in diﬀerent geographic area’s in 
The Netherlands. The prediction rule was derived from the results of the 
prognostic cohort study (n=350). The outcome was shoulder pain related 
sick leave during 6 months following ﬁrst consultation. The control groups 
of the trials were merged (n=128), and used to validate the prediction 
rule. Besides this population, the recently conducted Musculoskeletal 
Disorder Study (BAS) (n=224) was used to validate the prediction rule. 
Generalisability of the prediction rule was tested by studying calibration 
and discrimination in the validation cohorts.
Results The prediction rule showed reasonable calibration in both 
validation cohorts. The discriminative ability, with an area under the ROC 
curve (AUC) of 0.70 in the derivation cohort was stable in the BAS cohort 
(AUC 0.71). In the control groups of the three RCTs of the DSS the 
discriminative ability decreased to an AUC of 0.66. 
Conclusions The prediction rule for shoulder pain related sick leave 
during 6 months following ﬁrst consultation in primary care showed 
adequate generalisability to another population of workers with shoulder 
pain participating in an observational cohort study. In the control groups 
of the three RCTs the prediction rule performed less well. An important 
next step in validating this prediction rule is to study it’s applicability and 
predictive validity in daily practice. 
ABSTRACT
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Introduction
Shoulder pain is common with a one-year prevalence ranging between 
5% and 47%.1-7  In occupational settings, the one year prevalence ranges 
between 16% and 47%.3-5 A Finnish study8 reported a one-year incidence 
of shoulder pain of 14% among forestry workers. Shoulder pain has an 
unfavourable outcome in many patients. About 40 to 50% of all patients 
who present with a new episode of shoulder pain in primary care report 
persistent pain and disability after 6 to 12 months.9-11 
Early identiﬁcation (risk stratiﬁcation) of patients with a high risk of 
shoulder pain related sick leave might enable timely intervention and 
prevent sick leave and the concomitant high costs these patients generate 
(Chapter 3). We developed a clinical prediction rule consisting of  4 easily 
measurable prognostic factors: sick leave at baseline in the preceding 2 
months (0/0-1/≥1 weeks); shoulder pain (0-10); strain/overuse due to usual 
activities as a precipitating cause (yes/no); and concomitant psychological 
complaints (yes/no). This rule predicts shoulder pain related sick leave 
during 6 months after ﬁrst consultation for patients with a new episode of 
shoulder pain in primary care. The performance (that is, calibration and 
discrimination) of the prediction rule was evaluated in the development 
study.12 Calibration refers to what extent the observed frequencies agree 
with the predicted probabilities of sick leave. Discrimination refers to the 
ability to distinguish between a patient with a high risk of sick leave and a 
patient who will not have to stay oﬀ work because of shoulder pain. 
Before considering implementation of the prediction rule in clinical 
practice the generalisability needs to be tested.13-15 Generalisability refers 
to the performance in patients drawn from a diﬀerent but comparable 
population.13 Our objective was to evaluate the performance of our clinical 
prediction rule for shoulder pain related sick leave in two diﬀerent cohorts 
of patients with shoulder pain in a primary care setting. 
Methods
In this study we evaluated the generalisability of the derived prediction 
rule from the Dutch Shoulder Study (DSS) in a subgroup of other patients 
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from this cohort and among participants of another prospective cohort 
study in general practice; the Musculoskeletal Disorder Study (BAS).
Dutch Shoulder Study
The Dutch Shoulder Study (DSS) is a comprehensive cohort study, 
carried out between January 2000 and May 2005. The DSS consists 
of one prognostic cohort study and three randomised controlled trials, 
which were carried out alongside each other. Between January 2001 
and June 2003, 103 general practitioners (GP) recruited patients at ﬁrst 
consultation for a new episode of shoulder complaints in three geographic 
areas in the Netherlands (Amsterdam, Groningen and Maastricht). All 
patients in the DSS had to meet the same general inclusion criteria, and 
speciﬁc additional inclusion criteria if eligible for a trial (Table 1). For the 
prognostic cohort study no additional inclusion criteria were speciﬁed. 
Data from the prognostic cohort study were used to derive the prediction 
rule. Data from the control groups of the three trials were used to study the 
generalisability of the rule. For the current study only patients reporting 
paid work were used.
The Groningen Manipulation Study (GMO)16;17 evaluates the eﬀectiveness 
of manipulative therapy for the shoulder girdle in addition to usual care. 
In two other trials a Graded Exercise Therapy (GET)18 and an Education 
and Activation Program (EAP)19, respectively, were studied. Patients in the 
control groups of the trials received usual care, similar to the patients in 
the cohort study. 
Baseline and follow-up assessments for all patients in the DSS were 
identical. The outcome was measured by postal questionnaires at 6 weeks, 
3 and 6 months. 
Musculoskeletal Disorder Study
The Musculoskeletal Disorder Study (BAS) is a large observational cohort 
study conducted in 61 general practices (97 GPs).20;21 GPs recruited 
patients who consulted for a new episode of musculoskeletal pain. For our 
generalisability study we selected patients who consulted for shoulder pain, 
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and who had paid work at baseline. Selection criteria were comparable with 
the DSS. Follow-up questionnaires were sent after 3, 6, and 12 months. 
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Prediction rule
The rule predicted shoulder pain related sick leave (yes ≥1 day, no=0 
days) during 6 months after ﬁrst consultation, and was developed using 
information from the 350 patients of the derivation cohort who reported 
paid work at baseline. Sociodemographic variables, disease characteristics 
(i.e. pain intensity, disability, duration of complaints, sick leave in the 2 
months prior to consultation, onset, comorbidity), physical workload, 
work-related psychosocial factors, psychological factors and results of a 
physical examination were documented. The questionnaire also included 
a general single-item question regarding the presence (yes/no) of any 
psychological problems (e.g. distress, depression, anxiety). These factors 
were used to compose a prognostic model and derive the prediction 
rule. We tested the internal validity with bootstrapping techniques and 
corrected the prediction rule for overoptimism.13 The calibration of the 
prediction rule was adequate. The discriminative ability was satisfactory 
with an area under the receiver operating characteristic (ROC) curve of 
Table 1  Selection criteria for the Dutch Shoulder Study (DSS) and Musculoskeletal Disorder Study (BAS)
General inclusion criteria DSS and BAS
Patients 18 years of age or older 
Paid work
Not consulted GP or received any form of treatment for the aﬄicted shoulder in the preceding 3 months
Suﬃcient knowledge of the Dutch language 
Speciﬁc inclusion criteria trials DSS
Groningen Manipulation Study (GMO)
Dysfunction of the cervicothoracic spine and adjacent ribs with accompanying pain or restricted 
movement
Graded Exercise Therapy Study (GET)
Duration of complaints >3 months
Education and Activation Program (EAP) 
Duration of complaints <3 months
Exclusion criteria DSS and BAS
Severe physical or psychological conditions (i.e. fractures or location in the shoulder region; rheumatic 
disease; neoplasm; neurological or vascular disorders; dementia)
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0.70 (95% CI 0.64+ 0.76). In Figure 1 the prediction rule is presented as 
a score chart. The development of this score chart and prediction rule has 
been described in detail elsewhere.12  
Analysis
The performance of the prediction rule was tested in the validation 
cohorts by evaluating its calibration and discrimination. Calibration was 
assessed by plotting the predicted probabilities of sick leave according to 
the prediction rule, against the observed frequencies. For this, patients 
were grouped into quintiles according to their predicted probability of 
sick leave. The prevalence of the endpoint within each quintile equals the 
observed frequency. 
The area under the ROC curve was used to assess the discriminative ability 
of the prediction rule. An area under the curve (AUC) of 0.5 indicates 
no discrimination above chance, whereas an AUC of 1.0 indicates perfect 
discrimination. Since the discriminative ability of a rule is related to the 
Sick leave in preceding 2 months 
0-weeks
0-1 week
>1 week
Shoulder pain
0-3 points
4-6 points
7-10 points
Strain, overuse: usual activities
Concomitant psychological complaints
0
2
3
0
2
3
3
6
…
…
…
…
…
…
…
…
 Total score
≤1
2 – 3
4 – 5
6 – 7
8
9 – 10
11 – 12
13 – 15
Risk
10% - 20%
20% - 30%
30% - 40%
40% - 50%
50% - 60%
60% - 70%
 70% - 80%
80% - 90%
Total score …
Instruction
If a predictor is scored positively, the given weight needs to be ﬁlled in. Subsequently the scores are added to calculate the ‘Total score’. 
From the table next to the score chart the risk (%) of sick leave for an individual patient can be determined.
The predicted probability of sick leave during 6 months was determined by P=1/[1+ exp – (–1.72 + 0.53 × sick leave 0-1 week + 0.77 
× sick leave >1 week + 0.50 × shoulder pain (4-6 points) + 0.65 × shoulder pain (7-10 points) + 0.68 × overuse due to usual activities 
+ 1.38 × concomitant psychological disorders)].
Figure 1  Prognostic score chart for prediction of sick leave during 6 months following ﬁrst consultation
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homogeneity of the sample in which the rule is applied, we also estimated 
the maximum attainable AUC in the validation cohorts. Using the 
predicted risks of the patients in the validation cohorts, outcomes were 
generated with Monte Carlo Simulation.22;23 The simulation mimics 
the situation that the model is perfectly calibrated. The AUC that is 
subsequently estimated for the predicted risks and generated outcomes is 
considered the maximum attainable AUC for the validation sample.
Furthermore, to gain insight into the performance of our prediction rule, 
we estimated the multivariable logistic regression coeﬃcients for each 
of the predictors of our prediction rule in the validation cohorts. This 
analysis shows which of the diﬀerent elements of the rule are the strongest 
predictors of sick leave in the validation cohorts.
Results
Study population
Table 2 presents the baseline characteristics of the derivation cohort and 
validation cohorts. Patients in the DSS control groups clearly showed a 
longer duration of complaints at baseline (>3 months: 51% versus 38%), 
and reported 10% more concomitant low back pain in comparison with 
the derivation cohort. Patients in the BAS were less often male (42% 
versus 55%), reported more often strain/overuse due to usual activities 
as a precipitating cause (46% versus 28%), and more often concomitant 
musculoskeletal complaints of the neck/high back (58% versus 34%) and 
low back (34% versus 17%). Patients in the derivation and validation 
cohorts reported similar percentages of sick leave during 6 months 
following ﬁrst consultation of sick leave (DSS derivation cohort: 30%, 
DSS control groups: 34%, and BAS: 32%).
 
Performance 
Figure 2 shows the calibration of the predictions. For the DSS control 
groups the predicted risks of sick leave are generally too high. Nevertheless 
the mean predicted probability of 0.37 was only slightly higher than the 
overall observed sick leave prevalence (0.32). For the BAS cohort most of 
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the plotted points were rather close to the 45° line, although 3 prediction 
categories slightly overestimated the observed probabilities. Again, the 
mean predicted probability (0.39) there was only slightly higher than the 
overall observed sick leave prevalence (0.34). The discriminative ability 
(AUCs) of the prediction rule was 0.66 (95% CI 0.56;  0.77) for the DSS 
controls groups, and 0.71 (95% CI 0.63;  0.80) for the BAS cohort. The 
results of the Monte Carlo Simulation show that these estimates are close 
to the maximum attainable AUC: 0.66 for the DSS controls, and 0.70 for 
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Table 2  Description of baseline characteristics in workers with shoulder pain in the derivation and validation 
cohorts 
Derivation Validation
DSS DSS-controls BAS
n=350 n=128 n=224
Demographic
Age (years); mean (SD)
Gender: male; n (%)
45 (11)
193 (55)
46 (9)
63 (50)
44 (10)
95 (42)
Disease characteristics
Duration of complaints >3 months; n (%)
Sick leave at baseline in preceding 2 months*; n (%)
0 weeks
≤1 weeks
>1 weeks
Precipitating cause
Strain/overuse: usual activities*; n (%)
Shoulder complaints in the past; n (%)
Concomitant psychological complaints*; n (%)
Concomitant musculoskeletal complaints; n (%)
Neck/high back
Low back pain
Shoulder pain (0-10)*; mean (SD)
134 (38)
254 (74)
44 (13)
46 (13)
99 (28)
199 (57)
27 (8)
119 (34)
61 (17)
4.5 (2.3)
65 (51)
98 (78)
8 (6)
20 (16)
40 (31)
79 (62)
10 (8)
51 (40)
34 (27)
5.2 (2.3)
90 (40)
149 (67)
30 (13)
45 (20)
104 (46)
114 (50)
37 (17)
128 (58)
77 (34)
4.9 (2.2)
Work-related psychosocial factors$
Quantitative job demands (4-20); mean (SD)
Decision authority (3-12); mean (SD)
Co-worker support (4-16); mean (SD)
12.8 (2.7)
9.4 (1.8)
12.3 (2.0)
12.6 (2.6)
9.6 (1.9)
12.3 (1.9)
13.1 (3.2)
9.1 (2.1)
12.3 (1.7)
DSS= Dutch Shoulder Study; BAS = Musculoskeletal Disorder Study;  SD= standard deviation; IQR = Inter quartile range; *variables 
which are in the prediction rule predicting shoulder pain related sick leave; $a score between 10 and 15 points reﬂects fair quantitative 
job demands; a score > 9 points reﬂects high decision authority; a score >12 points reﬂects high co-worker support.
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Figure 2  Calibration plots showing the observed frequencies versus the predicted probabilities for shoulder 
pain related sick leave during 6 months following ﬁrst consultation in primary care, for the DSS-controls 
(n=103) and the BAS cohort (n=176) 
Patients were grouped into quintiles according to their predicted probability of shoulder pain related sick leave according to the 
prediction rules. The prevalence of the endpoint within each quintiles represents the observed individual frequency.
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the BAS population.
Table 3 shows the multivariable regression coeﬃcients when the rule is 
applied to the validation cohorts. Shoulder pain was a strong predictor of 
sick leave in the DSS control groups and in the BAS cohort. In the BAS 
cohort sick leave in the preceding two months at baseline also showed a 
strong relation with sick leave during follow-up. The category ‘0-1 weeks’ 
showed a remarkable negative association with outcome. A similar opposite 
association in both validation cohorts was seen for the category ‘4-6 points 
shoulder pain’ in the BAS cohort. 
Discussion
The performance of the prediction rule of shoulder pain related sick 
leave in the DSS control groups showed an unstable calibration and a 
slightly decreased discriminative ability (AUC of 0.66, compared to 0.70 
in the derivation cohort). The prediction rule calibrated better in the BAS 
population and showed a stable discriminative ability (AUC 0.70).  
The unstable calibration in the DSS control groups may partly be a result 
of the small numbers (n=103) in this validation cohort. Other studies 
have also demonstrated that calibration of prediction rules can be unstable 
when applied in a small population.24 
Table 3 shows large diﬀerences between the regression coeﬃcients in the 
derivation cohort  and the DSS-controls. Shoulder pain was the only 
predictor in the DSS-controls with a large and signiﬁcant regression 
coeﬃcient. The decreased AUC of 0.66 was conﬁrmed by an equal 
maximum attainable AUC. This decreased discriminative ability may be a 
result of diﬀerences in baseline characteristics between the derivation and 
this validation cohort. Another explanation could be that these patients 
origin form clinical trials, which may imply diﬀerent patients characteristics 
regarding factors we have not documented, such as treatment preferences.
In the BAS cohort shoulder pain and sick leave at baseline in the preceding 
2 months showed substantial and signiﬁcant regression coeﬃcients (Table 
3). This, combined with higher regression coeﬃcients for strain/overuse 
due to usual activities and concomitant psychological complaints in the 
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BAS cohort compared to the DSS-controls, may have resulted in a better 
performance of the prediction rule in the BAS cohort. The substantial 
baseline diﬀerences between the derivation cohort and the BAS, regarding 
factors which were not included in the prediction rule (gender, strain or 
overuse due to unusual activities, and concomitant musculoskeletal pain), 
did not seem to alter the performance. The maximum attainable AUC in 
the BAS cohort of 0.70 strengthens our ﬁndings of adequate discriminative 
ability in this cohort. 
 We developed a prediction rule to predict shoulder pain related sick leave 
during 6 months after ﬁrst consultation. The elements of the prediction 
rule were derived from a questionnaire, ﬁlled out by the patient. If the 
prediction rule is used in daily practice, it is the physician who will ask 
the questions and calculate the risk by using a score chart. Or in a more 
sophisticated way, enters the responses into a personal computer (PC) or 
personal digital assistant (PDA), which calculates the risk of sick leave 
over the next six months. So, future research should also evaluate the 
methodologic transportability of the prediction rule (i.e. performance 
when data are collected by using alternative methods13) in a new sample 
of workers. And perhaps most importantly, the clinical usefulness of the 
instrument should be established: can the prediction rule be helpful in 
making decisions in the management of patients with shoulder pain, for 
example, whether or not to consider additional diagnostic testing, start a 
certain treatment or refer the patient to secondary care.15
In conclusion, the prediction rule for shoulder pain related sick leave during 
6 months after ﬁrst consultation showed disappointing generalisability in 
the DSS-controls and adequate generalisability in the BAS. 
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Are psychological  factors associated with 
persistent pain and disabi l ity in patients 
with shoulder pain or low back pain?

Background Psychological factors are assumed to be of prognostic 
importance and to predict the transition from acute to persistent pain. 
The inﬂuence of psychological factors has mainly been studied in low back 
pain, but may be equally important in other types of pain.
Objective  To study the inﬂuence of psychological factors on the risk of 
persistent symptoms and disability at three months after consultation 
in patients with shoulder pain (SP) or low back pain (LBP) in general 
practice. 
Methods  Patients presenting in general practice with a new episode of 
SP or (sub)acute LBP were enrolled in a prospective cohort study. In both 
patient groups psychological factors (catastrophizing thoughts, distress, 
somatization, and fear-avoidance beliefs) were measured at baseline. 
Primary outcome measures after three months were 1) persistent symptoms, 
and 2) less than 30% reduction in functional disability. Logistic regression 
analyses were used to study the association between baseline scores on 
psychological factors and outcome. Interaction with symptom duration at 
baseline was studied for each of the psychological factors.
Results  A total of 587 patients with SP and 171 patients with LBP were 
enrolled in the study. Drop-out rate at three months was 12% in patients 
with SP and 4% in patients with LBP. In patients with SP most associations 
of psychological factors with outcome were weak and not statistically 
signiﬁcant. In patients with (sub)acute LBP catastrophizing thoughts and 
somatization were strongly and signiﬁcantly associated with a higher risk 
of persistent symptoms and disability at follow-up.
Conclusions Psychological factors, in particular somatization and 
catastrophizing thoughts, are more strongly associated with persistent pain 
and disability in patients who consult their general practitioner for LBP 
than in patients with SP. This seems to indicate that diﬀerent mechanisms 
may explain the progression to persistent symptoms among patients 
with diﬀerent types of pain in primary care. Additional research needs to 
conﬁrm these ﬁndings and further explore the role of psychological factors 
in the development of chronic pain problems.
ABSTRACT
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Introduction
The associations between pain, disability and psychological factors have 
been widely studied, but mainly in cross-sectional research1-3 or in patients 
with chronic pain syndromes.4;5 Research among patients with more acute 
pain, preferably in a primary care setting, is needed to establish whether 
psychological factors also inﬂuence the progression from acute symptoms 
to chronic pain and disability. If these associations can be conﬁrmed, an 
early identiﬁcation and subsequent modiﬁcation of these factors may 
prevent chronic disability.6-8 Although relatively few studies have been 
carried out in primary care settings, a systematic review of the inﬂuence 
of psychosocial factors in low back pain concluded that distress and 
somatization are implicated in the transition from acute to chronic low 
back pain. Fear-avoidance and catastrophizing were mentioned as factors 
that deserve further investigation.9 
So far, research on the transition from acute to chronic pain has mainly 
been carried out in patients with low back pain, but similar mechanisms 
are assumed to be of importance in other musculoskeletal pain problems, 
such as shoulder pain.10 As yet, the inﬂuence of psychological factors has 
rarely been addressed in patients with shoulder pain. Prospective cohort 
studies in primary care have mainly studied the inﬂuence of disease 
characteristics, demonstrating that a high pain intensity at baseline is the 
strongest predictor of a poor outcome.11 
The objective of this cohort study was to investigate the associations of 
psychological factors with the risk of persistent symptoms and disability 
at three months after consulting a general practitioner for a new episode 
of shoulder pain or low back pain. We speciﬁcally studied the inﬂuence of 
catastrophizing thoughts, fear-avoidance beliefs, distress, and somatization 
as these are assumed to be of potential importance in the development 
of chronic pain problems9, and may be susceptible to intervention. We 
compared the inﬂuence of these factors in low back pain and shoulder 
pain to study whether there is similarity between diﬀerent types of 
musculoskeletal pain regarding the mechanisms that may explain the 
progression to persistent pain and disability.
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Methods
Study population
Shoulder pain – A total of 103 general practitioners (GP) participated 
in the study.12 Patients who consulted their GP for a new episode of 
shoulder pain (SP) between January 2001 and June 2003 were eligible 
for participation. Patients were selected if they were 18 years or older, and 
had not consulted their GP for the aﬄicted shoulder in the preceding 
3 months. Suﬃcient knowledge of the Dutch language was required to 
complete written questionnaires. Exclusion criteria included the presence 
of fractures or dislocation in the shoulder region, dementia, or systemic 
disease that may explain the shoulder symptoms (e.g. rheumatic disease, 
neoplasms, neurological or vascular disorders).
Low back pain – In the same time period participants with low back pain 
(LBP) were recruited by 32 GPs (21 practices) who participated in a 
cluster-randomised controlled trial on the treatment of low back pain in 
primary care.13 Patients were selected if they were between 18 and 65 years 
of age, and the duration of LBP was less than 12 weeks at presentation, or 
there was an exacerbation of persisting back pain. Participation required 
suﬃcient knowledge of the Dutch language. Exclusion criteria were: 
LBP caused by speciﬁc pathological conditions (metastasis, osteoporosis, 
rheumatoid arthritis, or fracture), current treatment by another healthcare 
professional than the GP, and pregnancy. All patients receiving usual care 
(as their GPs had been randomised to the control group) were selected 
for the current study. Data collection for both cohorts was approved by 
the Medical Ethics Committee of the VU University Medical Center, 
Amsterdam, The Netherlands.  
Management 
All patients received usual care by their GP. For both LBP and SP the 
Dutch College of General Practitioners have issued national guidelines. 
The practice guidelines for SP recommend to provide information on 
the prognosis of shoulder pain, advice regarding provoking activities, 
and stepwise treatment consisting of analgesics, Non-Steroidal Anti-
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Inﬂammatory Drugs (NSAIDs), corticosteroid injection or referral for 
physiotherapy.14;15 Decisions regarding the content of treatment were made 
by the GP, dependent on the duration and severity of pain and disability. 
The practice guidelines for LBP advise a wait-and-see policy with pain 
medication and gradual uptake of activities for acute LBP (duration 
<6 weeks).16 For sub-acute LBP (6 to 12 weeks duration) the guideline 
recommends referral for exercise therapy, physiotherapy, or manual therapy 
in case of persistent disability. 
Psychological factors 
Within a few days after recruitment by the GP all participants were visited 
at home by a research assistant. During the visit the participants completed 
a baseline questionnaire, that included questions on psychological factors. 
In patients with SP catastrophizing was measured with the 6-item 
Catastrophizing subscale of the Pain Coping and Cognition List (PCCL, 
1-6 points).17 In patients with LBP the 6-item subscale Catastrophizing 
of the Coping Strategies Questionnaire (CSQ, 0-36 points) was used.18 
In both populations fear-avoidance beliefs were assessed using the 4-item 
physical activity subscale of  the Fear Avoidance Beliefs Questionnaire 
(FABQ; 0-24).19 Distress as well as somatization were measured in both 
patient groups with two 16-item subscales of the Four-Dimensional 
Symptom Questionnaire (4DSQ).20 Scores on all scales were standardized 
to scores between 0 and 100 to facilitate comparison. When scores were 
missing at least 75% of the items on subscales had to be present to calculate 
a total score. Otherwise, complete case analyses were performed.
Outcome measures
Outcomes were measured by postal questionnaires at 3 months after 
consultation. The primary outcome measures were perceived recovery 
and disease-speciﬁc functional disability. In both populations perceived 
recovery was measured on an 8-point Likert scale.21 Patients who did not 
report full recovery or very much improvement were denoted as having 
“persistent symptoms”.  
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For patients with SP functional disability was measured with the 16-
item shoulder disability questionnaire (SDQ).22 In patients with LBP 
functional disability was assessed by the 24-item Roland Morris Disability 
Questionnaire (RDQ).23 Both SDQ and RDQ scores were standardized 
to scores ranging between 0 (no disability) and 100 (severe disability). A 
reduction of 30% in baseline disability score has been suggested to be a 
minimal clinically important change for the RDQ.24 Research in patients 
with SP has shown that a reduction of18;19 points can be considered to be 
a clinically important change.25 Given a mean baseline scores of 60-75 
points12;26, this agrees with a change of 30% from baseline. Those reporting 
less than 30% improvement on either the SDQ or RDQ were denoted as 
having “persistent disability”.
Other potential predictors
Psychological factors were studied as independent predictors of outcome 
after three months. Age, gender, pain intensity at baseline (0-10 points 
rating scale), duration of symptoms, and the presence of additional 
musculoskeletal complaints were considered as potential prognostic co-
variates in both SP and LBP. Furthermore, in patients with SP a gradual or 
acute onset of pain, and repetitive movements (on at least two days a week) 
were considered as potential co-variates, whereas in patients with LBP the 
presence of radiating symptoms was included in the analyses. These factors 
have previously been shown to predict the outcome of SP12;26-29 or LBP30-33 
in primary care populations. Finally, treatment variables were considered 
as potential co-variates in the association between psychological factors 
and outcome: corticosteroid injection in patients with SP, and referral for 
physiotherapy, exercise therapy or manual therapy in patients with either 
SP or LBP.
Theoretical model
The interactions between pain stimuli, distress, beliefs, and pain behaviour 
have been described in biopsychosocial models of pain.34;35 These models 
provide a general explanation for the inﬂuence of psychological factors in 
149
the transition of acute pain to chronic pain. According to such models, 
following an injury or nociceptive stimulus patients make a judgement 
concerning its meaning. These beliefs and attributions do not necessarily 
need to be rational (e.g. catastrophizing thoughts), and are often based 
on prior experiences or information obtained from others. Attributions 
can be inﬂuenced by distress or depressive symptoms, and lead to the 
development of inadequate strategies to deal with the pain (e.g. fear-
avoidance behaviour). As fear-avoidance behaviours often occur in 
anticipation of pain rather than as a response to pain, pain behaviour may 
persist, resulting in more disability.34;35 
The core notion of somatization is that psychological distress can be 
expressed as somatic symptoms, for which medical help is sought.36 
This concept provides a more general explanation of the association 
between psychological factors and persistent symptoms in patients with 
musculoskeletal pain.
Analysis
Descriptive statistics were used to describe baseline characteristics of 
patients with LBP and SP. Logistic regression analysis was used to 
investigate the association between psychological factors and the risk of 
persistent symptoms or persistent disability. Associations were expressed as 
odds ratios (OR) along with 95% conﬁdence intervals (95% CI). 
The following steps were taken to study the association between 
psychological factors and persistent symptoms or disability. First, univariable 
analyses were carried out to calculate the unadjusted association between 
each of the four psychological factors and outcome. The linearity of the 
associations was studied. Factors were categorized into tertiles if they did 
not show a linear association with the outcome. Next, these associations 
were adjusted for each of the other potential predictors. Only those factors 
that resulted in a change of at least 10% in the univariable regression 
coeﬃcient of the psychological factor were considered as potential co-
variates in the multivariable regression models. Next, a manual forward 
selection procedure was used to sequentially include co-variates in the 
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model that induced the largest change in the regression coeﬃcient of the 
psychological factor. Co-variates that changed the multivariable regression 
coeﬃcient of psychological factors by more than 10% were retained in the 
model. Separate models were built for patients with SP and LBP. 
Finally, interaction was studied between each of the psychological factors 
and duration of symptoms at baseline. We considered it likely that 
psychological factors were stronger predictors of outcome in patients with a 
longer duration of symptoms (≥3 months) compared to those with a more 
recent onset of pain. In case of a signiﬁcant association of the interaction 
term with the outcome (p <0.10), stratiﬁed analyses were carried out for 
patients with short or long duration of symptoms ar baseline. All analyses 
were performed with the use of SPSS for Windows version 12.1 (SPSS 
Inc., Chicago, IL).
Results
Characteristics of the study populations
The study included 587 patients with SP and 171 with LBP. Table 1 
presents the distribution of demographic variables, clinical characteristics, 
and psychological factors in both groups. The populations were similar 
with respect to gender, and educational level, but patients with LBP were 
younger (mean age 42.0 versus 51.5 years for SP) and more often reported 
paid work (84.2% versus 65.4%). Patients with shoulder pain more often 
reported a long duration of symptoms at baseline (at least 3 months in 
41.3%), while the majority of patients with LBP reported a recent onset 
of their pain (less than two weeks in  61.4%). More patients with SP 
reported musculoskeletal pain elsewhere (71.0% versus 36.3% in those 
with LBP). Regardless of these diﬀerences the intensity of pain was similar 
in both groups.
Both groups scored equally high on fear-avoidance beliefs (median score 
58.3 for SP and 62.5 for LBP), and on catastrophizing thoughts (21.7 
versus 30.6). Baseline scores on distress and somatization were low in SP 
patients (median scores less than 7), and moderate in patients with LBP 
(median scores 25.0).
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Recovery of symptoms after three months
Nearly all patients (164/171; 96%) with LBP completed the follow-up 
questionnaire at three months follow-up. Response was 88% (517/587) 
in patients with SP. Drop-outs with SP were younger and more often had 
higher distress scores (>6 points) at baseline. 
Table 2 shows that more patients with SP reported persistent symptoms 
after 3 months (60.2% versus 45.7% in LBP). Median disability scores 
were higher in patients with SP, and a larger proportion showed less than 
30% reduction of disability. Pain intensity scores at three months follow-
up were slightly higher in LBP patients. 
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Table 1  Baseline characteristics of patients with shoulder pain (SP) or low back pain (LBP)
SP (n = 587) LBP (n = 171)
Demographic and work variables
Age (years)
Gender 
Educational level
low
middle
high 
Paid work
Repetitive movements (≥2 days/week)
mean (SD)
n (% female)
n (%)
n (%)
n (%)
51.5 (14.0)
295 (50.3)
210 (36.3)
234 (40.4)
135 (23.3)
350 (59.6)
384 (65.4)
42.0 (12.0)
81 (47.4)
56 (33.1)
72 (42.6)
41 (24.3)
144 (84.2)
 -
Disease characteristics 
Duration current episode
0 to 2 weeks
3 to 6 weeks
6 to 13 weeks
≥ 13 weeks
Gradual onset
Previous episodes 
Pain radiating below the knee
Musculoskeletal pain elsewhere
Pain intensity
Functional disability (SDQ or RDQ, 0-100)
n (%)
n (%)
n (%)
n (%)
n (%)
mean (SD)
mean (SD)
83 (14.2)
122 (20.8)
139 (23.7)
242 (41.3)
362 (61.7)
348 (59.3)
-
417 (71.0)
4.8 (2.3)
59.9 (24.2)
105 (61.4)
49 (28.7)
17 (9.9)
-
- 
138 (81.2)
73 (42.7)
62 (36.3)
4.8 (1.9)
50.8 (20.7)
Psychological factors 
Fear-avoidance beliefs (FABQ, 0-100)
Catastrophising (PCCL or CSQ, 0-100)
Distress (4DSQ, 0-100)
Somatization (4DSQ, 0-100)
median (IQR)
median (IQR)
median (IQR)
median (IQR)
58.3 (45.8; 75.0)
21.7 (12.5; 35.0)
0 (0; 6.3)
6.3 (0; 15.6)
62.5 (50; 79.2)
30.6 (16.7; 41.7)
25.0 (12.5; 43.8)
25.0(15.6; 34.4)
Abbreviations: SD: Standard Deviation, IQR: InterQuartile Range; SDQ: Shoulder Disability Questionnaire22; RDQ: Roland; 
Morris Disability Questionnaire23; FABQ: Fear Avoidance and Beliefs Questionnaire19; PCCL: Pain Coping and Cognitions List17, 
used in patients with shoulder pain; CSQ: Coping Strategies Questionnaire18, used in patients with low back pain; 4DSQ: Four-
dimensional Symptoms Questionnaire20
Association of psychological factors with outcome
Shoulder pain - Table 3 presents the association of baseline scores on 
psychological factors with persistent shoulder symptoms or shoulder 
disbility at three months follow-up. Associations were not linear in patients 
with SP, therefore psychological factors were categorised in tertiles. Given 
the fact that median baseline scores on distress and somatization were 
very low (0 for distress and 6.3 for somatization), scores on these two 
psychological factors were dichotomized (highest tertile versus lower 
scores). 
Associations of all psychological factors with outcome after three months 
were weak, and not statistically signiﬁcant. More catastrophizing thoughts 
at baseline were associated with a higher risk of a poor outcome at three 
months, but the association was not statistically signiﬁcant after adjustment 
for baseline pain intensity and duration of symptoms.
Low back pain – The associations of psychological factors with outcome 
in patients with LBP were stronger, in particular for higher baseline scores 
on catastrophizing thoughts, distress, and somatization (Table 4). After 
adjustment for previous episodes of LBP, the associations with persisting 
symptoms were statistically signiﬁcant for catastrophizing thoughts and 
somatization.
Interaction by symptom duration – As none of the participants with LBP 
reported chronic pain at baseline, interaction by symptom duration 
was only studied in patients with SP (Table 5). Signiﬁcant interaction 
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Table 2  Persistent symptoms, pain and disability three months after consultation for patients with shoulder 
pain (SP) and low back pain (LBP)
SP (n = 517) * LBP (n = 164)*
Persistent symptoms 
Pain intensity (0-10) 
Disability score (0-100)
Change in disability since baseline  
Less than 30% reduction in disability
n (%)
median (IQR)
median (IQR)
mean (SD)
n (%)
311  (60.2%)
2 (0;  4)
30.8  (0; 60.0)
26.9  (31.6)
216  (41.8%)
75  (45.7%)
3  (2; 5)
8.3  (0; 20.8)
35.1  (24.7)
28  (16.4%)
Abbreviations: SD: Standard deviation; IQR: InterQuartile Range  *11% of SP patients (n = 70) and 4% of LBP patients (n = 7) 
did not return the follow-up questionnaire at three months or did not complete questions on main outcomes.
(p<0.10) was only found for catastrophizing thoughts, and only for 
persistent symptoms as outcome measure. In patients with a long duration 
of symptoms at baseline (≥3 months) higher scores on catastrophizing 
thoughts were signiﬁcantly associated with persistent symptoms at three 
months (OR highest versus lowest tertile: 4.47,  95% CI 1.74; 11.5), 
while in patients with a shorter symptom duration a reverse association 
was found (OR highest versus lowest tertile: 0.47, 95% CI 0.25; 0.88). 
Treatment 
At baseline most patients received a wait and see policy with pain 
medication. In the ﬁrst three months 151 (26%) of SP patients received 
physiotherapy or manual therapy, and 99 (17%) reported treatment with 
local inﬁltration of a corticosteroid. Of the 171 patients with LBP 73 
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Table 3  Association of psychological factors with persisting symptoms and disability after 3 months in patients 
with shoulder pain 
Persisting symptoms <30% reduction in 
disability
OR 95% CI OR 95% CI
Catastrophizing thoughts (vs < 15 points), n = 493 *
 Crude
 Adjusted †
15 to 30
> 30
15 to 30
> 30
0.99
1.31
1.02
1.11
0.65; 1.53
0.83; 2.05
0.63; 1.64
0.67; 1.84
1.30
1.65
1.36
1.62
0.84; 2.01
1.05; 2.57
0.86; 2.15
1.00; 2.61
Distress (> 6 vs lower scores)‡, n = 514 *
 Crude 
 Adjusted †
1.14
0.73
0.78; 1.66
0.47; 1.13
1.07
0.86 
0.73; 1.55
0.57; 1.30
Somatization (>12 vs lower scores)‡, n = 514 *
 Crude 
 Adjusted †
1.50
1.15
1.03; 2.21
0.74; 1.79
1.50
1.37
1.03; 2.17
0.90; 2.01
Fear-avoidance beliefs (vs < 50 points), n = 508 *
 Crude
 Adjusted †
50 to 75
> 75
50 to 75
> 75
1.16
1.16
1.25
1.16
0.78; 1.73
0.72; 1.89
0.81; 1.94
0.68; 2.00
1.12
1.11
1.25
1.21
0.75; 1.67
0.68; 1.79
0.82; 1.91
0.72; 2.03
OR = Odds Ratio; CI = Conﬁdence Interval; * = incidental missing values on psychological factors; † = adjusted for baseline 
pain intensity and duration of symptoms; ‡ = Scores on distress and somatization were very low; analysis was carried out using 
dichotomised scores
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Table 4  Association of psychological factors with persisting symptoms and disability after 3 months in 
patients with low back pain (n=163)
Persisting symptoms
<30% reduction in 
disability
OR 95% CI OR 95% CI
Catastrophizing thoughts (vs < 20 points)
 Crude
 Adjusted †
20 to 40
> 40
20 to 40
> 40
1.89
2.41
2.00 ‡
2.45 ‡
0.89; 3.98
1.09; 5.36
0.93; 4.30
1.09; 5.51
2.81
4.88
2.27 *
3.31 *
0.84; 9.40
1.47; 16.21
0.66; 7.79
0.93; 11.85
Distress (vs < 15 points)
 Crude
 Adjusted †
15 to 35
> 35
15 to 35
> 30
0.90
2.02
0.80 ‡
1.86 ‡
0.42; 1.94
0.94; 4.34
0.37; 1.76
0.86; 4.05
1.40
3.94
1.34 †
2.77 †
0.42; 4.72
1.33; 11.71
0.39; 4.61
0.88; 8.66
Somatization (vs < 18 points)
 Crude
 Adjusted †
18 to 32
> 32
18 to 32
> 32
1.05
3.24
0.99 ‡
3.11 ‡
0.49; 2.26
1.42; 7.41
0.46; 2.16
1.34; 7.20
0.83
3.09
0.74 †
2.46 †
0.28; 2.65
1.08; 8.82
0.22; 2.42
0.83; 7.30
Fear-avoidance beliefs (vs < 50 points)
 Crude
 Adjusted †
50 to 75
>  75
50 to 75
> 75
1.29
1.56
1.45 ‡
1.58 ‡
0.61; 2.71
0.71; 3.46
0.67; 3.14
0.70; 3.53
0.84
2.17
0.83 †
1.73 †
0.28; 2.50
0.78; 6.02
0.27; 2.56
0.60; 5.04
OR = Odds Ratio; * = adjusted for baseline pain intensity; † = adjusted for baseline pain intensity and previous episodes of LBP; ‡ = 
adjusted for previous episodes of LBP
Table 5  Association of catastrophizing thoughts with persisting symptoms after 3 months: stratiﬁed analysis 
for patients with < 3 months or ≥ 3 months duration of shoulder pain at baseline 
Persisting symptoms
OR a 95% CI
Symptom duration < 3 months at baseline (n = 288)
Catastrophizing thoughts (vs < 15 points)
 15 to 30
  > 30
0.64
0.47
0.36; 1.13
0.25; 0.88
Symptom duration ≥ 3 months at baseline (n = 205)
Catastrophizing thoughts (vs < 15 points)
 15 to 30
 > 30
1.67
4.47
0.80; 3.51
1.74; 11.5
a adjusted for baseline pain intensity
(43%) were referred for therapy during follow-up period. These treatment 
variables did not signiﬁcantly aﬀect the reported associations between 
psychological factors and outcome at three months.
Discussion 
This prospective cohort study among patients with SP or LBP in general 
practice showed a signiﬁcant association between catastrophizing thoughts 
and somatization with persistent symptoms in patients with (sub)acute 
LBP. Despite longer duration of pain at presentation and a poorer 
prognosis, baseline scores on psychological factors were generally lower 
in patients with SP, and associations with outcome were weak and non-
signiﬁcant. Only in patients with a longer symptom duration at baseline 
more catastrophizing showed an increased risk of persistent shoulder 
symptoms at follow-up. 
Inﬂuence of psychological factors in SP
The most important ﬁnding of our study is that psychological factors 
appeared to be of little importance in the prediction of persistent shoulder 
pain. So far, few studies have investigated the association between 
psychological factors and outcome in patients with SP, even though it 
has been proposed that psychological factors may be equally important in 
diﬀerent types of pain.10 One population-based study showed that distress 
predicted outcome in patients with shoulder pain37, but these results 
could not be conﬁrmed in our study. Psychological factors were of lesser 
importance than clinical characteristics, such as baseline intensity of pain, 
duration of symptoms, or additional musculoskeletal problems. One may 
hypothesize that in patients who consult the GP for shoulder pain the 
symptoms are more severe than in a population-based sample, perhaps 
resulting from more serious physical pathology, and that in these patients 
psychological factors may be less important. 
A recently conducted prospective cohort study among patients with neck-
shoulder pain in Dutch primary care showed that worrying was associated 
with poor outcome after three months follow-up.27 Further research may 
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establish whether worrying or distress are especially important among 
patients with neck pain, or combined neck-shoulder pain, compared to 
those with shoulder pain only.
Inﬂuence of psychological factors in LBP
Our results strengthen the ﬁndings of previous research among patients 
with LBP, reporting signiﬁcant associations between high levels on 
catastrophizing thoughts or somatization at baseline and the risk of 
persistent symptoms at follow-up.9;30;38;39 Although frequently suggested 
as a potentially important predictor, associations between fear-avoidance 
beliefs and persistent symptoms were weak. This ﬁnding seems to coincide 
with the results of a prospective cohort study by Burton et al. among 
primary care patients with LBP.39 Apparently, fear-avoidance beliefs do 
not contain unique predictive qualities independent of other prognostic 
factors in these primary care populations. 
As we were speciﬁcally interested in the predictive value of each psychological 
factor, we adjusted the associations for other prognostic factors, such as pain 
intensity and previous episodes of LBP associations. Following adjustment 
most associations were weaker, and not statistically signiﬁcant. One might 
argue that adjustment for pain intensity or a history of pain is not sensible, 
as the level of distress, somatization or catastrophizing is likely to depend 
on the duration, history or intensity of pain.40 Longitudinal research with 
repeated assessment of psychological factors, symptoms, and disability 
in patients with acute pain is needed to address these assumptions, and 
further unravel the longitudinal associations between psychological factors 
and pain. 
Comparison of the inﬂuence of psychological factors in SP and LBP
Research in which the predictive value of psychological factors is 
simultaneously studied in patients with diﬀerent types of musculoskeletal 
pain is scarce. Most cohorts have used diﬀerent questionnaires for 
measuring predictors and outcomes, hampering the comparison across 
diﬀerent patient populations. Our study showed that the two populations 
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were clearly diﬀerent at baseline: due to diﬀerent selection criteria the 
mean duration of symptoms was longer in SP patients. Furthermore, SP 
patients reported more additional musculoskeletal pain and somewhat 
higher scores on baseline disability. Consequently, one might have expected 
higher scores on psychological factors. Yet, baseline scores were lower 
compared to patients with LBP, in particular for distress and somatization, 
and hardly inﬂuenced outcome. More patients with LBP reported having 
had previous episodes of LBP. It may be possible that psychological factors 
become more important once patients have experienced more episodes 
of pain. Inadequate beliefs and attributions of pain may become stronger 
when recurrences of pain occur. 
High scores on catastrophizing thoughts predicted a poor outcome in 
patients with (sub)acute LBP and also in patients with longstanding SP 
(duration more than 3 months at consultation). Catastrophizing is an 
exaggerated orientation towards pain stimuli, and is considered to be 
an inadequate coping strategy.41 This characteristic could be addressed 
by cognitive behavioural interventions. Future research might be aimed 
at the development and evaluation of interventions aimed at reducing 
catastrophizing thoughts in patients with LBP or chronic SP in primary 
care. The ﬁnding that catastrophing thoughts appeared to be associated 
with a favourable prognosis in patients with more acute SP is surprising, 
and diﬃcult to explain. It is the question whether these ﬁndings can be 
replicated in future research among primary care patients with SP.
Methodological considerations
The study among patients with LBP was characterized by a very low 
dropout rate and few missings. Dropout rate in the SP cohort was limited 
to 11%. Although dropouts were younger and more often had higher 
distress scores, the absolute diﬀerences in age and distress scores were small 
(less than 10 years, and less than 4 points for distress). Therefore, we do 
not believe that these diﬀerences have strongly inﬂuenced the reported 
associations between psychological factors and outcome in patients with 
SP. 
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The size of the SP cohort was more than adequate to detect relevant 
associations with statistical signiﬁcance. As the LBP cohort was smaller, it 
is possible that we have missed relevant associations between some of the 
psychological factors and outcome in patients with LBP. Power calculations 
for observational research are diﬃcult to make, but a frequently used 
general rule is that 10 cases (events) are needed for each variable in the 
model.42 With 75 patients reporting persistent LBP in our cohort we 
had suﬃcient power to establish statistically signiﬁcant associations for 
one (categorized) predictor, with adjustment for two to three co-variates. 
We consider it unlikely that a possible lack of power explains the absence 
of signiﬁcant associations for fear avoidance beliefs, as associations were 
rather weak. 
The SP patients participated in an observational study, giving a fair 
representation of patients consulting their GP for a new episode of (non-
traumatic) SP. Patients with LBP had been enrolled in a randomised 
trial, which usually generates a more selective and homogeneous study 
population. In this trial, however, no speciﬁc selection criteria other than 
duration of symptoms had been used. Furthermore, randomisation took 
place at the level of the practice, which means that GPs in the control 
group simply provided usual care to all LBP patients in their practice, and 
had not been trained to provide any other treatment. The participants, 
therefore, do represent patients with non-speciﬁc (sub)acute LBP in 
general practice, which increases the generalisability of our ﬁndings. 
In conclusion, psychological factors, in particular somatization and 
catastrophizing thoughts, are more strongly associated with persistent 
pain and disability in patients with LBP than in those with SP. Despite a 
longer duration of pain at presentation and a poorer prognosis, scores on 
most psychological factors were low in patients with SP and associations 
with outcome were weak. This seems to indicate that diﬀerent mechanisms 
may explain the progression to persistent symptoms among patients with 
diﬀerent types of pain. Further research in primary care populations is 
needed to conﬁrm these ﬁndings, and to look more closely at the role of 
psychological factors in the development of persistent pain and disability.
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9
General  discussion

The main objectives of this thesis were to derive and validate clinical 
prediction rules to predict persistent shoulder symptoms at 6 weeks and 6 
months after ﬁrst consultation, and to predict shoulder pain related sick 
leave during 6 months following ﬁrst consultation. Furthermore, this thesis 
presents a systematic review of the current literature on the prognosis of 
shoulder pain, an estimation of the total costs during 6 months after ﬁrst 
consultation, and a study of the association between psychological factors 
and the persistence of shoulder pain.
In this chapter the main ﬁndings will be summarized and the design and 
results of this prognostic study will be critically discussed. Subsequently 
the systematic review, costs of shoulder pain, the design and conduct 
of the prognostic cohort study, the development and generalisability of 
the prediction rules and the role of psychosocial factors will be critically 
reviewed. At the end of this chapter ﬁnal conclusions and recommendations 
for future research are given.
Systematic review of the literature
In our systematic review we found disappointingly little evidence for most 
factors which in the current literature are suggested to be of prognostic 
importance. There is consistent evidence that high baseline pain intensity in 
primary care populations and age between 45 and 54 years in occupational 
populations are strong predictors of a poor prognosis, while there is some 
evidence that a long duration of complaints and a high disability score at 
baseline are predictors of a poor prognosis in primary care populations. 
There were no studies of suﬃcient quality in secondary care. No evidence 
for the prognostic importance of psychosocial factors was found in our 
systematic review.
Besides methodological shortcomings there was considerable heterogeneity 
regarding design, study populations, prognostic factors and outcome 
measures. This heterogeneity impedes meta-analysis. Therefore we decided 
to perform a best evidence synthesis of the available evidence. Any system 
for deﬁning levels of evidence is arbitrary. We chose a system that has 
been used in a systematic review on prognostic factors for whiplash 
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related disorders1. Systematically reviewing prognostic studies is still in 
development and no validated or widely used criteria list is available. 
Moreover, because of the small number of studies on which our conclusions 
were based, and the heterogeneity across studies regarding duration of 
follow-up, types of outcome measures, and analysis, we feel that the results 
of our review need to be interpreted with considerable caution. In our 
opinion an appropriately designed and reported prospective cohort study 
should fulﬁl the criteria of our checklist (Chapter 2). Estimates of outcome 
should preferably be expressed as absolute risks, and not as RRs or ORs.
Our prognostic study earned 17 points (94% of the total score) on the 
criteria list and was of high quality according to our a priori deﬁnition. If 
we add our prognostic study to the best evidence synthesis of the systematic 
review, in primary care populations the evidence for ‘high pain intensity at 
baseline’ as important predictor would be conﬁrmed as being strong. The 
evidence for ‘long duration of complaints’ would change from moderate 
into strong. For occupational populations evidence for the prognostic 
value of ‘sick leave at baseline’ and ‘high pain intensity’ would change 
from inconclusive to moderate evidence.
Costs of shoulder pain
The present study is the ﬁrst to evaluate the overall costs generated by 
patients presenting with shoulder pain in primary care. With a mean total 
costs of  € 689 per patient during the 6 months after ﬁrst consultation, 
healthcare consumption and sick leave did not seem to be very high in this 
primary care population. A small part (12%) of the population accounted 
for 74% of the total costs. 
An explanation for the on average modest health care costs could be 
that general practitioners stick to the interventions recommended by 
the Dutch guidelines for shoulder disorders2;3 (wait-and-see policy with 
pain medication, followed by injections), which are relatively inexpensive. 
Indirect costs accounted for a large proportion (47%) of the total costs. 
Nevertheless, the total number of days sick leave per patient was small (2.8 
days) over a period of 6 months. Possibly, factors such as shoulder pain, 
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sleeping problems, or loss of function have caused loss of productivity in 
patients without sick leave from  paid work. Our study does not provide 
information on the actual loss of productivity among those who kept on 
working regardless of their shoulder pain. 
Similar to studies on low back pain4, in our study a small proportion of the 
population (12%) caused a substantial part (74%) of the total costs. In this 
subgroup sick leave from paid work accounted for 61% of the total costs. 
In our study we were able to include a follow-up period of 26 weeks. It is 
possible that prolonged and recurrent pain episodes generate additional 
costs for more expensive care, e.g. more physiotherapy, diagnostic 
imaging and surgical treatment, including hospitalisation. Given the 
poor prognosis of shoulder pain (approximately 40% of patients report 
persistent symptoms after 12 to 18 months5-7) higher health care costs 
and productivity losses may be expected when follow-up times are longer. 
In the 6 months following ﬁrst consultation, few costs were made due to 
referrals to other health care providers, additional diagnostic procedures, 
or surgery. We expect these kind of health care expenses to occur in the 
long-term in a small subset of the population. In our cohort patients 
with fractures, dislocation, or previous surgery were not included. These 
patients may also generate substantial costs.
Given the high incidence of shoulder pain (12/1000/year )8-10 in general 
practice the total costs to society can be substantial. Future studies on the 
cost of illness of shoulder pain should include a longer follow-up period, 
and include patients with fractures, dislocation, or previous surgery to 
estimate the total costs of illness for patients consulting with shoulder pain 
in primary care.
Prognostic cohort study
Patient selection 
We conducted a prospective cohort study in three geographic areas in The 
Netherlands. Patients who visited their general practitioner with a new 
episode of shoulder pain were included in the prognostic cohort study. We 
deﬁned a new episode as a patient who had not consulted his/her GP or 
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received any form of treatment for the aﬄicted shoulder in the preceding 
3 months. 
In this large prognostic cohort study of  587 patients, the response to the 
follow-up questionnaires was high (between 83% and 92%). Given the 
low drop-out rate and only slight diﬀerences at baseline between drop-outs 
and responders we consider the results to be valid. Of the 587 participants, 
41% reported a duration of their complaints at baseline of more than 3 
months, and 62% reported that they had experienced shoulder complaints 
in the past. These numbers indicate that we did not enrol many patients 
who experienced shoulder pain for the ﬁrst time in their lives, which 
potentially has had an inﬂuence on our prognostic models. However, 
patients did not seek any medical care in the preceding three months 
before inclusion, indicating a new episode of shoulder pain, which we feel 
is important for a prognostic cohort study.
Management
The ideal situation when conducting a prognostic cohort study is that 
patients do not receive any form of treatment. Because of the ethical 
problems when conducting such a study, and the expectation that not 
many patients would be interested to participate, this is not a feasible 
option. The second best option is to standardise treatment and have all 
participants treated in the same way. A third option is to register the 
management regime as good as possible.
In our study all patients received (standardised) treatment according to 
the 1999 version of the Dutch guidelines for shoulder disorders issued by 
the Dutch College of General Practitioners.2;3 The guidelines recommend 
giving information on the prognosis of shoulder pain, advice regarding 
provoking activities, and stepwise treatment consisting of paracetamol, 
Non-Steroidal Anti-Inﬂammatory Drugs (NSAIDs), corticosteroid 
injection or referral for physiotherapy. The GP made the decision 
regarding the content of treatment based on duration and severity of pain 
and disability. The participating general practitioners were educated and 
trained to apply treatment according to this guideline. 
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We decided not to select treatment as a potential predictor for our prediction 
models. Including treatment options in a prediction rule may provide 
confusing information: that is a risk of persistent symptoms, provided 
that the patient receives a certain treatment. This means that a GP could 
inﬂuence the calculated risk derived from the prediction rule, by choosing 
a certain treatment. Treatment as a predictor in our rule would seem to 
imply that we have studied the eﬀect of a certain intervention, which was 
no objective in our study (since our study was not a randomised controlled 
trial). Our prediction rules have been developed with the objective of risk 
stratiﬁcation, and are based on information gathered through history 
taking and physical examinations. Subsequent decisions regarding 
treatment can be based on this information. Information regarding eﬀects 
of treatment have possibly been inﬂuenced by confounding by indication. 
Patients with more severe symptoms and thus, with a higher risk of 
a poorer outcome were probably more likely to receive more extensive 
treatment.11 Only 68 patients (12%) received an injection and 58 (10%) 
were referred to a physiotherapist, which is a low proportion compared 
to an earlier study in The Netherlands.5 The Dutch practice guidelines 
on shoulder complaints, which recommend a wait-and-see policy during 
the ﬁrst 2 to 4 weeks may have lead to a change in practice over the past 5 
years. As most patients received wait and see policy or medication, we had 
a relatively homogeneous group regarding treatment at baseline. 
Outcome assessment
Outcome was measured by postal questionnaires at 6 weeks, 3 and 6 
months. In our study we focussed on persistent symptoms, and we chose as 
primary outcome measure patient perceived recovery, which was measured 
on a 8-point Likert scale12;13 Patients who did not report full recovery or 
very much improvement were denoted as having persistent symptoms. We 
feel this outcome measure reﬂects daily practice, in which questions are 
asked by physicians or therapists like ‘Has your shoulder pain recovered?’, 
‘How is your shoulder pain?’, or ‘Do you still have shoulder complaints?’. 
At 6 weeks 70% (340/486) and at 6 months 46% (249/536) patients 
reported persistent symptoms, which are similar percentages to those 
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found in other studies carried out in primary care populations.5-7 This 
may strengthen the generalisability of our ﬁndings to other primary care 
patients with shoulder pain. Secondary outcome measures were shoulder 
disability, pain, and severity of the main complaint. Our results show that 
patients with persistent symptoms at follow-up reported also more pain, 
more shoulder disability and higher severity of the main complaint than 
patients reporting improvement of symptoms. This strengthens the choice 
of our main outcome measure.
For studying shoulder pain related sick leave 350 patients who reported 
paid work were used, of whom 30% (89/298) reported sick leave during 6 
months after ﬁrst consultation, which was similar to the percentages found 
in the validation cohorts of our generalisability study. The duration of sick 
leave was limited to a few days in most workers. Our data were not suitable 
for studying predictors of long-lasting sick leave or frequent absenteeism as 
a consequence of the low incidence of these events.
Prediction rules
We developed clinical prediction rules consisting of a limited number 
of (easily measurable) prognostic factors to predict the risk of persistent 
shoulder symptoms at the short (6 weeks) and long term (6 months) and 
to predict shoulder pain related sick leave during 6 months following ﬁrst 
consultation. We developed the rules in the prognostic cohort study of the 
Dutch Shoulder Study, and subsequently evaluated their generalisability 
by testing them on the merged control groups of the three trials embedded 
in the DSS. The prediction rule for shoulder pain related sick leave was 
also tested in participants of the Musculoskeletal Disorder Study (BAS).
Development
During the development of our prediction rules it was not possible 
to select predictors based on clinical knowledge, because there was 
insuﬃcient evidence regarding their predictive value.14 So we had to 
base the selection of potential predictors on univariable analyses. We 
selected predictors showing statistically signiﬁcant associations with 
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the outcome using a relative high p-value of 0.20, in order not to miss 
any potentially relevant predictors for our multivariable analyses. In the 
current literature bootstrapping techniques are considered to be the most 
adequate for studying the internal validity of prediction models. We used 
these techniques to study the internal validity of the ﬁnal prediction 
model, i.e. to adjust the estimated regression coeﬃcients for overﬁtting 
and the model performance for overoptimism.15;16 The performance of the 
prediction rules was evaluated by studying calibration and discrimination. 
Calibration refers to what extent the observed frequencies agree with the 
predicted probabilities. Discrimination refers to the ability to distinguish 
between a patient with or a patient without persistent symptoms or sick 
leave. 
The calibration of the prediction rules for persistent symptoms in the 
derivation cohort was adequate. The discriminative ability was satisfactory 
for the short term (6 weeks) with an area under the curves (AUC) of 0.74 
and disappointing for the long term (6 months) and 0.67 at 6 months. 
The calibration of the prediction rule for shoulder pain related sick leave 
was adequate. The discriminative ability of the prediction model was 
satisfactory with an AUC of 0.70. 
Generalisability 
Before considering implementation of the prediction rules in clinical 
practice their generalisability needs to be tested.17-19 Generalisability 
refers to the performance of the prediction rules in patients drawn from a 
diﬀerent but comparable population.17
In general, the prediction rules showed better calibration in the derivation 
cohort than in the validation cohorts. This is not surprising because 
the models were ﬁt on the data of the derivation cohort. Since the 
discriminative ability of a rule is related to the homogeneity of the sample 
in which the rule is applied, we estimated the maximum attainable AUC. 
Given the predicted risks of the patients in the validation cohort, outcomes 
were generated with Monte Carlo Simulation.20;21 This simulation mimics 
the situation that the model is perfectly calibrated. The AUC that is 
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subsequently estimated for the predicted risks and generated outcomes is 
considered the maximum attainable AUC for the validation sample. 
The performance of the prediction rule for persistent shoulder symptoms 
at 6 weeks in the validation cohort was satisfactory, with a reasonable 
calibration, and discriminative ability similar to that found in the derivation 
cohort (AUC=0.72). The prediction rule for persistent symptoms at 6 
months showed poor calibration and discrimination. The AUC decreased 
to 0.57 in the validation cohort, not much more than a ﬂip of a coin 
(AUC=0.50). 
The prediction rule for shoulder pain related sick leave was validated in the 
merged control groups of the trials of the DSS, and in the Musculoskeletal 
Disorder Study (BAS). The prediction rule showed reasonable calibration 
in both validation cohorts. The discriminative ability was stable in the 
BAS (AUC 0.71 compared to an AUC of 0.70 in the derivation cohort). 
In the controls of the DSS the discriminative ability decreased to an AUC 
of 0.66.  
In the 10 day period between ﬁrst consultation and baseline assessment 
symptoms have changed, which may have resulted in a diﬀerent population 
at baseline assessment compared to the moment of GP consultation. This 
could have had an inﬂuence on the discriminative ability of our prediction 
rules. We do not have information that provides insight into the extent to 
which symptoms have changed between selection and baseline assessment, 
so we cannot estimate this inﬂuence on the performance of our prediction 
rules. This is another important reason why we want to stress the 
importance of validating the prediction rules in a daily practice situation, 
for which they have been developed.
In conclusion, we think these results are promising to test the performance 
of the prediction rules in a daily practice setting. The performance of the 
prediction rule for the long term (persistent symptoms at 6 weeks) in a 
daily practice situation is questionable given its poor performance in the 
derivation and validation cohort.
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Predictors
A longer duration of symptoms at baseline, gradual onset of shoulder 
complaints, and more severe pain intensity were associated with a poorer 
prognosis at both 6 weeks and 6 months. Furthermore, concomitant 
psychological complaints, repetitive movements, and more severe neck pain 
scores at physical examination were associated with persistent symptoms 
at 6 weeks. A poor prognosis at 6 months was additionally predicted by 
concomitant back pain and more severe shoulder pain scores at physical 
examination. In line with our systematic review of the literature we could 
conﬁrm the association between more severe pain intensity and outcome. 
A longer duration of sick leave prior to consultation, more severe shoulder 
pain, strain (overuse) as a result of usual activities and concomitant 
psychological complaints were associated with a higher risk of sick leave 
during 6 months following ﬁrst consultation. We could not conﬁrm the 
strong evidence found in our review for age between 45 and 54 years as a 
predictor of poor outcome. 
An important message of this study is that the strongest predictors of 
outcome were disease characteristics, results of physical examination, 
a single work-load factor, and a single yes or no question regarding 
concomitant psychological complaints. 
Psychological factors
A priori we expected associations between psychological (such as distress, 
somatization, fear and avoidance) and work related psychosocial factors 
(such as decision authority, job demands) in predicting the outcome of 
shoulder pain in primary care. No psychological factors where selected 
in our prediction models, except a single yes or no question regarding 
concomitant psychological complaints. For the applicability of the 
prediction rules in primary care this is an advantage, because in a prediction 
rule easy to measure predictors are preferred above predictors which 
are measured with time taking full-length questionnaires. In chapter 8 
we speciﬁcally studied the role of psychological factors, and found that 
in particular somatization and catastrophizing thoughts play a more 
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important role in the transition from acute to chronic pain in low back 
pain than in shoulder pain. Despite more chronic pain at presentation 
and a poorer prognosis, baseline scores on most psychological factors were 
lower in patients with shoulder pain and associations with outcome were 
weak and non-signiﬁcant. Only in patients who already reported chronic 
shoulder pain at baseline catastrophizing thoughts predicted a poor 
outcome at follow-up.
Absolute risks
As shown in our review most prognostic studies present their results in 
terms of RRs or ORs. For the patient (and the physician) these measures 
are not easy to interpret. We feel it is an important strength of our study 
that with the prediction rules rule absolute risks are calculated. 
Score charts
In this thesis we developed three score charts. With this charts the 
physician can calculate the risk of persistent shoulder symptoms at 6 weeks 
and 6 months after consultation and the risk of shoulder pain related sick 
leave during 6 months following ﬁrst consultation. The sum of the scores 
correspond with the risk of a poor outcome. We present our prediction 
rules as score charts because we think this as an easy-to-use tool, which 
facilitates the calculation of an individual patient’s risk in daily practice. 
It is important to present the predicted risks with some estimate of 
uncertainty. It is possible to present 95% Conﬁdence Intervals (CI) along 
with the calculated absolute risk derived with the prediction rule. This 
will provide the physician with information about the precision of  the 
estimate. We decided to present the calculated risks in categories of at least 
10%. These categories incorporates some uncertainty of the estimates, but 
are easy to understand and convey to the patient. As possible answers to 
questions of patients regarding his or her prognosis we have phrases in 
mind like: “You have 20-30% risk that your symptoms will persist for at 
least 6 weeks”.
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Conclusions
· In our systematic review we found little evidence for most factors 
which in the current literature are suggested to be of prognostic 
importance in patients with shoulder pain.
· The total costs (€ 689) in the 6 months following ﬁrst consultation in 
primary care are not very high. Only a small proportion (12%) of the 
population generated 74% of the total costs. 
· The prediction rule for the short term (6 weeks) prognosis of 
shoulder pain in general practice showed satisfactory performance 
in the derivation cohort and adequate generalisability to another but 
comparable population. 
· Predicting long term (6 months) outcomes of shoulder pain in 
general practice is diﬃcult; our prediction rule was not very successful 
in discriminating between patients with or without persistent 
symptoms. 
· The prediction rule for shoulder pain related sick leave showed 
satisfactory performance in the derivation cohort and adequate 
generalisability to another primary care population with shoulder 
pain. It performed less well in the merged control groups of the DSS.
· Psychological factors hardly inﬂuence the risk of a poor outcome in 
patients with shoulder pain.
Recommendations 
Future research
It is important to validate the developed prediction rules in a new set 
of patients and test their performance in daily practice. In other words, 
our prediction rules should be tested when the GP at ﬁrst consultation 
calculates the risk of persistent symptoms at 6 weeks and optionally at 6 
months, respectively the risk of shoulder pain related sick leave during the 
6 months following ﬁrst consultation.
Most importantly, the clinical usefulness of the rules should be established: 
can the prediction rules be helpful to the clinician when making decisions 
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in the management of patients with shoulder pain, for example, whether 
or not to consider additional diagnostic testing, start a certain treatment 
or refer the patient to secondary care.19 For this, the prediction rules could 
be tested in a randomised controlled trial. The question could be studied 
whether a subgroup having a high risk of persistent symptoms according 
to the prediction rule would beneﬁt more from a certain treatment than 
patients with a low risk of persistent symptoms. Such information could 
have an inﬂuence on daily practice. Patients with low risks of persistent 
symptoms could receive a wait-and-see policy, while patient with high 
risks of persistent symptoms would receive more extensive treatment, i.e. 
injection, physical therapy, or referral to secondary care.
Daily practice 
The prediction rule can be helpful in daily practice for GPs or other 
physicians to obtain an estimation of a patients prognosis of shoulder pain 
or the risk of shoulder pain related sick leave. Furthermore, it can provide 
patients with an adequate answer to questions regarding their prognosis as 
‘How long will my shoulder pain persist?’ or ‘When will I be recovered?’. 
The prediction rule for sick leave is not developed from a patients 
perspective, but to provide physicians insight in the risk of a patient 
reporting shoulder pain related sick leave in the 6 months following ﬁrst 
consultation for shoulder pain.
Futuristic recommendations
In the Appendix we present a digital score chart, which combines the three 
prediction rules of this thesis. In the future following history taking and 
physical examination, a GP enters the responses to the questions of the 
prediction rules (Appendix) into a personal computer (PC) or personal 
digital assistant (PDA), which after pushing the knob ‘Calculate risk!’ 
provides an estimate of the risk of persistent symptoms and sick leave for 
a patient with shoulder pain. In a latter stage the rule will have to change 
into a decision rule, providing recommendations regarding treatment that 
may be most beneﬁcial for that particular patient. 
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Appendix  Digital score chart 
Prediction of outcome of shoulder pain
Anamnesis
1 How many weeks ago did your 
shoulder complaints start?
 <6 weeks  6-12 weeks  >3 months
2 Did you have to stay home from work because of 
shoulder pain in the past 2 months?
 0 weeks  0-1 weeks  >1 week
3 Did your complaints start gradually 
(within a few days)?
 yes  no
4 In your opinion, are your complaints caused by 
overuse or strain doing usual activities?
 yes  no
5 Do you often perform repetitive movements in 
your work or spare time (on at least 2 days/week)?
 yes  no
6 Do you also have low back pain?  yes  no
7 Do you have any psychological complaints, 
such as distress, depression, or anxiety?
 yes  no
8 How do you rate your shoulder pain on a scale 
between 0 and 10? (0=no pain; 10=most severe pain)
          
0 1 2 3 4 5 6 7 8 9 10
Physical examination
 Shoulder pain score none little much severe
Abduction (active)    
Abduction (passive)    
Exorotation (passive)    
Impingement    
‘Hand in back’    
‘Hand in neck’    
 Neck pain score (passive) none little much severe
Forward ﬂexion    
Extension    
Rotation in neutral position    
Rotation in ﬂexed position    
Rotation in extended position    
Lateral bending    
Calculate risk!
Risk of persistent symptoms at 6 weeks %
Risk of persistent symptoms at 6 months %
Risk of sick leave during 6 months %
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11
Summary

This thesis presents the results of a study which was carried out within the 
framework of a large research program: The Dutch Shoulder Study (DSS). 
The DSS is a comprehensive cohort study, carried out between January 
2000 and May 2005. The DSS consists of a prognostic cohort study 
(presented in this thesis) and three randomised controlled trials, which 
were carried out alongside each other. Shoulder pain is common and has an 
unfavourable outcome in many patients. In this thesis ﬁrstly the literature 
on the prognosis of shoulder pain was systematically reviewed (Chapter 
2). Subsequently, the total costs during 6 months after ﬁrst consultation 
generated by patients experiencing shoulder pain were estimated (Chapter 
3). Then, the main objectives of this thesis were studied: derive and 
validate clinical prediction rules for persistent shoulder symptoms at 6 
weeks and 6 months after ﬁrst consultation, and to predict shoulder pain 
related sick leave during 6 months following ﬁrst consultation (Chapter 
4-7). Subsequently, the association between psychological factors and the 
persistence of shoulder pain was studied (Chapter 8). Finally, the results 
were critically reviewed and ﬁnal conclusions and recommendations for 
future research were given (Chapter 9).
In Chapter 2 the literature was systematically scored and 16 studies focusing 
on the prognosis of shoulder disorders were identiﬁed. The methodological 
quality of these 16 studies was assessed. Six of these were considered to be 
of relatively ‘high quality’. There was a wide variety among the studies in 
length of follow-up, study population, evaluated prognostic factors, type of 
outcome measure and method of analysis. Due to this large heterogeneity, 
we refrained from statistical pooling. Instead, we used a best-evidence 
synthesis. There was strong evidence that high pain intensity predicted a 
poorer outcome in primary care populations and that middle age (45-54) 
was associated with poor outcome in occupational populations. There was 
moderate evidence that a long duration of complaints, and high disability 
score at baseline predicted a poorer outcome in primary care. These results 
need to be interpreted with caution because of the small number of studies 
on which these conclusions are based, and the large heterogeneity among 
studies regarding follow-up, outcome measures, and analysis.
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In Chapter 3 shoulder pain related costs during the 6 months after ﬁrst 
consultation in general practice were determined. Information on the costs 
associated with health care use and loss of productivity in patients with 
shoulder pain is very scarce. A prospective cohort study with 6 months 
of follow-up was conducted among 587 patients with a new episode 
of shoulder pain. Data on costs were collected by means of a cost diary 
during 6 months. The mean consumption of direct health and non-health 
related care was low. The total costs in the 6 months after ﬁrst consultation 
in primary care, mostly generated by a small part of the population, were 
not very high (€ 689). Almost 50% of this concerned indirect costs, caused 
by sick leave from paid work. A small proportion (12%) of the population 
generated 74% of the total costs. However, after 6 months 46% of the 
patients still reported persistent symptoms. More extensive research with 
a longer follow-up is needed. It is important to include patients with 
fractures, dislocation, or previous surgery to accurately estimate the total 
costs of illness for patients consulting with shoulder pain in primary care. 
These patients were not included in our inception cohort, but possibly 
generate substantial costs.
In Chapters 4 and 5 clinical prediction rules for persistent shoulder 
symptoms at 6 weeks and 6 months after ﬁrst consultation were derived 
and validated. To develop a clinical prediction rule for calculating the 
absolute risk of persistent shoulder symptoms for individual patients, a 
prospective cohort study with 6 months follow-up was conducted among 
587 patients with a new episode of shoulder pain. Potential predictors 
included the results of a physical examination, sociodemographic variables, 
disease characteristics (duration of symptoms, pain intensity, disability, 
comorbidity), physical activity, physical workload, and psychosocial 
factors. The main outcome measure was persistent symptoms at 6 weeks 
and 6 months as perceived by the patient. Response rates to the follow-
up questionnaires were 83% at 6 weeks and 92% at 6 months. The 
following factors were associated with persistent symptoms at 6 weeks in 
a multivariable model: long duration of symptoms, gradual onset of pain, 
high pain intensity, concomitant psychological complaints, repetitive 
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movements, and increased neck pain score at physical examination. 
Persistent symptoms after 6 months were predicted by a long duration of 
symptoms at ﬁrst consultation, gradual onset of pain, high pain intensity, 
concomitant low back pain, and increased shoulder pain score at physical 
examination. The discriminative validity was satisfactory with area under 
the curves of 0.74 (95% CI 0.70; 0.79) at 6 weeks and 0.67 (95% CI 0.63; 
0.71) at 6 months.
The generalisability of these prediction rules was evaluated by applying them 
to a diﬀerent but comparable population of patients with a new episode of 
shoulder pain consulting their general practitioner. The control groups of 
the trials of The Dutch Shoulder Study were merged (n=212), and used to 
validate the prediction rules. Generalisability of the prediction rules was 
tested by studying calibration and discrimination in the validation cohort. 
The prediction rule for short term outcome (6 weeks) showed reasonable 
calibration and discriminative ability in the validation cohort. The area 
under the ROC curve (AUC) was 0.72 compared to 0.74 in the derivation 
cohort. The prediction rule for long term outcome (6 months) performed 
less well. Discriminative ability (AUC) decreased to 0.56 in the validation 
cohort compared to 0.67 in the derivation cohort. The prediction rule for 
the short term prognosis of shoulder pain in general practice showed good 
generalisability, whereas the prediction rule for long term outcome showed 
poor generalisability. Hence, it seems diﬃcult to make accurate predictions 
of the long term outcome of shoulder pain in general practice. 
 
In Chapters 6 and 7 a prediction rule for shoulder pain related sick leave 
during 6 months following ﬁrst consultation was derived and validated. 
To develop the clinical prediction rule for calculating the risk of shoulder 
pain related sick leave for individual workers, 350 workers with a new 
episode of shoulder pain from the prognostic cohort study were used. 
Potential predictors included the results of a physical examination, 
sociodemographic variables, disease characteristics (duration of symptoms, 
sick leave in the 2 months prior to consultation, pain intensity, disability, 
comorbidity), physical activity, physical workload, and (work related) 
psychosocial factors. The main outcome measure was sick leave during 6 
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months following ﬁrst consultation in general practice. Response rate to 
the follow-up questionnaire at 6 months was 85%. During the 6 months 
after ﬁrst consultation 30% of the workers reported sick leave. 16% 
reported 10 days sick leave or more. Sick leave during this period was 
predicted in a multivariable model by a longer duration of sick leave prior 
to consultation, more shoulder pain, strain (overuse) as a result of usual 
activities, and concomitant psychological complaints. The discriminative 
ability of the prediction model was satisfactory with an area under the 
curve of 0.70 (95% CI 0.64; 0.76). Although 30% of all workers with 
shoulder disorders reported sick leave during follow-up, the duration of 
sick leave was limited to a few days in most workers. 
The generalisability of this prediction rule was evaluated by testing it in 
two other populations of workers consulting for a new episode of shoulder 
pain in primary care. Again, the control groups of the trials were merged. 
All workers were selected (n=128), and used to validate the prediction 
rule. Besides this population, the recently conducted Musculoskeletal 
Disorder Study (BAS) (n=224) was used to validate the prediction rule. 
Generalisability of the prediction rule was tested by studying calibration 
and discrimination in the validation cohorts. The prediction rule showed 
reasonable calibration in both validation cohorts. The discriminative 
ability, with an area under the ROC curve (AUC) of 0.70 in the derivation 
cohort was stable in the BAS cohort (AUC 0.71). In the control groups of 
the three RCTs of the DSS the discriminative ability decreased to an AUC 
of 0.66. The prediction rule for shoulder pain related sick leave during 
6 months following ﬁrst consultation in primary care showed adequate 
generalisability to another population of workers with shoulder pain 
participating in an observational cohort study. In the control groups of the 
three RCTs the prediction rule performed less well. 
Chapter 8 studied the inﬂuence of psychological factors on the risk of 
persistent symptoms and disability at three months after consultation 
in patients with shoulder pain or low back pain in general practice. 
Psychological factors are assumed to be of prognostic importance and 
to predict the transition from acute to persistent pain. The inﬂuence of 
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psychological factors has mainly been studied in low back pain, but may 
be equally important in other types of pain. Patients presenting in general 
practice with a new episode of shoulder pain in our prognostic cohort study 
were compared with patients of  prospective cohort study on (sub)acute low 
back pain. In both patient groups psychological factors (catastrophizing 
thoughts, distress, somatization, and fear-avoidance beliefs) were measured 
at baseline. Primary outcome measures after three months were 1) persistent 
symptoms, and 2) less than 30% reduction in functional disability. Logistic 
regression analyses were used to study the association between baseline 
scores on psychological factors and outcome. Interaction with symptom 
duration at baseline was studied for each of the psychological factors. A 
total of 587 patients with shoulder pain and 171 patients with low back 
pain were enrolled in the study. Drop-out rate at three months was 12% 
in patients with shoulder pain and 4% in patients with low back pain. 
In patients with shoulder pain most associations of psychological factors 
with outcome were weak and not statistically signiﬁcant. In patients with 
(sub)acute low back pain catastrophizing thoughts and somatization 
were strongly and signiﬁcantly associated with a higher risk of persistent 
symptoms and disability at follow-up. Psychological factors, in particular 
somatization and catastrophizing thoughts, are more strongly associated 
with persistent pain and disability in patients who consult their general 
practitioner for low back pain than in patients with shoulder pain. This 
seems to indicate that diﬀerent mechanisms may explain the progression 
to persistent symptoms among patients with diﬀerent types of pain in 
primary care. Additional research is needed to conﬁrm these ﬁndings and 
further explore the role of psychological factors in the development of 
chronic pain problems.
Finally, in Chapter 9 the results of this thesis are critically reviewed and 
conclusions are presented. An important message of this study is that the 
strongest predictors of outcome were disease characteristics, results of 
physical examination, a single work-load factor, and a single yes or no 
question regarding concomitant psychological complaints. We think that 
the presented prediction rules for short term outcome and sick leave are 
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promising enough to test their clinical usefulness in a daily practice setting. 
The performance of the prediction rule for long term outcome (persistent 
symptoms at 6 months) in a daily practice situation is questionable, given 
its poor performance in the derivation and validation cohort.
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11
Samenvatting

Schouderklachten komen veel voor. Herstel van de klachten duurt lang bij 
veel mensen. Bij ongeveer 50% van de patiënten zijn de schouderklachten 
na een half jaar nog steeds aanwezig. In dit proefschrift worden scorekaarten 
gepresenteerd waarmee de huisarts een voorspelling kan doen over de 
prognose van een patiënt met schouderklachten. 
Hoofdstuk 2 bevat een systematische beoordeling op kwaliteit van 
alle beschikbare wetenschappelijke literatuur over de prognose van 
schouderklachten. De kosten die met schouderklachten gepaard gaan zijn 
geschat in Hoofdstuk 3. In Hoofdstuk 4 tot en met Hoofdstuk 7 worden de 
scorekaarten gepresenteerd waarmee de huisarts de kans op het voortduren 
van de schouderklachten na 6 weken en na 6 maanden kan berekenen, 
samen met de kans op ziekteverzuim in de 6 maanden na het eerste 
consult. In Hoofdstuk 8 wordt de relatie tussen psychosociale variabelen 
en het voortduren van schouderklachten beschreven. Uiteindelijk worden 
in Hoofdstuk 9 de resultaten van dit proefschrift kritisch onder de loep 
genomen, conclusies getrokken en aanbevelingen voor toekomstig 
onderzoek gegeven.
In Hoofdstuk 2 zijn na het systematisch doorzoeken van de literatuur 
16 onderzoeken gevonden die betrekking hebben op de prognose 
van schouderklachten. Zes van deze onderzoeken waren van relatief 
hoge methodologische kwaliteit. De studies bleken nogal te verschillen 
met betrekking tot de lengte van de follow-up, kenmerken van de 
onderzoeksgroep, onderzochte prognostische factoren, type uitkomstmaten 
en statistische analyse. Om conclusies te kunnen trekken is er een analyse 
uitgevoerd waarbij de kwaliteit en de resultaten van elk onderzoek gewogen 
zijn. Er bleek sterk bewijs te bestaan dat patiënten met veel pijn bij het 
eerste bezoek aan de huisarts een minder gunstige prognose hadden dan 
patiënten met milde pijnklachten. Bij werknemers met schouderklachten 
bleek een leeftijd tussen de 45 en 54 jaar een ongunstige invloed te hebben 
op de prognose. Er was verder matig bewijs dat een lange klachtenduur 
voorafgaande aan het eerste bezoek aan de huisarts en het hebben van veel 
beperkingen in dagelijkse activiteiten een ongunstige invloed hebben op 
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de prognose van schouderklachten. Deze conclusies moeten echter met 
de nodige terughoudendheid worden bekeken, omdat er nog maar weinig 
onderzoek is uitgevoerd en er grote variatie is in de kwaliteit en de opzet 
van de beschikbare onderzoeken. 
Hoofdstuk 3 omvat de kosten die gepaard gaan met schouderklachten 
in de 6 maanden na het eerste bezoek aan de huisarts. Informatie over 
kosten van de medische zorg en verlies van productiviteit ten gevolge 
van schouderklachten (werkverzuim en arbeidsongeschiktheid) is op 
dit moment schaars. Om de kosten te schatten hebben 587 patiënten 
gedurende 6 maanden een kostendagboek bijgehouden. De totale kosten 
in 6 maanden na het eerste bezoek aan de huisarts waren niet erg hoog 
(gemiddeld € 689 per patiënt). Bijna 50% van dit bedrag is veroorzaakt 
door indirecte kosten als gevolg van ziekteverzuim. Slechts een klein deel 
van de 587 patiënten (12%) was verantwoordelijk voor het grootste deel 
(74%) van de totale kosten. Dit is opvallend omdat 46% van alle patiënten 
na 6 maanden nog steeds schouderklachten rapporteren. In dit onderzoek 
zijn patiënten met fracturen, dislocaties, of patiënten die chirurgisch zijn 
behandeld uitgesloten van deelname. Toekomstig onderzoek naar de kosten 
van schouderklachten zou deze patiëntengroep wel kunnen insluiten en 
alle deelnemers gedurende langere tijd moeten vervolgen, zodat de totale 
kosten van schouderklachten in Nederland nauwkeurig kunnen worden 
geschat.
In Hoofdstuk 4 en 5  worden scorekaarten gepresenteerd die zijn 
ontwikkeld en getest voor het berekenen van de kans op het voortduren 
van schouderklachten na 6 weken en na 6 maanden. Aan dit onderzoek 
werkten 587 patiënten mee die de huisarts voor schouderklachten 
consulteerden. Kort na het eerste consult werden een groot aantal 
factoren gemeten die mogelijk van invloed zijn op de prognose van 
schouderklachten. De patiënten ontvingen 6 weken en 6 maanden later 
een vragenlijst over het beloop van hun klachten. De factoren die het 
voortduren van schouderklachten na 6 weken bleken te voorspellen waren: 
lange klachtenduur voorafgaand aan het eerste consult bij de huisarts, het 
geleidelijk ontstaan van de klachten, hoge schouderpijn score, bijkomende 
psychische klachten, het uitvoeren van herhaalde bewegingen en veel 
nekpijn tijdens het lichamelijk onderzoek. Factoren die het voortduren van 
de klachten na 6 maanden voorspelden waren: een lange klachtenduur, het 
geleidelijk ontstaan van de klachten, hoge schouderpijn score, bijkomende 
lage rugklachten en veel schouderpijn tijdens het lichamelijk onderzoek. 
De scorekaarten bleken redelijk goed in staat mensen met een hoge kans 
te onderscheiden van patiënten met een lage kans op het voortduren van 
hun schouderklachten.
Na het testen van de scorekaarten in een andere groep van patiënten met 
schouderklachten bleek de scorekaart voor 6 weken nog steeds redelijk 
goed te voorspellen. De scorekaart voor het voorspellen van klachten na 6 
maanden presteerde stukken minder en voegde niet veel informatie toe aan 
een voorspelling op basis van toeval. Het blijkt dus moeilijk uitspraken te 
doen over de lange termijnprognose van een patiënt met schouderklachten 
met behulp van een scorekaart die vlak na het eerste consult bij de huisarts 
wordt ingevuld.
Hoofdstuk 6 en 7 behelst een andere scorekaart die is ontwikkeld en getest 
om aan schouderklachten gerelateerd ziekteverzuim te voorspellen in 6 
maanden na het eerste bezoek aan de huisarts. Hiervoor zijn 350 werknemers 
geselecteerd en gedurende 6 maanden na het eerste consult gevolgd. 
Gedurende de 6 maanden na het eerste consult rapporteerde 30% van de 
werkers werkverzuim, van wie 16% 10 dagen of meer verzuimden. Factoren 
die ziekteverzuim voorspellen waren: langere periode van ziekteverzuim 
voorafgaand aan het eerste bezoek aan de huisarts, hoge pijnscore, oorzaak 
van de schouderklachten is overbelasting door gebruikelijke activiteiten en 
bijkomende psychische klachten. De scorekaart was redelijk goed in staat 
mensen met een hoge kans te onderscheiden van patiënten met een lage 
kans op ziekteverzuim. 
De scorekaart is vervolgens getest in twee andere groepen werknemers 
met schouderklachten. De scorekaart presteerde net zo goed in een 
onderzoeksgroep met vrijwel dezelfde kenmerken als de groep waarin de 
kaart ontwikkeld was. De prestaties van de scorekaart waren iets minder 
193
goed in de tweede onderzoeksgroep, die bestond uit de controlegroepen 
van enkele onderzoeken naar de eﬀectiviteit van de behandeling van 
schouderklachten. 
In Hoofdstuk 8 is de invloed bestudeerd van psychologische factoren op 
het voortduren van klachten en beperkingen in dagelijkse activiteiten 
bij patiënten met schouderklachten in vergelijking met patiënten met 
(sub)acute lage rugklachten. Psychologische factoren worden verondersteld 
van invloed te zijn op de ontwikkeling van acute naar chronische pijn. 
Bij schouderpatiënten zijn alleen zwakke associaties gevonden tussen 
psychologische factoren (gemeten direct na het eerste bezoek aan de 
huisarts) en klachten of beperkingen na 3 maanden, die niet statistisch 
signiﬁcant waren. Bij patiënten met lage rugklachten waren ‘catastroferen’ 
en ‘somatisatie’ sterk en signiﬁcant geassocieerd met een hogere kans op 
klachten en beperkingen na 3 maanden. Het lijkt er dus op dat verschillende 
mechanismen een rol spelen in de ontwikkeling van chronische pijn bij 
verschillende soorten pijnklachten. Extra onderzoek is nodig om deze 
bevindingen te bevestigen en om de rol van psychologische factoren in de 
ontwikkeling van chronische klachten aan het bewegingsapparaat verder 
te onderzoeken.
Uiteindelijk wordt in de algemene discussie (Hoofdstuk 9) geconcludeerd 
dat langdurige schouderklachten en ziekteverzuim het sterkst kunnen 
worden voorspeld met ziektekenmerken, uitkomsten van lichamelijk 
onderzoek, een enkele werkgerelateerde vraag en een ja/nee vraag over 
psychische klachten. Het is belangrijk om de klinische toepasbaarheid 
van de scorekaarten voor de korte termijnprognose (6 weken) en voor 
ziekteverzuim te testen in de dagelijkse praktijk. De toepasbaarheid van 
de scorekaart voor de lange termijn (6 maanden) is twijfelachtig, gezien 
de tegenvallende prestaties wanneer de kaart wordt toegepast in andere 
groepen patiënten.
194
Alan Silman • Wim Stalman • Raymond Ostelo • Carl Moons • Monique Frings-Dresen • Bart Koes
Faas • Sandra Bot • 103 huisartsen • 587 patienten • Brahim Oughzou • Cor Brasser • Cees de 
Boer • Wim Kraan • Michel Telkamp • Ellen Visser • Rob de Bie • Marielle Goossens • Jan Winters
Arlette Hesselink • Lonneke van de Poll • Petra Jellema • Koen van der Kooij • Marleen Hermens
Els Licht • Bettine Schreuders • Ingrid Bakker • Esther van Sluijs • Amika Singh • Hein van Hout
Berend Terluin • Els Pronck • Sophal Variosseau • Valentien Blom • Gieter • Antoon & Dorothée
Gouw# • De Passie • De Kutzeeuws • Mariska
Thanks to

Geboren te Oisterwijk 1974
Opleiding Fysiotherapie 
Hogeschool West-Brabant, Breda
1994-1997
Opleiding Bewegingswetenschappen
Universiteit Maastricht
1997-1999
Opleiding Epidemiologie
Universiteit Maastricht
1999
Promovendus 
EMGO-instituut, VU Medisch Centrum
2000-2005
Fysiotherapeut
Paramedicum Utrecht
2000-2003
Didactische opleiding
IDO, VU Amsterdam
2000
Docent Evidence Based Practice 
Landelijke verplichte nascholing voor Fysiotherapeuten
 2002-2003
Onderzoeker/docent
Lectoraat, Amsterdamse Hogeschool voor Paramedische opleidingen
2005 
Adviseur Richtlijnen/Indicatoren
Kwaliteitsinstituut voor de gezondheidszorg CBO 
2005
Curriculum Vitae


frikadel
